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 Bacterioferritin, an iron storage protein having a 24-subunit (α24) quaternary structure, 
was used as a model for the study of host-guest interactions and guest encapsulation, making 
use of its spherical cage-like structure.  A hexahistidine-affinity tag fused to the C-terminus of 
each bacterioferritin subunit was constructed.  The C-terminus of each subunit points toward 
the inside of the cavity, while the N-terminus is exposed on the surface of the protein.  The 
hexaHistag was able to form strong interactions with a nickel-nitrilotriacetic acid linked dye 
molecule (guest) and this interaction was used in attempts to develop a principle to control 
guest molecule encapsulation within the spherical cavity of the 24-mer bacterioferritin protein 
molecule.  The procedure involved (1) subunit dissociation under acidic pH, (2) affinity 
controlled dye-Histag binding with exposed C-terminal (His)6 residues and (3) reassociation of 
the subunits at neutral pH.  The encapsulation conditions involving step 1 and 3 were studied 
preliminarily using laser light scattering to measure size (hydrodynamic radius) of the protein 
particle with apoferritin as a model system as it resembles the size and structure of 
bacterioferritin.  In order to encapsulate guest molecules, the emptied shell of bacterioferritin 
was generated by site-directed mutagenesis resulting in ferroxidase- as well as heme-free 
bacterioferritin mutants (E18A/M52L/E94A), and these mutants were used to examine protein 
stability before conducting encapsulation experiments.  However, wild-type bacterioferritin 
possessed highest stability in maintaining its multisubunit structure; hence, it was used for the 
encapsulation studies.  It was found that 100% bacterioferritin with His6-tag at the C-terminus, 
and a combination of 60% bacterioferritin with His6-tag at the C-terminus and 40% 
bacterioferritin without His6-tag at the C-terminus yielded similar amounts of encapsulated 
 iv
guest molecules.  This suggested that all hexahistidine at the C-terminus were not equally 
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CHAPTER 1: INTRODUCTION 
 
1.1: Bacterial Iron Homeostasis 
1.1.1: Role of Iron in Living Organisms 
Iron is the fourth most abundant metal in the earth’s crust and is essential to virtually all 
organisms (Köster, 2001).  It participates in many major biological processes such as 
photosynthesis, N2 fixation, methanogenesis, H2 production and consumption, respiration, the 
tricarboxylic acid cycle, oxygen transport, gene regulation, and DNA biosynthesis (Andrews et 
al., 2003; Massé and Arguin, 2005).  It is also an extremely versatile prosthetic component for 
incorporation into proteins as a biocatalyst or electron carrier (Smith, 2004).  It mainly exists in 
one of two readily interconvertible redox states: the reduced Fe2+ ferrous form and the oxidized 
Fe3+ ferric form.  However, oxidation of the ferrous ion pool to the ferric form creates two 
problems.  Firstly, iron can be extremely toxic from the reaction of Fe(II) and dioxygen 
yielding the production of intermediate reactive oxygen species.  Therefore, it is important for 
cells to find suitable systems for managing cellular iron.  Secondly, Fe(III) has poor solubility 
under aerobic conditions at neutral pH.  This prevents its use as a readily bioavailable iron 
source, because storage of non-soluble Fe(III) is needed to be converted to soluble Fe(II) 
before use in living organisms. 
Oxidative stress is a universal phenomenon experienced by both aerobic and anaerobic 
organisms.  The cellular stress is caused by intracellular reactive oxygen species (ROS) that 
can generate a mixture of superoxide (O-•2) and hydrogen peroxide (H2O2) as products (Smith, 
2004).  From this mixture, superoxide can react with a ferric iron (Fe3+) yielding soluble 
ferrous iron (Fe2+) and dioxygen (O2) (Eq. 1).  Then, hydrogen peroxide, a powerful oxidant, is 
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able to react with free ferrous iron generating damaging hydroxyl radicals (HO•) through the 
Fenton reaction (Eq. 2).  The combination of theses two reactions is called the Haber-Weiss 
reaction (Wiedenheft et al., 2005; Andrews et al., 2003) (Eq. 3). 
 
O-•2 + Fe3+ → Fe2+ + O2    [1] 
Fe2+ + H2O2 → Fe3+ + OH- + HO•   [2] 
O-•2 + H2O2 → O2+ OH- + HO•   [3] 
 
Hydroxyl radicals can induce lipid peroxidation, DNA strand breaks, and degradation of 
various biomolecules (Andrews, 1998; Harrison and Arosio, 1996).  In order to avoid 
deprivation or over-abundance of iron, bacteria and eukaryotes have developed a tight 
regulatory system to keep this metal within a narrow concentration range. 
There are five strategies to regulate iron.  Firstly, high affinity iron transporters enable 
iron to be scavenged in various forms from the organism’s environment.  Secondly, 
intracellular iron is stored and released depending on the limitation of external supplies.  
Thirdly, employment of redox stress resistance systems such as degradation of iron-induced 
reactive oxygen species and repair of redox stress-induced damage determine the amount of 
iron in cells.  In addition, iron consumption is controlled by down-regulating the expression of 
iron-containing proteins under iron-restricted conditions.  Lastly, iron responsive regulatory 
systems coordinate the expression of the above iron homeostatic machinery according to iron 




1.1.2: Iron Transporters 
There are at least five systems that can secrete extracellular iron to the cytoplasm.  
These include siderophore-based iron acquisition, ferrous iron transport, ferric reduction, 
metal-type ATP binding cassette transporters, low-affinity iron transport, and iron acquisition 
by pathogens. 
 
Siderophore-based Iron Acquisition 
There are three ways to solubilize ferric oxides including lowering the external pH to 
render ferric iron more soluble, reducing ferric iron to the relatively soluble ferrous form, and 
employing ferric ion chelators as solubilizing agents (Guerinot, 1994).  In the last case, 
extracellular Fe3+ can be secreted and solubilized by high affinity extracellular ferric chelators, 
called siderophores, prior to transport (Wandersman and Delepelaire, 2004).  Gram-negative 
bacteria take up iron-siderophore complexes via specific outer membrane (OM) receptors 
(such as Cir, FecA, FepA, FhuA, FhuE, and Fiu in Escherichia coli K12), which are driven by 
the cytosolic membrane (CM) potential (Andrews et al., 2003) (Figure 1.1A).  Other sources of 
iron such as ferric citrate, heme, lactoferrin, and transferrin are also recognized by siderophores 
(Köster, 2001; Bullen et al., 1978).  These iron-siderophore complexes are transported across 
the OM by the energy-transducing TonB-ExbB-ExbD system, because they are too large to 
diffuse through the channels.  Then, periplasmic binding proteins shuttle ferri-siderophores 
from the OM receptors to ATP binding cassette transporters (FecBCDE, FepBCDEFG, and 
FhuBCD) that deliver ferri-siderophores to the cytosol, where the complexes are likely 
dissociated by reduction to the soluble form of iron (Fe2+) and sequestered into iron-utilizing 
proteins (Litwin and Calderwood, 1993).  Gram-positive bacteria lacking an OM require 
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neither OM receptors nor the TonB-ExbB-ExbD system to allow ferri-siderophores to traverse 
their CM (Figure 1.1B).  The protein-dependent ATP binding cassette permeases found in 
Gram-negative species are also employed in Gram-positive organisms.  These binding proteins 
are generally lipoproteins tethered to the external surface of the CM. 
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Ferrous Iron Transport and Ferric Reduction 
 This system traverses ferrous iron via Feo, the protein encoded by anaerobically 
induced iron-repressed feoAB genes (Kammler et al., 1993).  This iron transport system 
consists of three types of proteins; FeoA, FeoB, and FeoC (Cartron et al., 2006).  FeoA is a 
small, soluble SH3-domain protein consisting of 75-amino acid, while FeoB consists of 773 
amino acid residues.  The FeoB N-terminus possesses G protein functionality (Marlovits et al., 
2002).  It also has a C-terminal integral inner-membrane domain, which forms two motifs 
(gates) locating in the CM allowing Fe2+ to pass through from the OM and periplasm (Figure 
1.2).  In order for Fe2+ to go across the CM, it needs an ATP/GTP-driven active transport 
process for FeoA, which is required for maximum FeoB activity (Kammler et al., 1993).  FeoC 
consists of 78 residues and functions as an iron-sulfur ([Fe-S])-dependent transcriptional 
repressor (Cartron et al., 2006).  The hydrophilic FeoC is only associated with γ-













Figure 1.2: Schematic representation of ferrous iron uptake by Feo system in E. coli (the Figure is 
derived from Cartron et al., 2006). 
 
 
Metal-type ATP binding cassette transporters 
Under anaerobic conditions, ferric iron can be transported without involving any 
chelators.  Another type of bacterial iron transporter is the metal-type ATP binding cassette 
(ABC) systems that is specific to iron but does not necessarily require OM receptors or 
siderophores (Köster, 2001).  The ferric iron is delivered into the periplasm via receptor 



















Low-affinity Iron Transport 
Low affinity transport may be non-biological (i.e. iron binding to the cell surface) since 
in the absence of the high-affinity Feo system, this modality of uptake does not facilitate 
normal growth even in the presence of high iron concentrations (Velayudhan et al., 2000). 
 
Iron Acquisition by Pathogens 
The problems that bacteria face in acquiring sufficient iron from their surroundings are 
particularly pronounced for pathogens.  Pathogens often use low environmental iron levels as a 
signal for the induction of virulence genes (Litwin and Calderwood, 1993).  Pathogens are able 
to counter the iron restriction imposed by their hosts through the use of siderophores (Andrews 
et al., 2003). 
 
1.1.3: Iron Storage Proteins and Their Applications 
Iron storage proteins are widely distributed among prokaryotes, archaea, high- and low-
G+C gram-positive bacteria, cyanobacteria, Bacteroides, Thermotogales, and all four 
subdivisions of the Proteobacteria, suggesting that the facility to store iron is an important 
general requirement of prokaryotes (Abdul-Tehrani et al., 1999).  Iron is presented within the 
cells of living organisms either in iron-containing protein and enzyme complexes or in iron-
storage proteins.  It can be incorporated in protein molecules in heme-containing forms.  These 
heme-iron atoms bind to sulfur in various types of [Fe-S] clusters, in mixed-metal centers (e.g. 
containing nickel), as di-iron, or as mononuclear iron centers.  Three types of iron storage 
proteins are recognized in bacteria including the smaller DNA-binding protein from starved 
cells that is unique to prokaryotes, the archetypal ferritins found in eukaryotes, and the heme-
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containing bacterioferritins found only in eubacteria (Smith, 2004).  Although the three types 
of iron storage proteins belong to distinct evolutionary lineages, they are distantly related to 
each other in term of structural and functional similarities (Andrews et al., 1991b).  Iron 
storage proteins take up iron in the soluble ferrous form, but iron is deposited in the central 
cavity in the oxidized and less soluble ferric form. 
 
DNA-binding Protein 
DNA-binding protein from starved cells (Dps) is an approximately spherical 
multisubunit protein consisting of 12 identical subunits with a total molecular weight (MW) of 
~240 kDa.  The protein can store up to 500 iron atoms within the central cavity (Zhao et al., 
2002) (Figure 1.3a).  The outer shell diameter is ~10 nm and the interior diameter is ~5 nm 
(Wiedenheft et al., 2005).  The secondary structure of Dps shows that each subunit is folded 
into a four-helix bundle (A-D) (Figure 1.3b).  The ferroxidase center is located at the interface 
of two-fold symmetry-related subunits such that the iron ligands are contributed by both 
symmetry-related monomers (12-subunit).  The X-ray crystal structure of Listeria Dps 
(previously known as Listeria ferritin) showed that the ferroxidase center contains one bound 
iron coordinated by Glu62 and Asp58 from one subunit, a His31 from the symmetry-related 
subunit, and a water molecule that is located 3 Å from the iron atom, forming a hydrogen bond 
with His43 from the same monomer (Ilari et al., 2005; Ilari et al., 2000) (Figure 1.4).  The 










Figure 1.3: The schematic presents (a) the overall structure of Listeria Dps and (b) its secondary 
structure of one subunit, which consists of helix A (blue), helix B (purple), helix C (green), and 
helix D (yellow) (PDB entry 1QGH) (Ilari et al., 2000).  Each color in (a) represents one subunit, 








Figure 1.4: The iron binding residues (CPK ball and stick display) of Listeria Dps are His31, 
Asp58, Glu62, and a water molecule (blue) with iron atom (yellow) (PDB entry 1QGH) (Ilari et 
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Listeria Dps sequesters iron in three different reaction phases: iron binding to the 
ferroxidase centers, oxidation by dissolved oxygen, and mineralization to form a 
microcrystalline structure (Su et al., 2005).  The overall process of iron deposition and 
detoxification by Listeria Dps is described by the following equations.  
 
For ferroxidation,  
1) Fe2+ binding to each of the 12 sites of LiDps: Fe2+ + DpsZ → [(Fe2+)-Dps]Z+1 + H+  
2) Fe2+ oxidation/hydrolysis: [(Fe2+)-Dps]Z+1 + Fe2+ + H2O2 → [(Fe3+)2(O)2-Dps]Z+1 + 2H+. 
For mineralization,  
1) Fe2+ oxidation/hydrolysis: 2Fe2+ + H2O2 + 2H2O → 2Fe(O)OH(core) + 4H+.  
 
From the mineralization, it has been shown that H2O2, an efficient oxidant, is rapidly used in 
the ferroxidase center of Dps, which simultaneously eliminates the two components of the 
Fenton reaction (Fe(II) and H2O2) that contribute hydroxide radicals.  Upon site-directed 
mutation of the iron binding site in L. innocua Dps, it was found that this iron storage protein is 




Ferritins (FTs) are found in organisms as diverse as bacteria, fungi, plants and 
vertebrates.  Their wide distribution among living species implies a fundamental and ancient 
role in iron metabolism.  The structure of FT, which has been widely studied, is a 24-identical 
subunit protein with a molecular weight of ~480 kDa and forms a rhombic dodecahedral 
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protein shell that encloses up to 4500 iron atoms in an oxide/hydroxide/phosphate core 
(Harrison and Arosio 1996; Theil, 1987; Stillman et al., 2001; Liu and Theil, 2005) (Figure 
1.5a).  The outside diameter of the protein is 12–13 nm and the internal cavity diameter is 7–8 
nm.  Each subunit consists of a four-helix bundle (A-D) and a fifth shorter helix (E) (Figure 
1.5b) forming a cylinder that packs in a hollow shell of 432 (cubic) symmetry.  Mammalian FT 
consists of H- and L-chains (heavy- and light-chains, respectively), which are encoded on 
different chromosomes.  These H- and L-chains consist of 182 and 174 amino acids, 
respectively and share approximately 54% amino acid homology.  This protein shell has eight 
hydrophilic channels along its three-fold axes, six hydrophobic channels along its four-fold 
axes, 12 grooved structures on its interior along two-fold axes, and an intrasubunit ferroxidase 
site located between the four helices of the H subunits.  Each H-chain subunit has a ferroxidase 
center formed by seven amino acid residues, while the L-chain confers nucleation sites for iron 
binding (Chasteen, 1998; Harrison et al., 1998).  The FT ferroxidase center contains di-iron 
binding sites called site A, which uses nitrogen from a histidine residue and carboxyl group 
from acid residues as iron coordinating ligands, and site B where the metal is coordinated only 
by means of carboxyl group (Treffry et al., 1997) (Figure 1.6).  The bound iron atoms are 
separated by 3 Å but are connected by an oxo-bridge of a carboxyl group.  The residues at this 
site are highly conserved and act as ligands for the binding of two ferrous ions, the first step in 
the iron uptake process.  The bound ferrous ion pair is subsequently oxidized by O2 which 
results in the formation of an oxo-bridged di-ferric intermediate.  The ferric iron thus forms 
and migrates to the central cavity where either a ferrihydrite core is formed, or an amorphous 
ferric phosphate core builds up, depending on whether phosphate is present (as is the case in 
vivo) (Mann et al., 1987).  It was also found that the rate of Fe(II) oxidation was maximal for 
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additions of two Fe(II) atoms/subunit, and modification of site A ligands results in slow iron 
binding and slow oxidation, while modification at site B does not prevent Fe(II) binding at site 
A but greatly reduces the oxidation rate (Treffry et al., 1997).  Iron uptake is more efficient in 
the presence of L/H heteropolymers of mammalian FT than with either of the homopolymers.  
The H-chain facilitates ferric ion formation, and the L-chain facilitates the mineralization of 
ferric ion in the cavity.  In general, H-rich FTs are characteristic of brain and heart tissues 
having low iron content when compared with that of L-rich FTs, which are found in typical 
iron-storage organs such as liver and spleen (Carrondo, 2003).  Amphibian red cells contain 
three types of chain, H, L and M (medium), which can form heteropolymers.  When iron is 
needed by the cell, stored iron can be mobilized from FT by reduction of the ferric ion in the 
core.  This is followed by chelation of Fe(II) and removal of the ferrous ion.  FT can serve as a 
source of iron for “housekeeping” purposes, including acting as a source of iron for enzymatic 
active sites, other protein prosthetic groups (i.e. [Fe-S] cluster), and as a mechanism to detoxify 





















       
 
 
Figure 1.5: The ribbon diagrams represent the overall structures of Trichoplusia Ni secreted FT 
(PDB entry 1Z60) (Hamburger et al., 2005) (a) and one subunit structure of human mitochondria 
FT, which shows helix A (blue), helix B (red), helix C (purple), helix D (green), and helix E 































Figure 1.6: The di-iron binding site of the human FT (H-chain) contains Glu27, Tyr34, Glu61, 















The iron-storage protein bacterioferritin (bFT) has been isolated from many organisms 
i.e. Desulfovibrio desulfuricans (Romão et al., 2000b), Escherichia coli (Yariv et al., 1981), 
and Helicobacter pylori (Evans Jr. et al., 1995).  It was found that the production of hydroxyl 
radicals from the in vitro oxidation of ferrous ion by H2O2 was greatly decreased when bFT 
was present, and this process did not lead to the production of a hydroxyl radical as occurs in 
the Fenton reaction (Bou-Abdallah et al., 2002).  In this thesis, Escherichia coli bFT will be 
focused upon and discussed in more detail in the introduction to the Escherichia coli 
bacterioferritin section. 
Unlike mammalian or bacterial FT, bFT contains a cytochrome b component (heme 
group) (Yariv et al., 1981).  In early studies, there was some evidence indicating that bFT 
forms a protein family that was distinct from FT.  In a study of Azotobacter chroococcum bFT, 
it was found that antibodies directed against bFT did not cross-react with human and horse FT, 
but partially cross reacted with plant FT purified from lentil seeds (phytoferritin) (Chen and 
Crichton, 1982).  Similar results were found based on research of the immunological properties 
of Escherichia coli, Pseudomonas aeruginosa, and Azotobacter vinelandii bFT when compared 
with FT from plants and animals (Andrews et al., 1991a).  Besides, the prediction of 
preliminary structure based on N-terminal amino acid analysis combined with chemical 
modification of Escherichia coli bFT showed no homology between FT and bFT (Tsugita and 
Yariv, 1985).  Despite their low sequence similarity (~23% identity between Escherichia coli 
bFT and horse spleen FT amino acid residues) (Figure 1.7), the complete sequence of 
Escherichia coli bFT, the conservation of ferroxidase centre residues, and X-ray 
crystallographic results do indicate evolutionary relatedness between bFT and FT.  Both 
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proteins are similar in molecular weight, subunit weight, amino acid composition, isoelectric 
point (pI), size, and shape (Andrews et al., 1989b; Andrews et al., 1991b; Lawson et al., 1991; 
Frolow et al., 1994; Dautant et al., 1998).  Sequence alignment and model-building studies 
have also shown that FT and bFT have similar subunit conformations and quaternary structure 
(Grossman et al., 1992; Cheesman et al., 1993).  X-ray crystallography of bFT has also been 
studied recently for Azotobacter vinelandii (Liu et al., 2004), Desulfovibrio desulfuricans 
(Macedo et al., 2003), Escherichia coli (Frolow et al., 1994; Dautant et al., 1998), and 
Rhodobacter capsulatus (Cobessi et al., 2002) to gain more knowledge of bFT structural and 
functional properties.  
While E. coli bFT is the most frequently investigated study case currently, bFT from A. 
vinelandii had been studied previously and focused on structural and magnetic properties of the 
iron core (Stiefel and Watt, 1979; Mann et al., 1987).  It was found that A. vinelandii bFT 
consists of two non-identical subunits (Harker and Wullstein, 1985) similar to bFTs from P. 
aeruginosa and P. putida (Moore et al., 1986; al-Massad et al., 1992; Miller et al., 2000), 
while most bFTs from other bacteria such as E. coli consist of only one type of subunit.   
The maximum number of heme groups (heme IX) that can bind in each organism is 
varied.  There are normally 12 heme groups per 24 subunits in bFT from A. vinelandii (Stiefel 
and Watt, 1979) and E. coli (Smith et al., 1988; Yariv et al., 1981).  These proteins will not 
bind additional heme (Smith et al., 1989).  However, it has also been found that there are 5-9 
hemes per 24 subunits in P. aeruginosa (Moore et al., 1986) with the maximum binding of 24 
heme groups per 24 subunits (Kadir and Moore, 1990).  The difference in maximum heme 
binding suggests different protein shell configurations.  This may result from half-of-sites 
reactivity of A. vinelandii bFT with negative cooperativity preventing heme binding at 12 sites 
 17
(Moore et al., 1992a).  It was also found that not all bFTs contain heme IX (Figure 1.8).  The 
bFT in D. desulfuricans contains heme III (Figure 1.8) (Romão et al., 2000a; Coelho et al., 























H-chain FT      ATGACGACCGCGTTCCCCTCGCAGGTGCGCCAGAACTACCACCAGGAC-TCGGAGGCCGC 
L-chain FT      ATGA-------GCTCCC-----AGATTCGTCAGAATTAT-TCTACTGAAGTGGAGGCCGC 
bFT             ATGA--AAGGTGATACT----AAAGTTATA---AATTATCTCAACAAA-CTGTTGG--GA 
                ****       * * *      *  *       ** **   * *       *  **  *  
 
H-chain FT      CATCAACC-GTCAGA-TCAACCTGGAGCTCCACGCCTCC-TATGTGTACCTGTCC---AT 
L-chain FT      CGTCAACC-GCCTGG-TCAACCTGTACCTGCGGGCCTCC-TACACCTACCTCTCT---CT 
bFT             AATGAGCTTGTCGCAATCAATCAGTACTTTC-----TCCATGCCCGAATGTTTAAAAACT 
                  * * *  * *    **** * * *  * *     *** *      *  * *      * 
 
H-chain FT      GTCTTTCTATTTTGATCGCGATGATGTGGCTTTGAAGAACTT-TGCCAAATATTTTCTTC 
L-chain FT      GGGCTTCTATTTCGACCGCGACGATGTGGCTCTGGAGGGCGTATGCCAC-----TTCTTC 
bFT             GGGGT-----CTCAAACGTCTCAATGA---TGTGGAG----TAT---------------C 
                *   *      *  * **     ***    * ** **    * *               * 
 
H-chain FT      ACCAATCTCATG-AGGAGAGG---GAACATGCTGAGAAACT-GATGAAG--CTGCAGAAC 
L-chain FT      CGCGAGTTGGCGGAGGAGAAGCGCGAGGGTGCCGAGCGTCT-CTTGAAG--ATGCAAAAC 
bFT             ATGAATCCATTG-ATGAGATG---AAACACGCCGATCGTTATATTGAGCGCATTCTTTTT 
                    *      * * **** *    *    ** **         ***     * *      
 
H-chain FT      CAACGAGGTGGCCG-GATCTTCC----TT-CAGGACATCAAGAAACCAGACCAGGATGAC 
L-chain FT      CAGCGCGGCGGCCGCGCTCT-CT----TC-CAGGACTTGCAGAAGCCGTCCCAGGATGAA 
bFT             CTGGAAGG---------TCTTCCAAACTTACAGGACCTGGGCAAACTG-AACA------- 
                *     **         *** *     *  ****** *    ** *     **        
 
H-chain FT      TGGGAGAATGGGCTGAAGGCAATGGAGTGTGCATT-ACACTTGGAAAAAAATGTGAATGA 
L-chain FT      TGGGGTACAACCCCAGACGCCATGAAAGCCGCCAT-TGTCCTGGAGAAGAGCCTGAACCA 
bFT             TTGGTGAAGATGTTGA-GGAAATG----CTGCGTTCTGATCTGGCACTTGAGCTGGAT-- 
                * **  *           *  ***      **  *      ***         ** *    
 
H-chain FT      GTCACTATTGGAACTGCACA---AACTGGCCACTGACAAAAATGACCCCCACTTGTGTGA 
L-chain FT      GGCCCTTTTGGATCTGCATG---CCCTGGGTTCTGCCCAGGCAGACCCCCATCTCTGTGA 
bFT             GGCGCGAA-GAATTTGCGTGAGGCAATTGGTTATGCCGATAGCGT--------TCA-TGA 
                * * *    * *  ***         * *    ** * *    *         *   *** 
 
H-chain FT      CTTCCTCGAGACTCATTACCTGAATGAGCAGGTGAAAGC---CATCAAAGAATTGGGTGA 
L-chain FT      CTTCTTGGAGAGCCACTTCCTAGACGAGGAGGTGAAACT---CATCAAGAAGATGGGCGA 
bFT             TTACGTC---AGCCGCG----ATATGATGATA-GAAATTTTGCGTGATGAAGAAGG---- 
                 * * *    *  *         * **  *   ****     * * *   *   **     
 
H-chain FT      CCACGT-AACCAACCTGCGCAGGATGGG----GGCCCCCGAATCTGG-CATGGCAGAGTA 
L-chain FT      CCATCT-GACCAACATCCAGAGGCTCGT----TGGCTCCCAAGCTGG-GCTGGGCGAGTA 
bFT             CCATATCGACTGGCTGGAAACGGAACTTGATCTGATTCAGAAGATGGGCCTGCAAAATTA 
                ***  *  **   *       **          *   *  **  ***   **    * ** 
 
H-chain FT      TCTCTTTGACAAGCACACCCTGGGAGAGTGTGACGAGAGCTAA 
L-chain FT      TCTCTTTGAAAGGCTCACTCTC-AA--GC---ACGA---CTAA 
bFT             TCTG-----CAAGCACAGA-TCC------GCGAAGAAGGTTGA 
                ***       * ** **   *           * **    * * 
 
 
Figure 1.7: The multiple alignment of horse spleen ferritin (H-chain) sequence (Orino et al., 
2005), horse spleen ferritin (L-chain) sequence (Takeda et al., 1993), and E. coli bacterioferritin 
sequence (Andrews et al., 1989b) using CLUSTAL FORMAT for T-COFFEE online program 






































Figure 1.8: The chemical structures of protoporphyrin IX (left) and coproporphyrin III (right) 




Applications of Iron Storage Proteins 
In several species, the utilization of mutants lacking the ability to synthesize FT-like 
proteins has yielded information concerning the potential role that these biomolecules play in 
bacteria.  The data obtained by utilizing mutants indicate that the cellular effect of the bacterial 
FT-like proteins is not consistent, differing from species to species (Table 1.1).  These proteins 
have multifaceted functions.  Dps, for example, does not always bind DNA as protective co-
crystalline Dps-DNA complexes.  In addition, bacterial FT or bFT do not always protect the 
organism against oxidative stress, nor do these compounds necessarily serve as a source of iron 
during iron deprivation.  In a few cases, FT-like proteins serve to protect the bacterial cells 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.1.4: Regulatory Role of Iron 
The product of the fur gene, the Fur protein (ferric uptake regulator), acts as an 
intracellular iron regulator (Andrews et al., 2003; Massé and Arguin, 2005) (Figure 1.9).  After 
intracellular iron has reached acceptable levels, the activated Fur protein (with ferrous ion) 
binds to the promoters of most iron acquisition genes and represses their transcription.  The 
Fur-Fe2+ complex normally binds between the -35 and -10 sites at the promoters of the fur 
genes.  Fur-binding sites were originally found to conform to a 19-bp palindromic consensus 
sequence known as the ‘iron box’ or ‘Fur box’: 5’-GATAATGAT-3’ (Escolar et al., 1998), 
while an alternative consensus sequence 5’-TGATAATNATTATCA-3’ has also been 
proposed lately (Baichoo and Helmann, 2002).  The Fur-Fe2+ complex also activates the genes 
for bacterial FT and/or bFT synthesis leading to the removal of excess and potentially harmful 
ferrous ions from the cytosol, where Fe2+ is oxidized to Fe3+ and is stored in the protein core 
(Ratledge and Dover, 2000).  Besides, Fur also represses a small sRNA named RyhB, which 
facilitates degradation of the mRNAs responsible for the synthesis of several iron-utilizing 
proteins (sdhCDAB, acnA, fumA, ftnA, bfr, and sodB) and positively regulated by Fur (Massé 
and Gottesman, 2002).  RyhB found in E. coli (PrrF1 and PrrF2 in P. aeruginosa or Cth2 in S. 
cerevisiae) actively stimulates degradation of its mRNA targets by recruiting the RNA 
degradosome, a complex formed of RNaseE, polynucleotide phosphorylase, enolase and an 
RNA helicase (Massé and Gottesman, 2002; Wilderman et al., 2004; Puig et al., 2005).  
RNaseE degrades both RyhB and the mRNA simultaneously once they have paired.  This 
coupled degradation provides an intrinsic mechanism to shut down RyhB.  Indeed, when RyhB 
expression is stopped under iron-replete conditions, the sRNA level drops because of rapid 
turnover.  Destruction of RhyB quickly restores the expression of iron-using proteins, which 
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sequester iron as soon as it becomes available.  In contrast, under conditions of iron 
deprivation, Fur inactivation enables expression of iron-acquisition genes and RhyB, which 
represses iron-using proteins.  There are several advantages that are intrinsic to the mechanism 
of sRNAs.  The sRNAs do not require new protein synthesis and, thus, activity is fast and 
efficient in terms of cellular energy use.  Although several sRNAs alter translation or stability 
of their mRNA targets, they do not stop their transcription; therefore, when the sRNA 
disappears, mRNA expression swiftly resumes.  Besides, sRNAs such as RyhB can be quickly 






















Figure 1.9: Roles of Fur and RyhB in mediating Fe-dependent gene regulation in E. coli (Andrews 
et al., 2003).  Fur regulates the cellular iron uptake of the cell and ryhB gene expression, and 
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1.2: Escherichia coli Bacterioferritin 
 
1.2.1: Discovery of Bacterioferritin 
 Bacterioferritin was first isolated from E. coli whole cells based on its optical spectrum 
and was named cytochrome b1 (Keilin, 1934; Keilin and Harpley, 1941).  Later this 
cytochrome b1 was isolated as a pure protein and was found to have similar optical properties 
as cytochrome b557 based on its three optical bands for the heme group (Deeb and Hager, 
1964).  It was also found that the pI of this protein is 4.6 (Bartsch et al., 1971).  In 1973, the 
protein isolated from A. vinelandii had been found to be a FT-like protein, which contained 
heme, and thus was classified as a haemoprotein (Bulen et al., 1973).  Later, a transmission 
electron micrograph showed that this haemoprotein with cytochrome b557-like properties 
resembled FT in quaternary character (Stiefel and Watt, 1979).  It was found that E. coli FT-
like haemoprotein had absorption maxima at 417, 530, and 560 nm (Soret, β-, and α-bands, 
respectively), which were contributed by protohaem IX that was not present in FT (Yariv et al., 
1981).  From this discovery, the FT-like haemoproteins of bacteria were called bacterioferritin 
to distinguish this protein from FT (Yariv et al., 1981; Chen and Crichton, 1982).  The redox 
potential, sodium dodecylsulfate polyacrylamide gel electrophoresis results (size), and X-ray 
crystallographic data also suggested the identity of bFT and cytochrome b1 (Yariv, 1983; Smith 
et al., 1988).  The partial sequence was first found by chemical modification and amino acid 
analysis (Tsugita and Yariv, 1985).  The complete sequence of E. coli –K12 bFT (Figure 1.10) 
was derived from the nucleotide sequence of the cloned gene, in which it was comprised of 







  1     mkgdtkviny lnkllgnelv ainqyflhar mfknwglkrl ndveyhesid emkhadryie 
  61    rilfleglpn lqdlgklnig edveemlrsd laleldgakn lreaigyads vhdyvsrdmm 
  121   ieilrdeegh idwleteldl iqkmglqnyl qaqireeg 
 
 
Figure 1.10: Amino acid sequence of E. coli bFT (Andrews et al., 1989b). 
 
 
 Escherichia coli contains at least four genes that may be involved in iron storage: bfd 
that encodes the 64-residue [2Fe-2S]-containing bacterioferritin-associated ferredoxin (Bfd), 
bfr that encodes bacterioferritin, ftnA which encodes a ferritin (FtnA), and ftnB that encodes a 
ferritin-like protein (FtnB) (Izuhara et al., 1991; Abdul-Tehrani et al., 1999).  Only Bfd, FtnA, 
and bFT have been characterized.  Whether FtnB functions as an iron storage protein is 
uncertain because its primary structure suggests that it lacks an active ferroxidase center 
(Abdul-Tehrani et al., 1999).  FtnA takes up iron approximately three-fold more rapidly that 
does bFT in vitro, but bFT appears to accumulate more iron per molecule than FtnA in vivo 
(Andrews et al., 1993; Hudson et al., 1993).  Thus, it has been speculated that FtnA and bFT 
play roles in short- and long-term iron storage, respectively, like the mammalian H- and L-
subunit-rich FTs (Andrews et al., 1993). 
 
1.2.2: Overall Structure 
Before the X-ray structure of bFT was determined, there were several studies on 
predicting its structure.  First in 1981, a single crystal of E. coli bFT (Figure 1.11a) and its X-
ray precession photographs suggested a 432 point-group symmetry and the formation of 24 
identical subunits (Yariv et al., 1981).  The transmission electron micrograph showed an inner 
core of 6 nm diameter and an outer shell of 9.5 nm diameter (Figure 1.11b) (Yariv et al., 





modification and partial sequence analysis suggested that the formation of 24 subunits was 
from one kind of polypeptide chain (Tsugita and Yariv, 1985).  After the determination of its 
complete amino acid sequence, its secondary structure was predicted to possess a high α-
helical content consistent with a 4-helix-bundle conformation (Figure 1.12), and a tetracosamer 
bFT contained 12 heme moieties (Andrews et al., 1989a).  The study of self-assembly had 
shown that the formation of tetracosamer possibly involved structural intermediates as follows 
(Gerl and Jaenicke, 1988), 
24M1 →  24M1  8M2 + 8M1   8M3   4M6   2M12   M24, 
where M1 is an unfolded subunit, Mi is assembly intermediates with i subunits, and M24 is 
native tetracosamer.  Once the X-ray crystallographic data of four crystals was achieved, it 
indicated that the molecule had a diameter in the range of 119 to 128 Å (Smith et al., 1989).  
Later, structural comparisons between bFT and a related protein cytochrome ć (Moore, 1991), 
structural modeling by X-ray precession photographs of the tetragonal crystals (Smith, 1991), 
structural prediction by sequence alignments (Grossman et al., 1992), model-building studies 
(Cheesman et al., 1993), and low resolution X-ray crystallography (Frolow et al., 1993) 
confirmed the size and shape of bFT.  However, when the X-ray crystallographic results with 
higher resolution were finally achieved (Frolow et al., 1994; Dautant et al., 1998), it was 
shown that bFT is a slightly distorted spherical shell with an inner cavity diameter of ~80 Å (8 
nm) and an outer diameter of 120 Å (12 nm) (Figure 1.12).  When bFT forms a cage-like 
structure, the C-terminus of each subunit is pointing towards the core, while the N-terminus is 
pointing outward (Figure 1.13).  The monomeric E. coli bFT contains A (Thr5-Trp35), B 
(Lys38-Phe64), C (Val83-Val111), D (Tyr114-Met144) helices, which form the usual square 





perpendicular (78o) to the bundle axis (Figure 1.14).  Each heme is bound in a pocket formed 
by the interface between a pair of symmetry-related subunits, while the di-metal binding sites 
are located inside a monomer.  AB is antiparallel to the CD helices with loop L (Leu65-Asp82) 
connecting helix B and C.  The connection between the L loop and helix C adopts a random 
coil conformation.  Helix E provides stable interactions at four-fold symmetry axes.  Two-
subunit is stabilized by four hydrogen bonds between O and N atoms of the amide of Gln72 on 
one monomer and N (Leu77) and O (Gly75) of another parallel monomer, respectively (Figure 
1.15a).  The inner surface has a salt-bridge between Arg30 and Asp56, and Glu60, although 
Glu60 is not conserved in all bFTs (Figure 1.16b).  Additional intersubunit stability is two salt-
bridges that are formed by Glu128 and Glu135 with Arg61 and N-terminal amine of the 
perpendicular subunit, respectively (Figure 1.16).  The amino acid Glu128 also forms a salt 
bridge with Arg102 of the same subunit linking the C and D helices (Figure 1.16).  While, the 
interaction between intersubunits is hydrophobic, the inner surface of the sphere is hydrophilic 





Figure 1.11: Single crystals (a) and the electron micrograph of E. coli bFT (b) (adapted from 









      
 
Figure 1.12: The space-filled structure of E. coli bFT where each color represents one subunit (a) 
and half-the-sphere structure that shows the size of the outer surface and the inner cavity (b) 





     
 
Figure 1.13: The cross eyed stereo view of a 12-subunit E. coli bFT represents the heme binding 
groups (blue) and the C-terminal end (red) that are pointing toward the cavity.  The intact bFT is 

















Figure 1.14: The ribbon diagram of two neighboring subunit of E. coli bFT showing the heme-
binding site and ferroxidase center, where the heme group is colored in purple and two iron 
atoms are colored in orange.  The helices in each subunit are labeled as A (red), B (blue), C 







Figure 1.15: The ribbon diagram of two neighboring subunits of E. coli bFT (green) representing 
the residues (CPK ball and stick display) involved in intersubunit stability of two subunits of the 
E. coli bFT on (a) the outer surface and (b) the inner surface (PDB entry 1BCF) (Frolow et al., 
1994).  The L loop is colored as pink, the heme group is colored as purple, and two iron atoms are 



















Figure 1.16: The ribbon diagram of four subunits of E. coli bFT showing the residues involved in 
intersubunit and intrasubunit stability (CPK ball and stick display), which are Arg61, Arg102, 




1.2.3: Heme Binding Site 
The absorption of the heme group was first observed when studying the isolated 
haemoprotein from A. vinelandii (Bulen et al., 1973).  The heme was found to be intrinsically 
bound (Stiefel and Watt, 1979).  Electron paramagnetic resonance (e.p.r.) and near infrared 
magnetic circular dichroism (n.i.r.-m.c.d.) experiments combined with additional experiments 
using extended X-ray absorption fine structure (EXAFS) suggested a bis-methionine axial 
ligation of heme in P. aeruginosa and A. vinelandii bFT (Cheesman et al., 1990; Cheesman et 
al., 1992; George et al., 1993).  Based on preliminary modeling (Andrews et al., 1991b) and 
e.p.r. and m.c.d. spectra combined with molecular modeling of the E. coli bFT (Moore et al., 
1992a; Cheesman et al., 1993), two potential heme-binding sites were found; site I was an 
intra-subunit near the outer molecular surface with heme-iron ligands Met31 and Met86 (1 
heme per 1 subunit), and site II was an inter-subunit near the cavity surface with ligands Met52 









results did not have strongly supporting evidence because neither of these residues is 
absolutely conserved in the bFT family.  Subsequently, multiple sequence alignments 
suggested that site I was a heme-binding pocket (Grossman et al., 1992), however, low 
resolution crystallographic structural studies suggested that site II might be a heme site 
(Frolow et al., 1993).  Once the X-ray structure of the E. coli bFT was achieved (Frolow et al., 
1994; Dautant et al., 1998), it was shown that site II was the correct heme site (Figure 1.17).  
This site has an approximate two fold-symmetry related set of bimetal centers.  The iron of 
protoporphyrin IX has two axial sulfur ligands at 2.35 Å and from the iron with four nitrogen 
ligands at 1.97 Å.  The distances between the heme Fe atom and the two non-heme metal 
atoms are 14.5 and 12.8 Å.  The hydrophobic pocket, which encloses the heme, forms an 
indentation opening from the surface of the inner cavity and creeping along the hydrophobic 
interface between two subunits.  The pocket is lined with residues Leu19, Ile22, Asn23, and 
Phe26 (A helix), Tyr45, Ile49, Met52, Lys53, Ala55, and Asp56 (B helix), Leu71 of the L 
loop, and the equivalent twofold-axis-related residues.  The heme molecule is only accessible 
from the inside of the protein shell, where its two propionate groups protrude into the 
hydrophilic internal cavity, and is protected against the outside aqueous medium by the two 
symmetry-related L loops (Figure 1.18).  Heme binding also allows some maintenance of the 
tertiary and quaternary structure, which might explain the limiting stoichiometry of one heme 
per 2 subunits (Grossman et al., 1992).   
The presence of the iron core has been shown to have no detectable effect on the 
electronic states on the placement of the heme group (Cheesman et al., 1992).  Heme-free bFT 
variants from E. coli take up iron in vitro at rates indistinguishable from those of the wild-type 





al., 1998).  This is reasonable because the heme iron does not undergo redox cycling when 
Fe(II) and dioxygen are the substrates for the iron loading of bFT.  However, based on 
mutagenesis studies on the heme-binding site (Andrews et al., 1995) and the study of heme 
binding to horse spleen FT (Kadir et al., 1992), it has been found that the amount of iron 
incorporated into heme-free bFT in vivo is approximately four times higher than that of the 
wild-type bFT, which indicates that the heme group is involved in mediating release of iron 
from bFT by facilitating reduction of the iron core.  In addition, it is also found that heme 




















Figure 1.17: The schematic representation of the bFT heme-binding site, which lies between a two 
neighboring subunits interface shows the interaction of Met52 and Met52' with the heme-iron 
atom.  These two Met residues are close to the Glu51 residue of the ferroxidase center (adapted 























Figure 1.18: The ribbon diagram of two neighboring subunits of E. coli bFT (green) showing the 
two propionate groups of heme (CPK ball and stick display) that lies between this interface, two 
iron atoms (purple dots) at the ferroxidase center, L loops that protect the heme group from the 
aqueous medium, and the C-terminal end pointing toward the protein cavity (PDB entry 1BCF) 




1.2.4: Iron Core Formation 
Studies of the iron core in bFT analyzed by Mössbauer spectroscopy (Matzanke et al., 
1989) in combination with e.p.r. and m.c.d. spectroscopies (Cheesman et al., 1992) have 
shown some features of the core forms (magnetic ordering, anisotropy, and etc.) that differ 
from the iron core of FT.  Sequence alignment (Grossman et al., 1992), molecular modeling 
(Cheesman et al., 1993), site-directed mutagenesis (Le Brun et al., 1995), and predictions of 
the di-iron carboxylate protein based on structures and sequences of the related proteins 
(Nordlund and Eklund, 1995) have shown two potential iron-binding sites and have identified 
several iron binding residues.  The conserved key amino acid residues in the ferroxidase 
centers of FT compared to bFT have suggested that bFT possesses a ferroxidase center similar 
to that of H-chain FTs (Andrews et al., 1991b; Grossman et al., 1992).  Site-directed 











Dautant et al., 1998) have shown that the amino acids involved in coordination of the di-iron 
sites are residues Glu18, Glu51, His54, Glu94, Glu127 and His130, which interact with two 
non-heme iron atoms that are separated by 4.36 Å (Figure 1.19).  Each metal ion is capped by 
the carboxylate moieties of Glu and His ligands.  These two iron atoms are connected by two 
bridging carboxylate groups.  Tyr25 is conserved in bFTs and eukaryotic FTs, where its 
hydroxyl oxygen atom points towards the metal center (distance of 3.6 Å) and its hydrogen 
atom appears to stabilize the carboxylic oxygen atom of Glu94.  Since the tyrosine allows 
hyperoxidation of the cluster, this Tyr residue protects the active site and prevents permanent 
oxidative damage to the protein.  The channels in bFT that allow for the entry and exit of Fe(II) 
include 3-fold (Figure 1.20), 4-fold (Figure 1.21), and major channels.  Eight subunits of the 
bFT create 4-fold channels, while six subunits create 3-fold channels.  The eight 3-fold and six 
4- fold channels are hydrophilic and connect the inner core with the protein environment.  The 
3-fold channels are lined with Asp109, Arg117, and Asp118, while the 4-fold channels are 
extremely hydrophilic with four Asn148 residues on the outer surface of the protein shell and 
four Gln151 residues bound to a heavy atom on the inner surface.  The metal binding site is 
located on the 4-fold axis, while the major sites of iron transfer into the cavity are predicted to 
be the 3-fold channels.  Since bFT and H-chain FT are similar, it has been suggested that the 3-
fold channels are the major sites used by Fe(II) to enter and move to the di-iron sites (Levi et 
al., 1996).  Iron oxidation at the di-iron site produces Fe(III), which returns through the 3-fold 
channels and into the cavity for the formation of the ferrihydrite mineral core (Treffry et al., 
1993).  The di-iron center is at the bottom of the iron pore (ferroxidase pore), which is 
approximately circular in shape with an approximately elliptical wider base.  The entrance and 





through this pore to form the di-iron site.  By electrostatic potential calculations, it has been 
calculated that the outer entrance is surrounded by positive potential that leads to an 
electrostatic field that could direct cations towards the channel entrance (Carrondo, 2003).  It is 
likely that Fe atoms may have left the di-iron site to the solvent through the pore; however, 
under physiological conditions it is also possible that these Fe atoms may be translocated into 
the inner core via a concerted movement of the hydrophilic residues that lie below the iron 
position (Carrondo, 2003).  The major channel, which differs from 3- and 4-fold channels, 
extends to the interior of the protein shell and is large enough for the entry of iron to the 




























Figure 1.19: The ligands to the ferroxidase center of E. coli bFT are located on helices A-D: helix 
A, Glu18; helix B, Glu51 and His54; helix C, Glu94; and helix D, Glu127 and His130 (adapted 











Figure 1.20: The space-filled structure of six subunits of E. coli bFT creating a 3-fold channel (a) 
and a zoom-in ribbon structure representing the residues (CPK ball and stick display) that form 







Figure 1.21: The space-filled structure of eight subunits of E. coli bFT creating a 4-fold channel 
(a) and a zoom-in ribbon structure representing the residues (CPK ball and stick display) that 












Iron core formation is dependent upon Fe(II) concentration, pH, and the amount of iron 
already present in the core (Baaghil et al., 2003).  There are three kinetic phases for iron uptake 
into bFT.  First is the binding of two Fe(II) atoms per dinuclear center (t1/2 ~50 ms), second is 
the rapid oxidation of the Fe(II) ions to Fe(III) in the presence of dioxygen (t1/2 ~5 s), and third 
is the subsequent core formation (t1/2 ~300 s), which is seen only when more than 50 iron 
atoms are added to the protein (Le Brun et al., 1993).  The effective iron capacity is ~2700 
irons per cluster (24 subunits) while the theoretical limit is ~4500.   
The presence of E. coli bFT greatly attenuates the production of hydroxyl radical 
during Fe(II) oxidation by H2O2, consistent with the ability of bFT to facilitate the pairwise 
oxidation of Fe(II) by H2O2, thus avoiding single electron reduction products of oxygen and 
therefore oxidative damage to the protein and cellular components through oxygen radical 
chemistry (Bou-Abdallah et al., 2002).  Once Fe atoms move to the di-iron binding site, there 
are three main reactions, diferrous binding, ferroxidation, and mineralization that occur to store 
iron atoms in the protein core and reduce hydroxyl radical formation (Bou-Abdallah et al., 
2002; Yang et al., 2000).  The first step of two iron atoms binding at the ferroxidase site results 
in the production of four protons and [Fe(II)2-P]z, which represents a diferrous ferroxidase 
center complex of the protein P with the net charge Z in the diferrous binding reaction (Eq. 1).  
This di-Fe(II)-protein complex is oxidized in the presence of O2 and a water molecule to 
generate Fe(III) and H2O2 (Eq. 2).  This H2O2 is rapidly used in step two of ferroxidation to 
generate [Fe(III)2O-P]z, which represents a μ-oxo-bridged diferric ferroxidase complex, 
without hydroxyl radical production via Fenton chemistry.  This is an indication that the 
protein is capable of nullifying the toxic combination of Fe(II) and H2O2.  H2O2 is also an 





Then the inner surface will provide a site for Fe(III) binding and facilitate nucleation of the 
iron core.    
 
Diferrous binding, 
2Fe2+ + Pz → [Fe(II)2-P]z + 4H+      [1] 
Ferroxidation, 
Step one:  [Fe(II)2-P]z + O2 + H2O → [Fe(III)2O-P]z + H2O2   [2] 
Step two:  [Fe(II)2-P]z + H2O2 → [Fe(III)2O-P]z + H2O   [3] 
Net reaction:  2[Fe(II)2-P]z + O2 → 2[Fe(III)2O-P]z    [4] 
Mineralization, 
Step one,  2Fe2+ + O2 + 4H2O → 2FeOOH(core) + H2O2 + 4H+  [5] 
Step two,  2Fe2+ + H2O2 + 2H2O → 2FeOOH(core) + 4H+  [6] 





1.3: Nanotechnology and Encapsulation 
Nanotechnology refers to the methodology involved in the creation of functional 
materials, devices, and systems through control of matter on the nanometer (1 to 100+ nm) 
length scale (Niemeyer, 2001).  This technology allows for construction, using techniques and 
tools that are being developed today to situate individual atoms and molecules in desired 
locations.   
 One of the applications of nanotechnology is the encapsulation of small molecules 
(guests) by small particles or nanoparticles (host) with several limitations such as size, shape, 
orientation, and interaction that influence reactions and linkages between guests and host 
particles.  Self-assembled cage-like structures of nanoparticles can be used as constrained 
environments for the preparation of nanostructured materials and the encapsulation of guest 
molecules (Conn and Rebek, 1997).  These nanoscale containment systems have potential 
applications in drug delivery, catalysis, and nanoscale circuits (Perkel, 2004).   
 
1.3.1: The Host  
 Molecular capsules can act as hosts for appropriate guests and bring them into well-
defined and controlled nano-environments (Rebek, 2005).  There are many kinds of potential 
hosts including protein cages, viral capsids, polymers, lipid coats, and synthesized organic 
capsid-like structures.  These hosts generally consist of small subunits that self-assemble to 
form cage-like structures with target substances inside.  The interactions between host subunits 
that hold the complex together include hydrogen bonding, hydrophobic or hydrophilic 
interactions, which can be disrupted by altering pH, temperature, or using chemical reagents to 





encapsulated guest molecules.  For example, larger hosts permit more complicated 
arrangements of the guest molecules due to motional freedom from the capsule walls and the 
possibility of self-interactions.   
 
Protein Cages 
Several proteins are capable of acting as hosts for encapsulation.  Reported examples 
have included GroEL, enzymes, heat shock protein (Hsp), vault, and iron storage proteins 
(Dps, FT, and bFT).  Each of them has particular properties (sizes, shapes, and functions) that 
are suitable for varied and specific applications (Domínguez-Vera and Colacio, 2003; Ishii et 
al., 2003; Flenniken et al., 2006; Kickhoefer et al., 2005). 
Iron storage proteins are the most widely used for encapsulation especially for metal 
mineralization, and this has included metal clusters of uranium, copper, cobalt, manganese, 
vanadium, beryllium, cadmium, zinc, nickel, magnesium, iron phosphate, iron arsenate, iron 
vanadate, and iron molybdate (Hainfeld, 1992; Ensign et al., 2004; Meldrum et al., 1995; 
Grady et al., 2000; Price and Joshi, 1983; Pead et al., 1995; Douglas and Stark, 2000; 
Polanams et al., 2005).  Larger guest molecules such as Prussian blue, desferrioxamine B 
complex, and doxorubicin-HCl (anticancer drug) have recently been studied and investigated 
(Figure 1.22) (Domínguez-Vera and Colacio, 2003; Domínguez-Vera, 2004; Simsek and Kilic, 
2005).  While most applications are based on FT, few have been developed using Dps and bFT 
encapsulation, which are typically used only for metal mineralization.  It has been found that L. 
innocua Dps could be used as protein cage for two cobalt oxide minerals, Co3O4 and Co(O)OH 





GroEL is a chaperonin protein that functions in combination with GroES to refold 
misfolded proteins.  It consists of two supramolecular rings, in which each is comprised of 
seven subunits of 60 kDa that stack to form a double-decker architecture with a cylindrical 
cavity of 45 Å in diameter and a wall thickness of 46 Å (Braig et al., 1994).  An example of 
GroEL-utilizing encapsulation is the report of encapsulating cadmium sulfide (CdS) in the 
protein cavity to allow this semiconductor to have thermal and chemical stability in aqueous 
media (Ishii et al., 2003).  CdS can be released from GroEL cavity by ATP-triggered release 
and host conformational change (Figure 1.23). 
Heat shock proteins (Hsps) possess a chaperone activity similar to GroEL/GroES and 
form a hollow spherical 24-subunit complex.  The complex exhibits octahedral symmetry with 
an outer diameter of 120 Å and the inner diameter of 65 Å, which resembles those of FT and 
bFT (Figure 1.24) (Kim et al., 1998).  Applications of Hsps have included drug delivery to 
tumor cells and the formation of a H2 catalyst inside the Pt-Hsps cavity (Flenniken et al., 2006; 
Varpness et al., 2005). 
Vaults are large proteins formed with 13-MDa ribonucleoprotein particles and having 
an internal cavity of 5 × 107 Å that can sequester hundreds of proteins (Figure 1.25).  Vaults 
tend to have a hollow, barrel-like structure with two protruding caps and an invaginated waist 
with overall dimensions of 420 × 420 × 750 Å (Kong et al., 2000).  Due to its large structure, 
the encapsulation of vault particles can accommodate large guests such as green fluorescent 













Figure 1.22: A schematic diagram representing the encapsulation of Prussian-blue in FT, which 
involves declustering of the protein at pH 2.0, encapsulation at pH 8.5, and the formation of a 












Figure 1.23: A schematic diagram representing the GroEL-CdS nanoparticle complexes, which 
















Mg2+ + K+ 











Figure 1.24: The space-filling structure representing the interior of the small heat shock protein 
from Methanococcus jannaschii viewed along 3-fold axis (a) and 4-fold axis (b) (PDB entry 1SHS) 








Figure 1.25: Cryo-transmission electron microscopy of vault particles (a) and half-a-capsid 
images representing the inner and outer structure (b) (Kong et al., 2000).  The sale bar 











Viral capsids serve as proteins for nucleic acid storage and transport.  Viruses exist in a 
range of sizes and shapes.  For example, icosahedral structures range in size from 18 to 500 nm 
and >2 μm in length for filamentous or rod-shaped viruses.  These varieties provide a library of 
platforms for tailored applications where size, shape, and stability are required.  Several viral 
particles including Cowpea chlorotic mottle virus (CCMV) (Douglas and Young, 1998), 
tobacco mosaic virus (TMV) (Shenton et al., 1999), MS2 bacteriophage (Anobom et al., 
2003), herpes simplex virus (Heymann et al., 2003), polyoma virus-like particles (capsoids) 
(Abbing et al., 2004), Kaposi’s sarcoma-associated herpes virus (KSHV) (Trus et al., 2001), 
and papillomaviruses (Modis et al., 2002) can be used as constrained reaction vessels for 
packaging, entrapment of synthetic organics, site-isolated catalysts, and nucleation sites for 
crystal growth (Douglas and Young, 1998; Douglas and Young, 1999; Abbing et al., 2004).   
Most applications are currently based on the CCMV, which includes its chemical 
modification for multivalent presentation of ligands (Gillitzer et al., 2002), nanoscale building 
blocks (Wang et al., 2002), use as a viral cage for metal mineralization (Basu et al., 2003), use 
as a template for chemoselective linkers (Cheung et al., 2003), and as a host-guest 
encapsulation model (Douglas and Young, 1998).  CCMV is an icosahedral virus with a 
diameter of 30 nm formed by 60 copies of two different types of protein subunits (Liepold et 
al., 2005).  The stability of viral cage is pH dependent, which modulates the opening of 60 
separate pores and exposes the interior of the protein cage to the bulk medium.  This has also 
been used to induce the formation of a metal core inside the capsid (Figure 1.26) (Liepold et 





empty viral particle, and selective mineralization of guest molecules within the confines of the 
virus particle at pH 6.5 (Figure 1.27) (Douglas and Young, 1998). 
 
 
     
 
Figure 1.26: Cryo-transmission electron microscopy represents structural images of the closed 
conformation (a) and opened conformation (b) of CCMV (Douglas and Young, 1998). 
 
 
       
 
 
Figure 1.27: A schematic diagram representing the encapsulation of metals inside CCMV 
particle, a pH dependent process, which involved viral RNA removal to generate empty capsid 
(step I) and the formation of metal mineralization inside viral coat (step II) (adapted from 





There are several reported applications on the use of polymer encapsulations.  These 
reports are focused on polymer-based drug delivery.  A polymer such as commercially 
available poly(DL-lactide-co-glycolide) (PLG) is widely used as an antitubercular drug (ATD) 








The applications of lipid coats are generally based on drug delivery systems such as 
solid lipid nanoparticles (SLNs), which are defined as nanocrystalline suspensions in water 
prepared from lipids that are solid at room temperature.  Examples of guests for these systems 
have included antitubercular drugs and tobramycin (Pandey et al., 2005; Cavalli et al., 2003).  
The lipid coated encapsulated drugs can be visualized by cryo-transmission electron 
microscopy (cTEM) as has been shown for doxorubicin encapsulated in 1,2-dimyristoyl-sn-
glycero-3-phosphocholine (DMPC)/cholesterol (Chol) and 1,2-distearoyl-sn-glycero-3-
phosphocholine (DSPC)/Chol liposomes (Figure 1.28) (Abraham et al., 2002).  These 
encapsulations were dependent on lipid composition, pH, and the nature of the crystalline 




Figure 1.28: Cryo-transmission electron microscopy image of DMPC/Chol liposomes before (a) 




Synthesized Organic Capsid-like Structures 
Synthetic organic capsids can be varied in size, shape, and chemical functionality 
depending on the purpose of each particular experiment.  Most of them are self-assembling 
capsules and are a heterogeneous mixture of the synthesized subunits, which can form self-
assembled capsules by engaging in reversible non-covalent interaction (Conn and Rebek, 






aromatic π-stacking, polar interactions, and van der Waal’s interactions.  Some examples of 
various shapes for these synthetic hosts are Cram’s carcerand (American football-like), 
bis(glycouril) macrocycle (tennis ball-like), a glycouril derivative (softball-like), a 
dimerization of (R)-2-bromo-3-methylbutyric acid (cylindrical capsule), and pyrogallol[4]arene 
(hexameric cube-like) (Figure 1.29) (Starnes et al., 2001; Stoddart, 1988; Palmer et al., 2005; 
Palmer and Rebek, 2004; Palmer and Rebek, 2005).   
 
           
 
         
 
Figure 1.29: The structures representing various sizes and shapes of the synthesized organic 
particles, which are Cram’s carcerand (a), bis(glycouril) macrocycle (b), softball-like glycouril 
derivative (c), a dimerization of (R)-2-bromo-3-methylbutyric acid (d), and pyrogallol[4]arene (e) 
(Starnes et al., 2001; Stoddart, 1988; Palmer et al., 2005; Palmer and Rebek, 2004; Palmer and 
Rebek, 2005).   
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1.3.2: The Guest  
There are several types of guests that have been studied in encapsulation experiments 
such as entrapped metals, small organic compounds, peptides, and proteins.  Many factors such 
as size, shape, number of molecules to be encapsulated, orientation, and interaction within the 
host particles are pertinent to optimize encapsulation processes.  Encapsulated guest molecules 
become conformationally constrained and their environment is altered in a host cavity, which 
can lead to higher chemical reaction rates due to orientation effects provided by the host.  The 
immobilization of guest molecules may promote stereoselectivity of a chemical reaction of 
interest (Palmer et al., 2005). 
Generally, guests can enter and exit capsules through the opening and closing of host 
flaps (Figure 1.30), but smaller guest molecules can exchange simply by diffusion through 
holes in the host subunits.  However, some hosts must undergo complete dissociation to allow 
guests to enter, which would be followed by reassembly to form the entire intact capsule 
(Figure 1.31).  The arrangement of guest molecules within nanocapsules and the development 
of methods to control entrapment and manipulation of guests molecules are investigated and 
















     
 





Figure 1.30: The diagram represents the host opening for guests exchange.  Initially one flap 
opens with entrance of the incoming guest, which drives the opening of second flap.  The previous 








Figure 1.31: The diagram represents the dissociation of one subunit host to allow the exit of a 










1.3.3: Linkage  
 There are three important interfaces that can be exploited to allow interaction between 
host and guest molecules: the exterior, the interior, and the interface between subunits making 
up the host.  The exterior can be chemically modified, so the host particle is targeted to desired 
binding sites.  For example, the anticancer drug, doxorubicin-HCl, has been encapsulated in FT 
and targeted to cancer cells (Simsek and Kilic, 2005), a viral template TMV has been used for 
inorganic-organic mineralization (Shenton et al., 1999), and an antibody-antigen outer surface 
modification has been designed for binding to cell surfaces (Mann et al., 2000).  Host 
extension by addition of constituent subunits can form larger capsules under particular 
incubation conditions (Naumann et al., 2001), and guest exchange can be promoted by using 
dissociable subunits or subunits with conformational flexibility that can create an opening of 
the capsule, which permits entrance and exit of guest molecules (Palmer and Rebek, 2004).  
Both of these processes involve the manipulation of host subunit (or molecule)-host subunit (or 
molecule) interactions.  In contrast, interaction between the capsule interior (host) and the 
guest molecule is considered most critical in successful encapsulation techniques. 
There are many potential methods for linkage forming between host and guest 
molecules such as the application of affinity tags (Futaki et al., 2004; Xu et al., 2004), 
antibody-antigen interactions (Mann et al., 2000), chemical modification (Hooker et al., 2004; 
Flenniken et al., 2005), DNA directed assembly (Li and Mann, 2004), and protein engineering 
techniques (Kramer et al., 2004).  Affinity tag approaches are interesting and frequently 
utilized systems in biochemistry to purify proteins from crude extracts.  These affinity tags 
including Arg-tag, calmodulin-binding peptide, cellulose-binding domain, DsbA, c-myc-tag, 





SBP-tag, Strep-tag, and thioredoxin (Table 1.2) with various sequences and sizes (Table 1.3) 
can also be used as tools for host-guest interaction (Terpe, 2003; Li et al., 1999; Lichty et al., 
2005).  In order to determine suitable affinity tags for each experiment, the size of tags and 
proteins, their efficiency, cost, availability (source), and eluting agents are important factors to 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.3.4: Applications of Encapsulation Processes 
There are many applications for encapsulation processes such as in the area of chemical 
catalysis, biological applications, as well as to demonstrate fundamental aspects of the design 
and control of artificial host-guest systems.  The applications on chemical techniques are 
mostly based on synthesized organic coats.  For example, there has been a report on a water-
soluble cavitand (the host component defined as an organic molecule or ion whose binding 
sites converge in the complex) that acts as a phase transfer catalyst (a type of chemical 
compound, which facilitates the migration of a particular chemical hydrophobic component 
from one phase into another phase in a heterogeneous system) (Hooley et al., 2006).  
Biological applications of nanotechnology are generally focused in the areas of therapeutics, 
drug delivery, tissue reconstruction, diagnostics and biolabels (Perkel, 2004).  To demonstrate 
this, some encapsulated metals activated by an exogeneous energy source have been used to 
heat and destroy surrounding tumors (Hainfeld, 1992).  There are many applications for drug 
encapsulated nanoparticles, which could be made to minimize side effects of drugs, increase 
bioavailability, and/or enhance solubility of the medicinal agent.  For example, a colloidal 
suspension of nanoscale ferrous oxide has been coupled to antibodies raised against an 
epithelial cell-adhesion molecule.  This facilitates labeling of rare human epithelial cells such 
as circulating cancer cells in blood.  This system could be useful for subsequent automated 
staining and analysis techniques (Perkel, 2004).  For nanoparticles as model systems, there are 
metal and semiconductor nanoparticles that could make them suitable models for the study of 
fundamental biological phenomena.   
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1.4: Possible Aspects for Bacterioferritin Encapsulation 
Most of the previous researches on host particles for bFT have been based on metal 
mineralization, organic, and inorganic encapsulation that had been accomplished by diffusion 
through the protein’s natural pores.  A few applications involved encapsulation with partially 
dissociated subunits.  These methods were limited by many factors such as type, size, and 
amount of guest molecules, while the linkage between host and guest molecules was not the 
focus of these studies.  However, linkage between guest and host may be beneficial for 
controlling the amount of guest inside the cavity and forming strong interactions, thereby 
increasing the success of the encapsulation process.  Using a chemical linker would eliminate 
the dependency on guests being randomly entrapped by the reclustering process, rather they 
would be brought into the cavity directly as the cavity was being formed.  This should produce 
a higher local concentration of host molecules during the encapsulation process. 
In this thesis, the interactions between host particles and guest molecules were 
investigated to broaden the encapsulated applications and overcome limiting factors.  Based on 
the knowledge of host (FT, viral capsid, and etc) encapsulation, there are several possible 
encapsulating methods for bFT including the use of affinity tags, protein engineering (fusion 
protein), chemical modification, and heme group interaction.  Overall the thesis explores 
several approaches to carefully control encapsulation processes of complex multisubunit hosts 
using E. coli bFT as the model system.  These approaches should be useful in extending 






Beyond protein purification applications, the affinity tag approach might be useful in 
the encapsulation process which could make use of similar interactions to those between 
immobilized transition metals (stationary phase) and the tagged protein.  These affinity-tag 
systems share the following features: (a) one-step adsorption purification, (b) a minimal effect 
on tertiary structure and biological activity, (c) easy and specific removal of the tag to produce 
the native protein, (d) simple and accurate assay of the recombinant protein during purification, 
and (e) applicability to a number of different proteins (Terpe, 2003).  Since the C-terminal bFT 
is pointing toward the protein cavity, the linkage could be formed between the C-terminal tag 
and a cognate guest molecule, for example, a nickel nitrilotriacetic acid (Ni2+-NTA)-modified 
guest (fluorescent probe) (Figure 1.32).  Another affinity tag applied to many applications in 
drug delivery is the antibody-antigen interaction, which normally is utilized for the 
identification of target proteins.  The encapsulation of guest-bFT is possible by generating an 
antibody linked C-terminal bFT that forms a linkage with a guest molecule that has a 
recognizable epitope sequence.  A commonly used antibody-antigen tag system is the FLAG 
set of peptides that consist of eight amino acids, DYKDDDDK, which are fused with a protein 
of interest that has an affinity for a fragment of a monoclonal antibody to this sequence (Terpe, 
2003).   
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Figure 1.32: The schematic diagram represents the example of a bFT (green ribbon structure) 
encapsulation using His-tag affinity binding at the C-terminus that interacts with a nickel 
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 Protein Engineering 
 Protein engineering (the alteration of protein sequence by means of recombinant DNA 
methods) is the most convenient method to introduce new polypeptide sequences into a protein 
by generating an extended peptide sequence (linker) that can link two proteins.  In this case, 
the fused genetic construct is possible by joining the 3' end of the bFT gene with linker and 
guest genes.  This gene could then be introduced into cells (i.e. E. coli cells) and yield an 
expression system from which the protein fusion can be purified (Figure 1.33).  The 24-subunit 
or higher formation of the fusion protein (guest protein attached to the C-terminal bFT) can be 
expected after protein purification.  Linkers of various lengths may be required for adequate 
spacing between the guest and host when encapsulation involved the inside of the cavity.  A 
strong affinity interaction between bFT and guest molecules is critical.  However, there are 
several factors that need to be considered for success of this approach such as size of the guest 
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Figure 1.33: The schematic diagram represents a fusion protein approach to encapsulate guest 
molecules in bFT cavity, which is utilized by a guest gene (yellow) that is attached to the 3' end of 
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 Chemical Modification 
Chemical modification of the inner cavity could be also utilized to control 
encapsulation.  Amino acid substitution would be required at the interior of a capsid using site-
directed mutagenesis (Hooker et al., 2004).  For example, introduction of cysteine is 
commonly employed to create a reactive site for disulfide bond formation.  Wild-type bFT 
contains no cysteine making this an ideal modification achievable by conventional mutagenesis 
techniques using the bFT-encoding gene.  The guest molecule, containing a thiol group, could 
then be connected to the protein containing Cys residue through the formation of a mixed 
disulfide bond.  However, there are some limiting factors to this approach such as structure 
changed, protein stability, and formation of cluster (24-subunit) of the mutated protein that 
should be considered and controlled.   
Another possibility is to use a guest molecule containing a Cys residue or a sulfhydryl 
(–SH) group, which could react with the heme-iron atom to form a [-S-Fe-] linkage (Figure 
1.34).  Since heme-iron atom is close to the cavity, the iron attached guest molecule is 














Figure 1.34: The image represents the possible encapsulation of a guest molecule inside bFT 
cavity by the interaction of a guest containing a Cys residue and heme-iron atom of bFT forming 
five-coordinate sulfur donor-ligated ferrous heme adducts. 
 
Guest containing Cys residue 
Heme group of bFT 
 63
 Heme Group Interaction 
 This proposed encapsulation approach for bFT takes advantage of the heme groups.  
Since heme propionic acid side chains are pointing into the cavity, the linkage between bFT 
and a guest molecule can be generated by connecting the guest to these propionate sites.   
Guest molecules containing a hydroxyl group (–OH) can react with an acid group of 
exogenous heme (–CO2-) to form an ester (–COOC–).  This modified heme would then be 
introduced to declustered bFT and allow for heme incorporation (and guest) into the 24-subunit 
reclustered protein.  Another possibility is a use of amide bond formation (–CONH–), where 
the propionic acid side chains are reacted with a guest containing amino group (–NH3+) (Figure 








Figure 1.35: The schematic diagram represents possible encapsulated method by using a covalent 
site chain heme propionate-guest interaction.  The formation of the 24-subunit protein is expected 
to contain the guest inside the protein particle once it is formed. 
NH3+ 
Amide interaction 
Guest attached amine 





1.5: Summary of Experimental Objectives Achieved 
The encapsulation of guest molecules with bFT using a His-tag affinity approach was 
an area of interest throughout this thesis.  In order to increase the possibility of the 
encapsulation process for multisubunit host systems of protein bacterioferritin, it may be 
necessary to allow the subunits of the host molecule to dissociate and form tight interactions 
with guest molecules, which could then be followed by allowing the subunits to recluster with 
their tightly held guest molecules being brought inside the cavity during the reclustering 
process (Figure 1.36).  Our goal was to find and understand the conditions required to achieve 
the successful encapsulation of small molecules/biomolecules into the bFT central cavity.  
Suitable conditions for these encapsulated steps were investigated using apoferritin, a 
commercially available protein, as a study model and a size standard to visualize the 
hydrodynamic radius of these proteins under various environments.  Since the iron core of bFT 
as well as the presence of heme groups might influence the encapsulation, ferroxidase- and 
heme-free bFT mutants were generated by site-directed mutagenesis.  The reclustering of the 
24-subunit of wild-type and mutant bFTs were also examined and studied in terms of protein 
stability.  Using data from optimizing conditions for encapsulation and knowledge of protein 
stability of these systems, His-tagged bFT was used as a model system for the encapsulation of 
nickel nitrilotriacetic acid containing guest molecules, which was investigated under studied 








Figure 1.36: The diagram showing the aspect of the guest molecules encapsulated into bFT cavity, 
which involves declustering of the native 24-subunit cluster in acidic solution, binding with the 









CHAPTER 2: CONDITIONAL TESTS FOR DISSOCIATION AND 
REASSOCIATION OF APOFERRITIN SUBUNITS USING LIGHT 
SCATTERING TECHNIQUES 
 
2.1: Literature Research on Dissociation and Reassociation of Horse Spleen Apoferritin 
Horse spleen apoferritin (apoFTHS) is an iron-free FT that resembles bFT in terms of 
size and function (Petsev et al., 2000; Lee and Richter, 1976).  Horse spleen apoFT was first 
found to consist of three different multimeric forms that included aggregations of quaternary 
structure such as two 24-subunit, three 24-subunit, and four 24-subunit forms (Kopp et al., 
1963; Suran and Tarver, 1965; Harrison and Gregory, 1965).  Several experimental 
approaches, namely laser light scattering (LLS), starch-gel electrophoresis, and electron 
microscopy, were used to predict the size of the 24-quaternary structure and higher oligomers 
(Richter and Walker, 1967; Williams and Harrison, 1968).  The interaction causing the 
formation of higher oligomers was found to be related to water structure around apoFT 
molecules (Suran and Traver, 1965; Richter and Walker, 1967; Harrison and Gregory, 1968; 
Williams and Harrison, 1968; Petsev et al., 2000).  It was also determined that the interfaces 
along the 3- and 4-fold axes play the most important roles in the stability of the assembled 
molecule (Santambrogio et al., 1992; Stefanini et al., 1996; Santambrogio et al., 1970).  There 
are at least five factors that are known to modulate the interaction of inter- and intrasubunits of 
apoFT.  These variables include protein concentration, pH, presence of denaturants, 
temperature, and ionic strength.  Interprotein interactions describe the associative/dissociative 
factors governing assembles of intact 24-mers to yield higher order arrangements of the intact 
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protein.  Intraprotein interactions describe factors for association of the polypeptides within a 
single 24-mer. 
Protein concentration was found to affect both inter- and intraprotein interactions.  The 
interchange between 24-subunit and oligomer is dependent upon dilution and concentration 
(Lee and Richter, 1976).  It was found that two 24-subunit quaternary structures were favored 
when the protein concentration was above 0.1 mg/mL, while higher oligomers were dominant 
when the protein concentration exceeded 0.4 mg/mL (Jaenicke and Bartmann, 1972).  Smaller 
subunit dissociation of horse spleen apoFT was not detected at concentrations of 4.43×103 
mg/mL (Crichton et al., 1973).   
Size-exclusion chromatography and circular dichroism (CD) experiments were used to 
investigate (apo)ferritin assembly as a function of pH (Chiaraluce et al., 2000; Stefanini et al., 
1987).  It was found that the horse spleen apoFT oligomer was stable between pH 2.8–10.6.  
Aggregation was observed at pH ≤ 1.0.  Smaller subunit oligomers such as a dimer (2 subunits) 
and monomer (1 subunit) were detected between pH 1.0–1.6, while higher oligomers, dimer, 
and monomer were found at pH 1.6–2.8 and pH 10.6–13.0 (Richter and Walker, 1967; 
Crichton and Bryce, 1973).  The relationship between pH and apoFT subunit dissociation can 
be explained with respect to the protonation states of the protein’s amino acid residues.  
Decreasing the pH results in repulsive interactions, leading to the loss of secondary and tertiary 
structures.  Conversely, for oligomeric proteins, acid denaturation is not limited to the 
destruction of secondary and tertiary structure of each 24-subunit monomer, but entails the 
perturbation of intersubunit interactions.  In addition, it was found that the presence of the iron 
core did not influence the acid-induced dissociation of the protein (Chiaraluce et al., 2000). 
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The denaturants that are widely used in dissociation studies of multisubunit proteins are 
guanidinium hydrochloride (Gdn-HCl) and urea.  It was found that apoFT is stable in 8-10 M 
urea-containing solutions (Hofmann and Harrison, 1963).  FT is dissociated in 9 M urea at pH 
2.5 (Otsuka et al., 1981), and Rhodobacter capsulatus bFT is completely unfolded in solutions 
containing more than 10 M urea (Kilic et al., 2003).  For Gdn-HCl, apoFT is dissociated in the 
presence of 7 M Gdn-HCl at pH 4.5, while FT is declustered at the same Gdn-HCl 
concentration but at a higher pH (Listowsky et al., 1972).  The R. capsulatus bFT is unfolded 
when Gdn-HCl concentrations are greater than 5 M (Kilic et al., 2003).   The re-association 
can be achieved by removal of denaturant, in which most of the helical structure has been 
restored. 
FT and bFT are heat stable proteins.  FT can tolerate high temperatures up to 80 °C for 
10 min at neutral pH (Listowsky et al., 1972; Crichton and Bryce, 1973), while bFT is fully 
unfolded at 90 °C (Kilic et al., 2003).  By using CD measurements in the near and far UV 
regions, it was found that melting (denaturating) temperature (Tm) of apoFT (Tm ≥ 93 °C) was 
higher than FT (Tm = 77 °C), in which Tm of apoFT > H-chain FT > L-chain FT (Stefanini et 
al., 1996).  Re-association occurred if the temperature was 5–10 °C lower than Tm, while 
aggregation occurred if the temperature was higher (Stefanini et al., 1996).   
Static light scattering was used to evaluate the effects of electrolytes and the reversible 
association of apoFT by plotting the second virial coefficient (a representative of the strength 
of particle-solvent interactions) against concentration (Petsev et al., 2000; Richter and Walker, 
1967).  It was found that apoFT was stable in solutions containing 0.06–0.34 M NaCl (Richter 
and Walker, 1967), and while 0.01-0.15 M NaCl decreased repulsion between two 24-
quaternary structures, protein stability was increased outside this range (Petsev et al., 2000).  
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The salt dependence was also investigated in L. innocua Dps, in which the protein was 
dissociated at pH ≤ 2.0; however, with the addition of sodium sulfate (Na2SO4) this protein 
was stable at pH ≥ 1.5 (Chiaraluce et al., 2000).   
Beyond these factors, only apoFT undergoes partial denaturation, which is the slight re-
arrangement of the 24-subunit or the opening of the loop regions in the peptide chain to reveal 
the hydrophobic regions of the helices.  ApoFT can partake in the formation of higher 
oligomers (Petsev et al., 2000).  Denaturations do not significantly change the shape and size 
of the 24-subunit protein but expose groups that locally decrease the repulsion and increase the 
attraction between them. 
The purpose of this part of the project is to evaluate the behavior of horse spleen apoFT 
and particularly the stability of oligomers (based on size) in response to pH variation.  This 
protein will be studied initially to obtain some basic information on the declustering and 
reclustering phenomenon reported previously in the literature, which will be of use in our 
studies with E. coli bFT encapsulation systems.  The effects of protein concentration, pH, ionic 
strength, presence of glycerol, and incubation time for dissociation and re-association were 
investigated as to their effects on protein cluster stability.  DLS was used to determine the size 
of the oligomers as a function of the above effects.  This technique has been previously utilized 
to study the interactions of apoFT molecules (Petsev et al., 2000; Richter and Walker, 1967).   
Light scattering is mainly elastic scattering, in which the wavelength of incident light is 
equal to the wavelength of scattering light.  If there is an individual molecule in a solution and 
if it is assumed that the molecule is small relative to the wavelength of incident light, then that 
molecule may be treated as a point scatterer.  The oscillating electric vector of the incident 
light creates oscillating electrons in the molecules, which in turn cause oscillating dipole 
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moments and electric fields, whose intensities can be detected by a detector (Van Holde et al., 
1998).  Laser light scattering allows for two main measurements: (1) the angular distribution of 
time-averaged scattered intensity or static light scattering (SLS) and (2) time-dependent 
scattered intensity due to density and concentration fluctuations or dynamic light scattering 
(DLS).  Only DLS provides information on the hydrodynamic radius (Rh), which is used to 
measure particle size distribution in a given sample.  
 Dynamic light scattering measures and analyzes the intensity of fluctuations in the 
scattered light.  When laser light interacts with particles, most light will pass through 
unscattered, while some will be recorded by the detector and causing bright and dark areas of 
fluctuated particles (Figure 2.1).  The bright areas indicate that light is scattered by the 
particles arriving at the screen with the same phase and interferes constructively to form a 
bright patch.  The dark areas are where the phase additions are mutually destructive and cancel 
each other out.  Since particles move under Brownian motion (a random movement caused by 
thermal energy), the constructive and destructive phase addition of the scattered light will 
cause the bright and dark areas to grow and diminish in intensity so that the intensity appears 
to fluctuate.  According to the relationship between diffusion speed and particle size in which 
smaller particles move more quickly in a liquid than larger particles (Figure 2.2), the particle 
size can be determined using the Stokes-Einstein relationship, D = kBT/6πηRH, where D is the 
diffusion coefficient, RH is the hydrodynamic radius, kB is Boltzmann’s constant, T is 










Figure 2.1: The scattered light on the detector shows constructive and destructive phase (Malvern 











Figure 2.2: The relationship between diffusion speed and size of (A) small particles and (B) large 
particles (Malvern manual, Malvern Instruments Ltd, Worcestershire, England, 2004). 
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2.2: Reagents, Materials, and Equipment 
 Reagents and Materials 
Hydrochloric acid (HCl), sodium chloride (NaCl), and glycerol were obtained from 
EMD Pharmaceuticals (Durham, NC), while sodium hydroxide (NaOH) was obtained from 
EM Science (Gibbstown, NJ).  Horse spleen apoFT (Sigma A3660) was obtained from Sigma 
Chemical Company, St. Louis, MO).  Water used in all experiments was Milli-Q water (18 
MΩ-cm conductivity). 
Whatman Anotop 10 plus or 0.02 μm-pore filter membranes were obtained from 
Whatman Inc. (Florham Park, New Jersey) while 0.2 μm GHP membrane was obtained from 
PALL (East Hills, NY). 
 
Equipment 
The particle size measurement was performed on a particle sizer (Zetasizer Nano ZS 
model ZEN3500, Malvern Instruments Ltd, Worcestershire, England) equipped with a He-Ne 
laser with 4.0 mW power at a 532 nm wavelength using the size measurement (DLS method) 
as a software protocol.  The scattering light is collected at an angle of 90º through fiber optics 
and converted to an electrical signal by an avalanche photodiode array (APDs).  The refraction 
index was set to 1.450 with 0.001 absorptions.  The samples were run in triplicate with the 
number of runs set to 5 and run duration set to 10 seconds.  The particle shape was assumed to 
be a spherical molecule and can be calculated according to the Stokes-Einstein relationship (D 
= kBT/6πηRH) as above.  For all measurements, dispersant viscosity (η) was set as sample 
viscosity.  The result calculation was in General Purpose mode, which is appropriate for the 
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majority of dispersions and emulsion (Malvern manual, Malvern Instruments Ltd, 
Worcestershire, England, 2004). 
 
2.3: Experimental Protocols 
The samples were prepared by diluting 25 mg/mL stock horse spleen apoFT (pH 7.0) 
with Milli-Q water and filtering through 0.2 μm GHP membranes.  Samples of 45 μL were 
gently injected into a low volume quartz cuvette (45 μL) to avoid formation of air bubbles and 
particulate matter.  The z-average diameters (sizes) of the samples were measured at room 
temperature (25 °C).   
 
Effect of protein concentration 
The 0.2 mg/mL horse spleen apoFT solution was prepared by diluting stock protein 
with Milli-Q water.  The sample was incubated overnight and the molecular size was re-
measured to test for protein stability.  The control experiment was performed in order to 
compare the sizes of the sample with 24-subunit protein.  Since the hydrodynamic radius of 24-
subunit quaternary structure of apoFT is ~12 nm in diameter, only this 24-subunit protein will 
pass through the 0.02 μm-pore filter membrane, while generally higher oligomers would 
remain on the filter.  The 0.2 mg/mL horse spleen apoFT was filtered through a 0.02 μm pore 
filter and incubated for 5 min before measurement of the horse spleen apoFT’s diameter.   
 
Effect of pH 
A 1.0 mg/mL horse spleen apoFT preparation was used in probing pH effects on 
quaternary structure.  The protein was filtered through a 0.02 μm-pore filter membrane and 
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incubated for 1 min in the solution containing HCl (pH 1.0–3.0 with 0.5 pH interval).  Then 45 
μL sample was loaded into small volume quartz cuvettes and the diameter was measured.  The 
graph of apoFT size versus pH was plotted. 
 
Effect of electrolytes 
A 0.7 mg/mL horse spleen apoFT solution was prepared and its size was measured.  
The sample was then filtered through a 0.02 μm-pore filter membrane and the protein diameter 
was re-measured.  To examine the effect of electrolytes, the protein sample was incubated for 5 
min in a solution containing 500 mM NaCl.  The whole solution was then filtered through a 
0.02 μm-pore filter membrane and the protein size was measured. 
The effect of salt and low pH was then investigated by incubating the solutions of 0.7 
mg/mL horse spleen apoFT for 5 min in a solution containing 500 mM NaCl for 5 min, filtered 
through 0.02 μm-pore filter membranes, incubated in HCl solution (pH 1.5) for various periods 
of time (1 min–3 hours), and the protein size was re-measured. 
Another set of experiments was to test for suitable salt concentrations that could 
stabilize the declustered protein.  The 0.7 mg/mL horse spleen apoFT solution was incubated 
for 5 min in solutions containing 50-500 mM NaCl.  The whole solution was then filtered 
through a 0.02 μm-pore filter membrane and incubated in HCl solution (pH 2.5) for various 
period of time (1-30 min).  The size of the protein was measured by DLS. 
 
Effect of glycerol 
The effect of glycerol concentration on native protein was examined by mixing 0.7 
mg/mL horse spleen apoFT with 10-60% glycerol (10% glycerol increments).  The protein was 
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then filtered through a 0.02 μm-pore filter membrane, and the protein size was measured by 
DLS.   
The effect of glycerol on protein declustering was tested by mixing 0.7 mg/mL horse 
spleen apoFT with 10% glycerol, filtering through a 0.02 μm-pore filter membrane, and 
incubating in HCl solution (pH 2.5) for 1-20 min.  The size of the declustered protein was then 
measured by DLS. 
The effect of a combination of glycerol and salt (NaCl) on subunit dissociation was 
investigated by mixing 0.7 mg/mL horse spleen apoFT with 10% glycerol and 10-300 mM 
NaCl (10, 50, 100, 200, 300 mM NaCl), filtering through a 0.02 μm-pore filter membrane, and 
incubating in HCl solution (pH 2.5) for 1 min.  The size of declustering protein was measured 
by DLS.   
Further experiments on the effect of glycerol and salt on stability of the protein were 
performed by mixing 0.7 mg/mL horse spleen apoFT with 10% glycerol and 200 mM NaCl, 
filtering through a 0.02 μm-pore filter membrane, and incubating in HCl solution (pH 2.5) 
overnight.  The control experiment was done without addition of glycerol. 
 
Effect of incubation time on dissociation 
A 0.7 mg/mL horse spleen apoFT solution was mixed with 10% glycerol and 200 mM 
NaCl, filtered through a 0.02 μm-pore filter membrane, and incubated in HCl solution (pH 1.5) 





Effect of reassembly time 
 Horse spleen apoFT (0.7 mg/mL) in solution containing 10% glycerol and 200 mM 
NaCl was filtered and incubated in HCl solution (pH 1.5) for 8 min.  Then a solution of 1 M 
NaOH was added immediately to neutralize the sample’s solution to pH 7.0, and the sample 
was incubated for 1, 4, and 17 min before measuring protein size.   
 
2.4: Results and Discussion 
2.4.1: Effect of Protein Concentration 
The Zetasizer Nano ZS instrument requires at least 0.5 mg/mL protein if the size of the 
particle is less than 10 nm in diameter, while a minimum concentration of 0.1 mg/mL is needed 
if the particle size is in the range of 10 to 100 nm.  The size of 45 μL of 0.2 mg/mL horse 
spleen apoFT was measured using DLS, and the average hydrodynamic diameter of peak 1 was 
~18 nm, while the diameter of peak 2 was ~250 nm (red line, Figure 2.3).  By comparing with 
the control experiment (blue line, Figure 2.3), it appeared that peak 1 referred to the size of 24-
subunit apoFT and peak 2 was indicative of higher aggregates.  The size of 24-mer cluster 
measured by DLS appears somewhat different from the size measured by electron microscopy 
and X-ray crystallographic data (~12 nm in diameter) and might be due to the shape of apoFT, 
which is not perfectly spherical (Smith et al., 1989; Yariv et al., 1981).  Similar to reports by 
Yang and his co-workers, the formation of large aggregates (greater size than the 0.2 μm pore 
size of the filter membrane) of apoFT (peak 2) were observed even though all of the protein 
solution samples were filtered before DLS measurement.  These observations might be 
explained as follows (Yang et al., 1994).  Large aggregates might be broken up during 
filtration but reaggregate quickly after passage through the membrane.  This explanation is 
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consistent with the finding that aggregation was fast under low-salt conditions.  The aggregates 
were not rigid spheres, in which they might be forced to penetrate through the membrane pore 
during filtration.  The size calculation was based on a spherical shape assumption; therefore, 
nonspherical particles would give larger apparent sizes due to their smaller diffusivity in 
solution in the DLS measurement. 
The protein was found to be quite stable after remaining overnight at room temperature, 
since the particle size distribution does not change under these conditions (green line, Figure 
2.3).  However, in order to study the encapsulation reactions of bFT, only the 24-mer cluster is 
the focus of our studies.   
Under acidic conditions, higher protein concentrations were used due to the 
requirement of the Zetasizer Nano ZS instrument.  Some of the protein dissociated into smaller 
subunits, which could not be detected due to their small size (less than 10 nm in diameter) and 
lower protein concentration (lower than 0.5 mg/mL).  Therefore, higher protein concentrations 
(1.0 mg/mL) were used in pH dependence experiments.  However, high protein concentrations 
under acidic conditions may contain larger oligomers.  This aggregation resulted from the 























Figure 2.3: The size distribution by intensity plot of 0.2 mg/mL apoFT (pH 7.0) shows the 
intensity of apoFT that was incubated at room temperature overnight (red line), the intensity of 
apoFT that was incubated for 5 min (green line), and the intensity of filtered apoFT that was also 
incubated for 5 min (blue line).  
 
 
2.4.2: Effect of pH  
A rapid decrease in the size of apoFT was found when the pH was decreased from pH 
3.0 to 1.5 (Figure 2.4).  A size of 9 nm was detected at pH less than 1.5, and 18 nm size was 
detected at pH greater than 3.0.  This decrease in size was almost two times lower (from ~18 
nm to ~9 nm) than the normal size of 24-mer apoFT, which indicated the possible subunit 
dissociation.  This dissociation is expected from the changes in charge repulsion that is a result 
of the protonation of carboxyl residues or charge shielding by Cl- ions that destabilize 
interhelical interactions (Petsev et al., 2000).  Site-directed mutagenesis studies on the residues 
involved in intersubunit stability of R. capsulatus bFT has shown that the carboxylates of 
Glu128 and Glu135 forming the key salt-bridges with Arg61 and amino-terminal amine, 
respectively, were disturbed at a pH close to their pKa values (4.3 for Glu and ~7.8 for amino-
terminal amine), which lead to dissociation of its 24-mer structure (Kilic et al., 2003).  
However, after the protein dissociates into smaller clusters, it can quickly form aggregates 




aggregation may be induced by partial denaturation of the 24-mer cluster apoFT, which then 
exposes hydrophobic portions of the molecule to the water environment and makes aggregation 
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Figure 2.4: The plot of pH of protein solution (HCl addition) versus average size of apoFT (1.0 
mg/mL) as determined by DLS shows a rapid decrease in average hydrodynamic diameter of the 
protein as pH decreases from 3.0 to 1.5.   
 
 
2.4.3: Effect of Electrolytes   
The size measurement of non-filtered apoFT in solution containing no salt gave two 
forms of protein, the 24-mer cluster with a size of ~18 nm and higher oligomer of ~200 nm 
(red line, Figure 2.5).  It was observed that filtered apoFT through a 0.02 μm-pore membrane 
aggregated very quickly without addition of salt to form a self-associated cluster with a size of 
~150 nm (green line, Figure 2.5), while filtered apoFT in solution containing salt exhibits 
predominance of stable 24-mer cluster protein (blue line, Figure 2.5).   
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The protein in a solution containing salt was then declustered at low pH.  When the 
filtered protein in HCl solution (pH 1.5) containing salt was incubated for various times, 
aggregation was observed.  Further experiments on salt concentrations showed that the amount 
of salt added should be in the range of 300-350 mM in order to stabilize the protein in HCl 
solutions (pH 2.5).  However, it was found that although [Na+] did prevent protein aggregation 



















Figure 2.5: The size distribution by intensity plot of apoFT (0.7 mg/mL) with salt control (pH 
7.0).  The red line represents apoFT before filtering, the green line represents apoFT after 
filtering, and the blue line represents apoFT after adding NaCl followed by filtration through a 
0.02 μm-pore membrane. 
 
 
2.4.4: Effect of Glycerol  
Glycerol is another additive evaluated for influencing protein conformational stability 
and preventing aggregation.  It was found that 10% glycerol stabilized the native protein; 
however, aggregates were observed when declustering the protein in solution containing HCl 
(pH 2.5) with the same concentration of glycerol.  This indicated that only glycerol was not 
sufficient to stabilize protein.  The combination of salt and glycerol was then prepared to 
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examine their effect on protein stability.  It was found that 10% glycerol with 100–300 mM 
NaCl stabilized the declustered protein.  Further experimentation showed that a combination of 
200 mM NaCl and 10% glycerol stabilized declustering protein in acid solution (pH 2.5) over 
time (green line, Figure 2.6), while the sample in the acidic solution (pH 2.5) containing only 


















Figure 2.6: The size distribution by intensity plot represents the effects of glycerol on protein 
stability.  The filtered apoFT (0.7 mg/mL) was incubated in solution containing 200 mM NaCl 
and HCl (pH 2.5) with 10% glycerol (green) and without glycerol (red).  The solution was 
measured after incubating at room temperature overnight. 
  
 
2.4.5: Effect of Incubation Time on Dissociation  
 This experiment was done under acidic condition by using HCl solution (pH 1.5) to 
observe fast dissociation processes.  Aggregates were observed after incubation for 5 min 
under acidic condition (pH 1.5) (green line, Figure 2.7).  The 8 min incubation yielded a single 
peak at ~16 nm, which corresponds to the size of 24-mer cluster (blue line, Figure 2.7).  After 
incubation in acid for 12 min, the peak was shifted to the left of the one incubated in acid for 8 
min; however, it also caused a peak shift to the right (~20 nm) and higher aggregation (~1000 
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nm) (black line, Figure 2.7).  This indicated that additional aggregation was occurring.  These 
findings suggest that neutralization to pH 7.0 was necessary after 5 to 8 min to minimize 
protein aggregation.  Another possible cause of aggregates was the direct addition of a high 
concentration of acid to the protein solution.  Therefore, in order to perform encapsulation with 
bFT, the sample could be dialyzed against a solution containing acid to possibly allow for a 



















Figure 2.7: The size distribution by intensity plot represents the effects of declustering time.  The 
filtered apoFT (0.7 mg/mL) in solution containing 200 mM NaCl and 10% glycerol was 
declustering in HCl solution (pH 1.5) for 5 min (green), 8 min (blue), or 12 min (black).  The size 
distribution of the native apoFT is shown in red.   
 
 
2.4.6: Effect of Reassembly Time 
It was shown that declustered protein reformed its 24-subunit quaternary structure (size 
of 18 nm in diameter) within 1 min of neutralizing with NaOH (green line, Figure 2.8), while 
aggregation occurred very rapidly after that.  Aggregation, which is the formation of 
amorphous oligomers, might be due to the rapid increase in pH (blue and black lines, Figure 
2.8).  In order to eliminate aggregation during the reclustering process with bFT, the sample is 
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dialyzed in solution (pH 7.0) for an extended period of time to allow for a more controlled 


















Figure 2.8: The size distribution by intensity plot represents the effects of reassembly time.  The 
filtered 0.7 mg/mL apoFT in solution containing 10% glycerol and 200 mM NaCl was incubated 
in HCl solution (pH 1.5) for 8 min, then NaOH solution was added to neutralize the protein to pH 
7.0.  The sample was then measured for the size distribution immediately (green), or it was 
incubated for 4 min (blue) or for 17 min (black) before measuring the size distribution.  The size 




 It was shown that the particle sizer (Zetasizer Nano ZS) can be used to measure the 
sizes of the spherical particles under specific conditions, in this case, horse spleen apoFT, 
where the 24-subunit cluster size was ~18 nm comparing to 12 nm in diameter from the 
literature.  This offsize measurement might be explained in terms of apoFT shape, which is not 
completely spherical (Singh et al., 1991), or the accuracy of the instrument (Zetasizer Nano 
ZS).  Since the duration setting (10 seconds were used in this thesis) was found to affects the 
accuracy and repeatability of the size results (Malvern manual, Malvern Instruments Ltd, 
Worcestershire, England, 2004), longer duration might increase the accuracy of the 
measurements.  Another possibility is the error bar of the size measurement for small 
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molecules using Zetasizer that is larger than that of the large molecules (such that the size 
measurement of large molecules is more accurate than that of small molecules).  This 
observation is also observed for human FT (Wade et al., 1991).  Another peak shown by DLS 
suggested higher aggregation of apoFT, which was greater than 200 nm in size due to quick 
reaggregation of apoFT after passage through a filter membrane and its nonspherical shape that 
caused incorrect diffusivity in solution. 
It was demonstrated that horse spleen apoFT declustered under acidic conditions (pH < 
3.0), in which the 24-subunit cluster was dissociated into smaller subunits.  At least 1 mg/mL 
samples are required to exceed detection limits of the Zetasizer Nano ZS instrument.  The 
horse spleen apoFT solutions are prepared in a solution containing 200 mM NaCl and 10% 
glycerol to stabilize subunit dissociation under acidic pH.  The slow declustering and 
reclustering processes are best performed by use of protein dialysis as opposed to direct 
acid/base titration of the sample.  This information will be used and the time for declustering 
and reclustering steps will be considered for bFT declustering and reclustering experiments. 
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CHAPTER 3: OVEREXPRESSION AND PURIFICATION OF 
FERROXIDASE CENTER- AND HEME-FREE BACTERIOFERRITIN 
 
3.1: Literature Research on the Ferroxidase Center- and Heme-free Bacterioferritin 
The amino acid residues that are directly involved in the E. coli ferroxidase center are 
Glu18, Glu51, His54, Glu94, Glu127 and His130, while the residue that forms an interaction 
with the heme moiety is Met52.  It was found that mutations of Glu18 to Ala (Glu18→Ala or 
E18A), Glu51→Ala (E51A), Glu94→Ala (E94A), Glu127→Gln (E127Q), and His130→Glu 
(H130E) have greatly reduced abilities to store iron and to maintain Fe(II) oxidation activities 
with no significant affect on the heme environment (Le Brun et al., 1995; Yang et al., 2000; 
Stillman et al., 2003; Baaghil et al., 2003).  It was also found that the E18A mutated protein 
forms an iron core more slowly than the E94A mutant (Keech et al., 1997).  The heme-free 
bFT can be generated by the replacement of Met52 to Leu (M52L).  From site-directed 
mutagenesis studies, it was found that there were no major differences observed in the overall 
rate of iron accumulation for M52L compared to wild-type bFT (Andrews et al., 1995).  
Although the assembly of bFT at physiological pH is not affected by the lack of heme, the iron 
content of bFT-M52L is at least four times greater than that of wild-type bFT (bFT-WT) 
(Andrews et al., 1995).  The substitution of Met52 might have an affect on the coordinating 
ability of Glu51, the adjacent residue that provides a carboxylate side chain bridging the two 
divalent metal ions bound to the ferroxidase center (Figure 1.15).  Besides, kinetic studies have 
shown that heme plays no role in oxygen uptake and iron oxidation (Yang et al., 2000), but 
bound heme to FT does increase the rate of iron release as observed in a reductive assay 
system (Kadir et al., 1992). 
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In order to perform encapsulation experiments with bFT, the iron core must be empty 
before adding guest molecules into the cavity.  There are several methods to empty the iron 
core including utilization of low concentrations of denaturants such as 1 M urea (Liu et al., 
2003), reduction with various thiols such as thioglycollic acid followed by dialysis (Price and 
Joshi, 1983; Funk et al., 1985; Pead et al., 1995), and mutagenesis of residues involved in pore 
formation (Jin et al., 2001).  Under mild conditions that can be used for subunit declustering 
(please see Chapter 2) such as low concentration of denaturants or low pH can also apply to 
iron release.  Frequently, literature applications use reducing agents such as ascorbate to reduce 
Fe(III) stored in the iron core to Fe(II) followed by using an iron chelator such as ferrozine to 
capture free Fe(II) ions that migrate through the protein channels (Moore et al., 1992b; 
Laulhère and Briat, 1993; Stookey, 1970).  However, these methods were selected for their 
ability to restore protein quaternary structure after iron release.   
In this thesis, the ferroxidase- and heme-ligands in bFT were mutated to examine the 
effect of the presence of iron atoms and heme molecules on the formation of the 24-subunit 
cluster.  Ferroxidase-free bFT (bFT-E18A/E94A) and heme-free bFT (bFT-M52L) were 
generated by site-directed mutagenesis.  The combination of these two mutants (bFT-
E18A/M52L/E94A) yielded ferroxidase- and heme-free bFT.  All these bFT variants were then 
purified using heat denaturation, ammonium sulfate precipitation, and gel filtration 
chromatography (Superose 6) to investigate how iron core and/or heme groups affect protein 
stability (Deeb and Hager, 1978; Andrews et al., 1993).  As well, other single mutations (bFT-
E18A, bFT-E94A, and bFT-M52L) and double mutations (bFT-E18A/E94A, bFT-
E18A/M52L, and bFT-M52L/E94A) were also generated to increase our understanding of the 
ability of the triple mutant to remain a stable 24-subunit protein.  Control experiments varying 
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salt concentration, types of salt, protein concentration, and pH were performed to determine the 
most suitable conditions for protein purification. 
 
3.2: Reagents, Materials, and Equipment 
 Reagents and Materials 
 All reagents and materials used in this section of the thesis are listed below otherwise 
they are included in Chapter 2. 
Salts were obtained from various companies such as sodium bicarbonate (NaHCO3) 
from EMD Pharmaceuticals (Durham, NC), ammonium sulfate ((NH4)2SO4) from BHD 
(Toronto, ON), calcium chloride (CaCl2) from Fisher Scientific (Nepean, ON), and sodium 
azide (NaN3) from Sigma Chemical Company (St. Louis, MO). 
Acid-base reagents acquired from Fisher Scientific (Nepean, ON) were as follows: 
phosphoric acid, glacial acetic acid (CH3CO2H), and ethylenediamine tetraacetic acid (EDTA).  
Trichloroacetic acid (TCA) was obtained from EMD Pharmaceuticals (Durham, NC). 
General reagents such as Tris-OH (2-amino-2-(hydroxymethyl)-1, 3-propanedial-
hydroxide) was obtained from VWR (Mississauga, ON), acetone was supplied from EMD 
Pharmaceuticals (Durham, NC), and ethidium bromide and β-mercaptoethanol were from 
Sigma Chemical Company (St. Louis, MO). 
Microbiological reagents acquired from EMD Pharmaceuticals (Durham, NC) were as 
follows: trypton, yeast extract, and isopropyl-β-D-thiogalactopyranoside (IPTG).  
GE Healthcare (Piscataway, NJ) provided sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS PAGE) gel and buffer stripes.  Agarose was obtained from EM Science 
(Gibbstown, NJ).   
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Antibiotic ampicillin (Amp) was obtained from Sigma Chemical Company (St. Louis, 
MO), and carbenicillin (Carb) was obtained from EMD Pharmaceuticals (Durham, NC). 
The 100 bp DNA ladder and all restriction enzymes including T4 DNA ligase, NdeI 
and XhoI were obtained from New England Biolabs (Beverly, MA), while PWO DNA 
polymerase was provided by Roche Diagnostics (Laval, QC). 
Bovine serum albumin (BSA) was obtained from Sigma Chemical Company (St. Louis, 
MO).  Hen egg white lysozyme was obtained from ICN Biochemicals, Inc. (Costa Mesa, CA).  
Bio-Rad protein standard for gel filtration chromatography (thyroglobulin, γ-globulin, 
ovalbumin, myoglobulin, and vitamin B12 with molecular weight 670, 158, 44, 17, and 1.35 
kDa, respectively) was received from Bio-Rad laboratories (Hercules, CA).  Low molecular 
weight calibration kit for SDS electrophoresis (phophorylase b, albumin, ovalbumin, carbonic 
anhydrase, trypsin inhibitor, α-lactalbumin with molecular weight of 97, 66, 45, 30, 20.1, and 
14.4 kDa, respectively) was obtained from GE Healthcare (Piscataway, NJ). 
Coomassie brilliant blue G-250 was obtained from Eastman Kodak Co. (Rochester, 
NY), while Coomassie brilliant blue R, and bromophenol blue were supplied from Sigma 
Chemical Company (St. Louis, MO). 
SuperoseTM 6 10/300 GL column was obtained from Amersham Biosciences (now GE 
Healthcare, Piscataway, NJ).  DNA manipulation including DNA purification, DNA digestion, 
and DNA ligation was performed under construction from QIAprep Spin Miniprep Kit 
(QIAGEN, Mississauga, ON).  Dialysis tubing used in all experiments was Spectra/Por® 
molecular porous membrane with 12-14 kDa molecular weight cutoff (Spectrum laboratories, 
Inc., Rancho Dominguez, CA).  The 0.22 μm GV filter membrane 0.45 μm HV filter 
membrane were obtained from Millipore (Billerica, MA). 
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Equipment 
A SonicatorTM cell disruptor (model W225) with converter model #2 and a standard 
tapered microtip with the output control set at 5 (Heat Systems-Ultrasonics, Inc., Plainview, 
NY) was used for cell wall disruption of crude cell extracts in protein purification. 
The large volume centrifugation in protein purification steps was performed using a 
Avanti® J-E Centrifuge from Beckman Coulter, Inc. (Palo Alto, CA), while small volume 
samples (sample that fits into microcentrifuge tubes) were centrifuged in a tabletop Biofuge A 
microcentrifuge at 13 000 rpm (Heraeus Sepatech GmbH, Germany). 
A fast peptide and protein liquid chromatography (FPLC®) system from Pharmacia 
(now GE Healthcare, Piscataway, NJ) having a LCC-500 chromatography controller, two P-
500 pumps, MV-7 motor valve, UV-M monitor, and REC-482 chart recorder was used to 
purify protein samples and to test for protein quaternary structure. 
A spectrophotometric scanning for confirmation of heme-binding proteins, and optical 
density reading at the specific wavelength for DNA and protein concentration measurements 
were performed using a Varian Cary 3 spectrophotometer (Mississauga, ON) with associated 
software package (designated version 3.04). 
Electrospray mass spectrometer used in this thesis was a Micromass Q-TOF UltimaTM 
Global and supplied by the Waterloo Chemical Analysis Facility, University of Waterloo. 
Cell growth for protein expression and induction was performed by using an incubator 
shaker (series 25) from New Brunswick Scientific Co., Inc. (Edison, NJ) at 220 rpm 37 ºC.  
Antibiotic agar plates for bacterial growth were incubated at 37 ºC using a Precision® gravity 
convection incubator from Precision Scientific, Inc. (Chicago, IL). 
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All polymerase chain reactions were performed using a Techne (TC-512) Thermal 
Cycler from Techgene, Inc. (Princeton, NJ). 
 
3.3: Experimental Protocols 
3.3.1: Protocols for Control Experiments 
The protein was prepared and filtered through a 0.2 μm-pore filter membrane before 
performing fast peptide and protein liquid chromatography using a SuperoseTM 6 10/300 GL 
column to separate globular proteins with molecular weight between 5000-5×106 Da.  The 
Superose 6 column was washed with Milli-Q water for 2 hours and sample buffer for another 2 
hours before sample loading.  The FPLC lamp was warmed up 1 hour prior to sample injection.  
The samples were filtered through 0.2 μm GHP membrane filters before injecting into a 100 
μL loading loop.  The pressure was set to 1 MPa (maximum 1.5 MPa) and the flow rate was set 
to 0.5 mL/min (maximum 1 mL/min).  Eluted fractions were collected immediately after the 
flow was started with sample buffer.  After collecting the eluted sample (~1 column volume), 
the column was washed again with sample buffer for 2 hours and continued washing with 
Milli-Q water for another 2 hours.  At this stage, the column could be kept at 4 ºC for 1-2 days.  
To store the column at room temperature, after washing with water the column was washed 
with 20% ethanol for 2 hours.  All buffers and water were filtered either through a 0.22 μm GV 
filter membrane (for aqueous solution) or a 0.45 μm HV filter membrane (for organic solution) 
and degassed before use. 
Eluted fractions from Superose 6 gel filtration chromatography were visualized by 
staining of SDS PAGE gels.  However, due to low protein concentrations, each eluted fraction 
was concentrated using TCA precipitation.  A mixture of 100 μL of the sample and 100 μL of 
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20% TCA was vortexed before incubating on ice for 30 min and centrifuging at 13 000 rpm for 
15 min at 4 ºC using Beckman JA-14 rotor.  The collected pellet was washed with 300 μL 
acetone and centrifuged for 5 min.  The protein pellet was collected by evaporating the acetone 
under a fume hood.   
SDS PAGE was run using a semi-automated electrophoresis apparatus, Pharmacia 
PhastSystemTM, to separate and visualize proteins in collected fractions.  A sample was 
prepared by dissolving a protein pellet with 10 μL of loading buffer (150 mM Tris-OH, 2% 
SDS, 1% β-mercaptoethanol, 10% glycerol, 0.1% Bromophenol blue pH 8.0).  The mixture 
was boiled for 10 min and centrifuged at 13 000 rpm for 30 seconds before loading onto a 8-
25% acrylamide gel containing SDS.  A staining solution (0.1% Coomassie brilliant blue R, 
30% methanol, 10% acetic acid) was used to stain the gel for 2-3 hours before destaining 
overnight with destaining solution (30% methanol and 10% acetic acid).  Then the gel was 
incubated with a solution containing 5% glycerol and 10% acetic acid to preserve the gel. 
The molecular weight (MW) was calculated using Bio-Rad protein standards for 
Superose 6 gel filtration chromatography, where standard calibration curves of logarithm of 
molecular weigh versus the ratio of elution volume minus void volume to total bed volume 
minus void volume were plotted (Appendix 7).  Superose 6 chromatograms and normalized 
graphs of proteins in different stability conditions were plotted and analyzed.  The control 
experiments included the effect of salt concentration, type of salt, protein concentration, and 





Effect of Salt Concentration 
Three salt concentrations were used to investigate the effect of salt on protein stability 
and quaternary structure.  Horse spleen apoFT (1.35 mg/mL) was diluted into buffer containing 
20 mM Tris-OH (pH 8.0) with various concentrations of NaCl (100, 150, and 200 mM).  These 
buffers were also used as running buffer for gel filtration chromatography. 
 
Effect of Salt Type 
The 3.35 mg/mL bFT solution was diluted in either buffer containing 20 mM Tris-OH 
(pH 8.0) and 100 mM NaCl or buffer containing 20 mM Tris-OH (pH 8.0) and 100 mM KCl, 
which were used as running buffers in gel filtration chromatography. 
 
Effect of Protein Concentration 
Lower protein concentrations of 0.34, 0.68, and 1.35 mg/mL horse spleen apoFT in 
buffer containing 20 mM Tris-OH (pH 8.0) and 100 mM NaCl were prepared before 
performing gel filtration chromatography to study the effect of protein concentration on the 
stability of the 24-subunit cluster.  Higher protein concentrations were studied using bFT.  The 
1.35 and 3.35 mg/mL bFT were prepared under the same conditions as horse spleen apoFT as 
above. 
 
Effect of pH 
Two buffers with different pH were investigated by preparing 3.35 mg/mL bFT in (1) 
buffer containing 20 mM Tris-OH (pH 7.0) and 100 mM NaCl and (2) buffer containing 20 
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mM Tris-OH (pH 8.0) and 100 mM NaCl.  Both buffers were also used as running buffers for 
gel filtration chromatography. 
 
3.3.2: Protein Engineering  
Preparation of Luria-Bertani Media 
 Luria-Bertani (LB) media was prepared by dissolving 10 g tryptone, 5 g yeast extract, 
and 5 g NaCl in 1 L distilled deionized water (ddH2O).   
 
Antibiotic Agar Plate Preparation 
Antibiotic agar plates were prepared by dissolving 3 g agar in 250 mL LB in a warm 
water bath.  The mixture was cooled down to ~37 ºC before adding 100 μg/mL ampicillin.  
The solution was then poured onto plastic petri plates, and the gel was allowed to settle for 2-3 
hours before being stored at 4 ºC. 
 
Preparation of Competent Cells 
The stock cell lines (E. coli strains DH5α for cloning processes and BL21 (DE3) for 
protein expression) were inoculated in LB (3 mL) and shaken at 220 rpm overnight at 37 ºC.  
The culture was transferred to 100 mL LB and shaken until a cell density of OD600 was reached 
0.4-0.6.  The cell pellet was collected by centrifugation (5 min at 4 000 rpm) before 
resuspension in 50 mL ice-cold 50 mM CaCl2.  The mixture was kept on ice for 30 min and 
centrifuged for another 5 min at 4 000 rpm to collect the cell pellet, which then was 
resuspended in 10 mL of 50 mM CaCl2 containing 15% glycerol.  The competent cells were 
then kept on ice for 4 hours before being stored at -80 ºC. 
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Site-directed Mutagenesis, DNA Manipulation, and Cloning 
Site-directed mutagenesis was performed on pT7bFT, the stock plasmid generated from 
the insertion of the bFT encoding gene into the pET-22b(+) plasmid (Novagen, Mississauga, 
ON) (generated by Dr. Elisabeth Daub and Liz Gargatsougias, the Honek Lab, 2004) by 
utilization of the polymerase chain reaction (PCR).  The complement primers were obtained 
from Sigma-Genosys Canada (Oakville, ON) and were designed as in Table 3.1.  The mutation 
was generated by the QuikChange® Site-Directed Mutagenesis method, where complementary 
primers were used to extend each strand of the vector in its entirety while incorporating the 
codon for the desired amino acid substitution.  PCR reagents and plasmids were set up as in 
Table 3.2 and programmed as in Table 3.3.  Standard DNA manipulation and bacterial cloning 
were performed as stated using standard molecular biology protocols (Sambrook et al., 1989).  
PCR plasmids were digested with DpnI restriction enzyme that was specific to methylated 
DNA before heat shock transforming into competent E. coli cells (strain DH5α) followed by 
growth on Amp containing agar plates overnight at 37 ºC.  A single colony was picked and 
inoculated overnight with 5 mL LB containing Amp (50 μg/mL LB) at 37 ºC in a 220 rpm 
shaker.  Plasmid purification was performed using a QIAprep Spin Miniprep Kit.   
 The concentration of purified DNA was calculated by measuring the OD260, in which 
one unit optical density at OD260 was approximately 50 μg/mL of DNA.  DNA samples were 
sent for sequencing when appropriate (Mobix Central facility, DNA Synthesis Laboratory, The 
Institute for Molecular Biology and Biotechnology, McMaster University, Hamilton, ON).  
The determined DNA sequences were compared with that of wild-type bFT using BLAST2 
program (Tatusova and Madden, 1999) to check and confirm successful mutagenesis.   
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The purified plasmid was used for generating double and triple mutations by repeating 
the site-directed mutagenesis steps.  The double mutation, bFT-E18A/M52L, was generated 
using bFT-E18A as the host plasmid with bFT-M52L.For and bFT-M52L.Rev oligonucleotides 
as primers.  The DNA for bFT-E18A/E94A was generated similarly.  The plasmid generated 
for bFT-M52L/E94A used bFT-M52L as host plasmid and bFT-E94A.For and bFT-E94A.Rev 
as primers.  The triple mutation, bFT-E18A/M52L/E94A, was generated using double 
mutation, bFT-E18A/E94A, as host plasmid and bFT-M52L.For and bFT-M52L.Rev as 
primers.  The protocols are summarized in the flow chart in Appendix 1.   
All single, double, and triple mutations were generated using the QuikChange® Site-
Directed Mutagenesis method except for the bFT-E94A mutation.  This single mutation was 
generated by digesting bFT-E18A/E94A and bFT-WT plasmids with BsmI and HindIII 
restriction enzymes at 37 ºC for 3 hours.  Digested DNA was mixed with sample buffer 
provided by New England Biolabs (Beverly, MA) before loading to 1% agarose gel, which was 
prepared by dissolving agarose (1 g) with 100 mL TAE (Tris-acetate-EDTA buffer containing 
40 mM Tris-OH (pH 8.0), 20 mM glacial acetic acid, and 1 mM EDTA) with the addition of 
10 μL of ethidium bromide, poured into a plastic chamber and allowing the gel to settle.  The 
agarose gel was run at 100 V for approximately 2 hours before visualization under UV light.  
The bands containing the desired DNA were cut and plasmid purification was performed using 
a QIAprep Spin Miniprep Kit.  Ligations were performed using T4 ligase enzyme (3 hours at 
14-16 ºC) to insert the E94A fragment into the bFT-WT plasmid.  Plasmid DNA was 
transformed into heat shocked E. coli cells (strain DH5α) followed by visualizing similar 
cloning protocols as other variants generated by PCR (Appendix 2).   
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Table 3.1: The forward and reverse primers used to generate each mutation by site-directed 
mutagenesis. 
 
Mutation Primer name  Sequence of primer (5′ to 3′) 
bFT-E18A† bFT-E18A.For  CTG TTG GGA AAT GCG£ CTT GTC GCA ATC 
 bFT-E18A.Rev GAT TGC GAC AAG CGC ATT TCC CAA CAG 
 
bFT-M52L† bFT-M52L.For CC ATT GAT GAG CTG AAA CAC GCC G 
 bFT-M52L.Rev  C GGC GTG TTT CAG CTC ATC AAT GG 
 
bFT-E94A† bFT-E94A.For GAT CTG GCA CTT GCG CTG GAT GGC GCG 
 bFT-E94A.Rev
  
CGC GCC ATC CAG CGC AAG TGC CAG ATC 
£ The bold-italics indicate the codons modified to obtain the desired amino acid substitutions.   
† The melting temperature (Tm) for bFT-E18A primers is 61 ºC, for bFT-M52L primers is 59 




Table 3.2:  PCR recipe for bFT variants except bFT-E94A derived from QuikChange® Site-
Directed Mutagenesis Instruction Manual from Stratagene (La Jolla, CA). 
 
Plasmids/Reagents Stock Concentration Amount Used (μL) Final Concentration 
DNA a x 20 ng 
Primer.For 1 μM 5.0 1 pmol 
Primer.Rev 1 μM 5.0 1 pmol 
dNTP 10 mM 1.0 0.2 mM 
PWO Buffer 10× 5.0  
Mg2+ 25 mM y b 
ddH2O  z  
PWO polymerase  0.5  
Total  50.0  
a depends on efficiency of plasmid purification and b depends on amount of Mg2+ used. 
x depends on DNA stock concentration and will yield same final concentration of 20 ng DNA.   
y is variable, which normally was 1, 2, or 3 μL (0.5 mM, 1.0 mM, and 1.5 mM, respectively) 
used to maximize PCR products.   











Table 3.3: PCR Programming protocols for QuikChange® Site-Directed Mutagenesis method. 
 
Steps Temperature (ºC) Time 
Initial Denaturation† 95 5 min 
Hot Start‡ 85  
Denaturation 95 30 sec 
Annealing* 55 1 min 
Elongation 72 10 min 
Final Extension 72 10  min 
Hold 4  
† Initial denaturing temperature was used to ensure DNA template denaturation. 
‡ Hot start was used to maintain the temperature at 85 ºC during adding PWO DNA 
polymerase to minimize self annealing of primers. 
* Annealing temperature was altered depending on the Tm of the primers (~6 ºC lower than Tm) 
i.e. annealing temperature for generating bFT-E18A, bFT-E18A/M52L, bFT-E18A/E94A, and 
bFT-E18A/M52L/E94A is 55 ºC, for bFT-M52L is 53 ºC, and for bFT-M52L/E94A is 60 ºC. 
 
 
3.3.3: Protein Expression, Induction, and Purification 
The purified plasmid was heat shock transformed into competent E. coli cells (strain 
BL21 (DE3)), and the transformed cells were grown on agar plates containing Amp (overnight 
at 37 ºC).  Single colonies of E. coli cells containing desired plasmids were picked and 
inoculated overnight with LB (5 mL) containing Amp (50 μg/mL LB) at 37 ºC incubator 
shaker (shaken at 220 rpm).  The culture was then transferred into 1 L LB containing 40 
μg/mL carbenicillin and allowed to grow for 3 hours at 37 ºC with shaking (220 rpm or until 
OD600 reached 0.6).  The proteins were induced by addition of 1 mM IPTG, and shaking was 
continued at the same speed for 3 hours.  The culture was then centrifuged (10 000 g for 10 
min) using Beckman JA-14 rotor.  The supernatant was discarded, and the remaining pellet 
was resuspended in a minimal volume of buffer containing 20 mM Tris-OH (pH 8.0) and 0.5 
M NaCl before centrifugation at 15 000 g for an additional 10 min.  The cell pellet was then 
collected and flash frozen in liquid nitrogen before storing at -80 ºC. 
Repeat 16 cycles 
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The frozen pellet was resuspended in buffer containing 20 mM Tris-OH (pH 8.0) with 
the addition of 1 mg/mL hen egg white lysozyme.  The temperature shock by placing the 
suspension in liquid nitrogen and then warm water immediately (repeated 5 times) was used to 
rupture the cells.  Heat denaturation was used for deactivation of lysozyme and was performed 
by warming the suspension in a water bath (60-70 ºC) for 15 min before cooling to 4 ºC.  
Sonication was performed at the same temperature (4 ºC) for 15-20 rounds (10 sec each) using 
SonicatorTM cell disruptor.  The suspension was then centrifuged at 20 000 rpm for 15 min 
using a JA-25.50 rotor.  The pellet was discarded, while the supernatant was heated in a hot 
water bath (60-70 ºC) for 15 min followed by cooling to 4 ºC to eliminate E. coli proteins 
before continuing centrifugation at the same speed and time to collect the supernatant.  E. coli 
proteins in this supernatant were eliminated by slow addition of a 25% (w/v) ammonium 
sulfate solution on ice followed by centrifugation at 15 000 g for 30 min.  The supernatant after 
this centrifugation contained bFT, which was collected by addition of a 40% (w/v) ammonium 
sulfate solution on ice and centrifuged at 15 000 g for 30 min.  The protein pellet was 
solubilized by dialysis for 2 days against 20 mM Tris buffer (pH 8.0) which contained 100 mM 
NaCl (dialysis buffer was changed twice) using a 12-14 kDa cutoff dialysis membrane, which 
was prepared as follows.  In order to eliminate other chemicals that might contaminate the 
protein during the preparation, the dialysis tubing was boiled in a wash solution (300 mL 
ddH2O, 6 g NaHCO3, and 150 mg EDTA) for 10 min, then rinsed with ddH2O several times.  
The clean dialysis tubing was then stored at 4 ºC in Milli-Q water containing 0.02% sodium 
azide to prevent bacterial growth.  The overall protein purification is shown as a flow chart in 
Appendix 3. 
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The existence of the proteins was confirmed by mass spectrometry (MS).  In order to 
determine their molecular weight by positive ion mode-electrospray mass spectrometry, the 
samples were prepared by exchanging sample buffer with Milli-Q water using Nanosep® 
Centrifugal devices with 10K molecular weight cutoff (PALL, East Hills, NY).  The samples 
were then diluted into a solution containing 50/50 acetonitrile/water with 0.2% formic acid in 
the ratio of 1:1 before injecting into the mass spectrometer.   
The Bradford assay was used to determine protein concentration (Bradford, 1976).  
Bradford dye was prepared by dissolving 100 mg Coomassie Brilliant Blue G-250 with 50 mL 
95% ethanol.  Then 100 mL of 85% (w/v) phosphoric acid was added to the solution, which 
was then diluted to 0.5 L with ddH2O.  The solution was mixed and added up to 1 L with 
ddH2O before filtering through Whatman#1 filter paper.  The reference sample was prepared 
by diluting 10 mg/mL BSA to 1 mg/mL with the same buffer as the unknown samples.  The 
Bradford assay standard curves were plotted (OD595 vs. BSA concentrations) by preparing 
triplicate sets of different concentrations of BSA (0, 5, 15, 25, 35, 45 μL).  Each standard 
sample was made up to 50 μL with sample buffer before addition of 2.5 mL of dye solution.  
The solution was vortexed, and absorption at 595 nm was measured using spectrophotometry.  
Bradford assays for samples were performed similarly to standard samples.  The protein 
concentration was calculated by comparing OD595 values with those of Bradford assay standard 
curve values. 
Heme-binding was investigated using spectroscopic methods.  The protein samples 
were prepared by filtering through 0.2 μm-pore filter membranes before loading onto 1 mL 
quartz cuvettes.  Absorption was scanned from 300-600 nm at room temperature.  The values 
of absorption versus wavelength were plotted.  The comparison between wild-type bFT and 
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each bFT variant’s chromatograms demonstrated the absorption of heme groups present in the 
mutant bacterioferritin. 
Gel filtration chromatography (Superose 6) was used for further purification and 
investigation of protein stability (ability to maintain 24-subunit clusters for bFT wild-type and 
variants).  The protein samples were diluted with running buffer containing 20 mM Tris-OH 
(pH 8.0) and 100 mM NaCl to 1.35 mg/mL before filtering through a 0.2 μm-pore filter 
membrane.  The running buffer was filtered through a 0.22 μm GV filter membrane and 
degassed before use.  To detect proteins presented in each eluted peak, Superose 6 fractions 
were concentrated by TCA precipitation before visualization by dye staining of SDS PAGE 
gels.  The molecular weight was calculated using a Bio-Rad protein standard plot for gel 
filtration chromatography.  This MW was related to protein size and its conformation (i.e. MW 
with two times greater than that of literature subunit MW represented dimeric subunits).  The 
normalized Superose 6 gel filtration chromatograms of bFT-WT and bFT variants were also 
plotted to demonstrate the overlap of eluted peaks that contained similar protein quaternary 
structure.  For the triple mutant, bFT-E18A/M52L/E94A, the eluted 2-subunit and 24-subunit 
fractions from Superose 6 gel filtration chromatography were concentrated by centrifuging at 
10 000 rpm using Nanosep® Centrifugal devices with 10K molecular weight cutoff until 
reaching minimal volume (~300 μL).  The concentrations of these concentrated proteins were 
measured using the Bradford assay.  The protein samples were then reloaded onto Superose 6 








3.4: Results and Discussion 
3.4.1: Control Experiments 
Effect of Salt Concentration 
Superose 6 gel filtration chromatograms of commercial apoFT in various salt 
concentrations contained two peaks, which eluted at the time ~25 and 29 min (Figure 3.1).  
The MW calculation from the Bio-Rad protein standard plots for gel filtration chromatography 
was used to determine that peak 1 consisted of self-associated cluster of apoFT with MW 
~1000 kDa and peak 2 was the native 24-subunit containing native protein (MW ~330 kDa).  
The comparison of these chromatograms showed that salt concentrations between 100-200 mM 
possessed similar effects on protein quaternary structure (Figure 3.2).  Since the MW of the 24-
subunit apoFT in buffer containing 100 mM NaCl was similar to that of the literature (~440 
kDa), then buffer conditions might be appropriate to stabilize the 24-subunit cluster protein 
(Table 3.4).   
A small difference in MW between experimental and literature protein suggested 
possible interference of salt with the interaction between the protein and resin in Superose 6 
column.  It was found that nitric reductase behaved similarly (smaller MW determined by gel 
filtration chromatography than MW estimated by other methods), in which the authors 
suggested that gel filtration was not suitable for the MW determination and the MW could not 
be used to determine the behavior of the macromolecules upon gel filtration (Husain and 
Sadana, 1974).  In addition, the plot of MW versus relative mobility measured by SDS PAGE 
was used to evaluate MW (Husain and Sadana, 1974).  It was also suggested that the gel 
filtration chromatography could be used to determine Stokes radius (Husain and Sadana, 1974; 
Siegel and Monty, 1966).  By plotting the graph of Stokes radius versus elution volumes of 
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protein standards, the Stokes radius of protein sample could be predicted.  It is showed that by 
plotting experimental elution volume of protein standards with their known Stokes radius 
(Appendix 7) (Qasim and Salahuddin, 1979; Andrews, 1970; Cui et al., 2002; Husain and 
Sadana, 1974; Siegel and Monty, 1966), the experimental Stokes radius of apoFT (14.5 mL 
elution volume) is 62.8 Å, which corresponds to that of the literature (67.1 Å Stokes radius) 
(De Haën, 1987).  By using the combination of the Stokes-Einstein and Svedberg equations 
and literature sedimentation coefficient (17S) (Notides and Williams-Ashman, 1967; Rothen, 
1944) (calculation is shown in Appendix 7), it is found that the calculated molecular weight of 
24-subunit apoFT is 446 kDa.  It was also found that the literature elution volume of FT is 
14.82 mL determined by Superose 6 gel filtration chromatography (14.5 mL elution volume 
for apoFT) (Chilkova et al., 2003).  Therefore, from this data it is suggested that the 
experimental elution volume at ~29 min (14.5 mL) corresponds to the 24-subunit protein.  It is 
also suggested that the low MW of protein samples determined by Superose 6 gel filtration 
chromatography might be shape dependence, in which the protein samples loading into the 
Superose 6 column might possess packed quaternary structures (smaller size than the native 
proteins), causing smaller MW than that of the literature MW.  In addition, if the sedimentation 
coefficient is known (with the uses of the plot of Stokes radius versus elution volume and the 
combination of the Stokes-Einstein and Svedberg equations), then the correct MW of bFT can 
be calculated.  However, Superose 6 gel filtration chromatography can be used to demonstrate 

















Figure 3.1: Superose 6 gel filtration chromatograms of 1.35 mg/mL apoFT in buffer containing 20 
mM Tris-OH (pH 8.0) and either 100 mM (a), or 150 mM (b), or 200 mM (c) NaCl show two 





























Figure 3.2: Normalized Superose 6 gel filtration chromatograms of apoFT in 20 mM Tris-OH 
(pH 8.0) containing 100 mM (blue), 150 mM (black), or 200 mM (green) NaCl.  The molecular 




Table 3.4: The molecular weight of each eluted peak of Superose 6 gel filtration chromatography 
varies under different salt concentrations. 
 
[NaCl] (mM) Molecular weight (kDa) 
 Peak 1 Peak 2 
100 1034 359 
150 1034 334 
200 898 312 
 
 
Effect of Salt Type 
Different types of salts might generate particular effects on protein quaternary structure 
and/or interaction between protein and Superose 6 resin due to ion characteristics such as 
charge, size, and electrostatic properties.  Superose 6 gel filtration chromatograms of bFT-WT 
in Tris buffer (pH 8.0) containing two types of salts, NaCl and KCl, showed the overlap of 24-
subunit peaks (Figure 3.3).  Since this protein was experimentally purified, it might contain 
smaller subunit combinations of bFT that are observed as eluted peaks after 35 min.  The MW 
of the 24-subunit bFT-WT in buffer containing NaCl was 250 kDa, while that of protein in 








closer to that of the literature, NaCl might be a better choice of salt to stabilize the 24-mer 
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Figure 3.3: The normalized Superose 6 gel filtration chromatograms of 3.35 mg/mL bFT-WT in 
buffer containing 20 mM Tris-OH (pH 8.0) and either 100 mM KCl (blue) or 100 mM NaCl 
(black).   
 
 
Effect of Protein Concentration 
It was suggested in the Introduction section of Chapter 2 that protein concentration has 
an effect on the formation of 24-subunit apoFT (Lee and Richter, 1976).  It was shown that the 
protein concentration is related to stability of the 24-subunit cluster, in which high apoFT 
concentration yielded a greater amount of 24-subunit formation (Figure 3.4).  However, 
Superose 6 chromatograms and MW calculations for different concentrations of apoFT 
demonstrated the overlap of 24-subunit peaks with similar MWs (334.6, 335.0, and 359.0 kDa 
for 0.34, 0.67, and 1.35 mg/mL protein, respectively) (Figure 3.4).  A greater amount of self-
associated clusters (eluted peak at ~25 min) at higher protein concentration (1.35 mg/mL) 
suggested strong interaction between clusters with higher possibility to form aggregates.  The 
smaller subunits (eluted peak after 35 min) were not observed even in low protein 







The effects of protein concentration were similar for bFT, where the normalized 
Superose 6 gel filtration chromatograms of 1.35 mg/mL and 3.35 mg/mL bFT in Tris buffer 
(pH 8.0) containing 100 mM NaCl represented the overlap of 24-subunit peaks (Figure 3.5).  It 
was confirmed that protein concentration for both apoFT and bFT had similar effects on 








Figure 3.4: The normalized Superose 6 gel filtration chromatograms of 0.34 (blue), 0.68 (black), 
and 1.35 (green) mg/mL apoFT in buffer containing 20 mM Tris-OH (pH 8.0) and 100 mM NaCl 
represents the overlap of different intensity of 24-subunit peaks and the formation of self-
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Figure 3.5: The normalized Superose 6 gel filtration chromatograms of 1.35 mg/mL bFT-WT 
(blue) and 3.35 mg/mL bFT-WT (black) in 20 mM Tris-OH (pH 8.0) and 100 mM NaCl show the 
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Effect of pH 
Buffer at different pHs might influence the protonation of acidic residues in the 
proteins, which would in turn affect protein-protein interactions and/or protein-resin 
interactions.  Two buffers with pH 7.0 and 8.0 were examined as to how and as to which one 
would yield higher native protein structure stability.  It was shown that protein in both buffers 
yielded similar 24-subunit peak intensities (MW = 187 and 250 kDa, respectively) (Figure 
3.6).  Since the MW of the protein in solution at pH 8.0 was closer to that of the literature, this 
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Figure 3.6: The normalized Superose 6 gel filtration chromatograms of 3.35 mg/mL bFT-WT in 
buffer containing 100 mM NaCl and either 20 mM Tris-OH (pH 8.0) (blue) or 20 mM Tris-OH 
(pH 7.0) (black).   
 
 
3.4.2: Cloning of Wild-type and Bacterioferritin Mutants 
The results for cloning, all the sequences of wild-type bFT and bFT variants, are 
presented in Appendix 4.  All sequences were compared with the sequence of bFT-WT using 
the online BLAST2 program (http://www.ncbi.nlm.nih.gov/blast/bl2seq/wblast2.cgi), which 







inserting the E94A fragment into bFT-WT plasmid is shown in Figure 3.7.  The digested DNA 
fragment of bFT-WT was ~5400-base pair (bp) and that of bFT-E18A/E94A was ~300 bp.  
The inserted fragment was not clearly shown due to its small size.  The difficulty of generating 
this single mutation by QuikChange® Site-Directed Mutagenesis method suggested a strong 
self-secondary structure of the primers even with high annealing temperature (61 ºC).  Another 
possibility due to the successful insertion of E94A into bFT-E18A and bFT-M52L by PCR was 
that bFT-WT DNA might form a strong hairpin or complicated loop at this area (E94), so that 




Figure 3.7: The 1% agarose gel illustrates the digestion of bFT-WT and bFT-E18A/E94A with 




3.4.3: Overexpression and Purification of Wild-type and Bacterioferritin Mutants 
 The purification of wild-type bFT and all variants yielded similar results.  The 
purification protocols were sufficient, yielding pure proteins after a final dialysis step.  The 
most effective method in the purification was found to be the heat treatment at 65-70 ºC.  
Indeed, it would appear that heat stability is a universal property of bFT and FT, possibly 
reflecting the need for an iron-storage molecule that does not easily denature and release its 








1 1 kb DNA ladder 
2 bFT-WT digested with BsmI and HindIII 
3 bFT-E18A/E94A digested with BsmI and HindIII 
~300 bp 
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showed two bands at 40 and 18.5 kDa (Figure 3.8), which corresponded to the size of a dimer 
(2 subunits) and a monomer (1 subunit).  The 40 kDa MW suggests a strong interaction 
between two subunits, which could not be completely denatured.  It is believed that a dimer 
subunit is the main multimeric form of the protein compared to other possible oligomers other 
than the intact 24-mer cluster. 
 Mass spectrometry of all wild-type and bFT variants support the proper molecular 
weight of each protein sample, in which MW calculated from the amino acid residues was 
similar within experimental error to the MW determined by MS (Appendix 5).   
 UV spectroscopy provided evidence for the presence of heme in the protein samples, in 
which the absorption peaks at 418, 525, and 560 nm associated with the Soret, β, and α bands 
of the oxidized heme moiety, respectively, are present (Appendix 6).  An example of the UV 
spectrum from the chromatogram of bFT-WT represents a clearly observed peak at 418 nm and 
two small peaks at 525 and 560 nm (Figure A6.1).  The peak at 418 nm was absent in the 
chromatogram of bFT without the heme group (i.e. bFT-M52L) (Figure A6.3).  The low iron 
content of overproduced bFT was expected and was presumably due to the increased iron 
storage capacity of the overproducing strain relative to the cellular iron content. 
Superose 6 gel filtration chromatograms of wild-type bFT and all bFT variants were 
plotted, MW of eluted peaks containing proteins were calculated (using Bio-Rad standard 
protein plot), and eluted peaks containing proteins were visualized by staining the SDS PAGE 
gels (Appendix 7).  For example, the Superose 6 gel filtration chromatogram of 3.35 mg/mL 
bFT-WT consisted of six main peaks, which were found to be a self-associated cluster at ~26 
min (919 kDa), 24-subunit at 29 min (247 kDa), a dimer at 36 min (27 kDa), and a monomer at 
38 min (19 kDa) of the running time (Figure 3.9, Figure 3.10, and Table 3.5).  By comparing 
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this chromatogram with that of apoFT, similar eluted peak at ~29 min from both 
chromatograms supports the existence of the 24-mer cluster.  The molecular weight of the 24-
subunit cluster calculated by protein standards was off by approximately 250 kDa (literature 
MW is 440 kDa), which might be due to similar reasons as those of apoFT as above.  It was 
also shown that 24-subunit was a dominated quaternary structure.  The eluted peak at 44 and 
46 min (peak 5 and 6 in Figure 3.9) might contain small proteins, nucleic acids, or heme-
containing proteins.  Spectroscopic analysis of the chromatograms of peak 5 and peak 6 were 
similar.  There were no absorptions at 418 nm, which indicated no heme-binding protein or a 
low amount of heme-containing protein, which could not be detected by UV (Figure 3.11).  A 
less intense peak at 280 nm suggested low protein concentration in this fraction, while 
absorption at ~250-260 nm suggested a trace of nucleic acid (Figure 3.12).  Therefore, these 
two eluted peaks might contain low concentration of protein or no protein, in which they might 



















Figure 3.8: SDS PAGE gel of the protein purification of bFT-E18A by heat denaturation and 
ammonium sulfate precipitation.  The molecular weight at 18.5 kDa represents a monomer and 
40 kDa represents a dimer bFT mutant.  The list below indicates each step of the purification 
protocol. 
 
Lane Sample Lane Sample 
1 MWM 6 Pellet from 25% ammonium sulfate 
2 Pellet from sonication 7 Supernatant from 25% ammonium sulfate 
3 Supernatant from sonication 8 Pellet from 40% ammonium sulfate 
4 Pellet from heat denaturation 9 Supernatant from 40% ammonium sulfate 








Figure 3.9: The Superose 6 chromatogram of 3.35 mg/mL bFT-WT in 20 mM Tris-OH (pH 8.0) 

























Table 3.5: The calculated molecular weight of each eluted peak from gel filtration 
chromatography (Superose 6) of 3.35 mg/mL bFT-WT in 20 mM Tris-OH (pH 8.0) and 100 mM 
NaCl calculated using the Bio-Rad protein standard. 
 
bFT-WT  MW (kDa) log (MW) Ve (mL) Ka 
Peak 1 (self-associated cluster) 919.39 2.9635 12.80 0.3000 
Peak 2 (24-mer) 247.05 2.3928 14.70 0.4188 
Peak 3 (dimer) 27.01 1.4316 17.90 0.6188 
Peak 4 (monomer) 19.12 1.2814 18.40 0.6500 
Peak 5 2.09 0.3202 21.60 0.8500 










Figure 3.10: SDS PAGE results of Superose 6 eluted peaks of 3.35 mg/mL bFT-WT in 20 mM 
Tris-OH (pH 8.0) and 100 mM NaCl.  The list below indicates loading samples (Superose 6 eluted 
peak) in each lane. 
 
 
Lane  Sample    
      1  MWM    
       2  Eluted peak 1 of bFT-WT   
      3  Eluted peak 2 of bFT-WT 
      4  Eluted peak 3 of bFT-WT 
      5  Eluted peak 4 of bFT-WT 
  6  Eluted peak 5 of bFT-WT 
  7  Eluted peak 6 of bFT-WT 
 
 
















Figure 3.11: The UV-visible spectrum of peak 6 bFT-WT from Superose 6 (peak 6 in Figure 3.9) 
scanned from 300-600 nm shows that there is no absorption at 418 nm wavelength (corresponding 






Figure 3.12: The UV spectrum of peak 6 bFT-WT from Superose 6 (peak 6 in Figure 3.9) scanned 
from 220-300 nm shows an intense peak at ~260 nm and small peak at 280 nm. 
 
 
3.4.4: Protein Stability of Wild-type and Bacterioferritin Mutants 
Protein stability was examined by Superose 6 gel filtration chromatography by 
comparing chromatograms of bFT-WT with bFT variants.  All single mutations (bFT-E18A, 
bFT-M52L, and bFT-E94A) possessed similar Superose 6 chromatograms.  It was shown that 
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bFT-E18A formed 24-mer, 12-mer, dimeric, and monomeric oligomers (Figure 3.13).  
However, the 12-mer peak was not clearly shown, and the dimer was a stable conformation for 
this mutation.  For bFT-M52L, it was shown that only the 24-subunit cluster and the dimer 
were the stable forms, and the dimer was more stable than the 24-mer (Figure 3.14).  The 
Superose 6 chromatogram of Bfr-E94A represented the presence of a higher amount of the 24-
mer cluster than the dimer (Figure 3.15).  From these single mutations, it was observed that the 
bFT-E94A mutation stabilized the highest proportion of 24-subunit cluster, which was the 
lowest fraction in bFT-E18A even thought both amino acids (E18 and E94) are components of 
the ferroxidase center (Table 3.6).  The positions of Glu18 and Glu94 that are located at the 
outer helices of bFT face the inner core and have less possibility to affect protein-protein 
interactions, which may relate to the formation of the 24-subunit cluster (Figure 3.22).   
For double mutations, it was shown that bFT-E18A/M52L and bFT-E18A/E94A exist 
predominantly as the 24-mer cluster and the monomer (Figure 3.16 and 3.17).  However, bFT-
E18A/M52L possessed a higher proportion of single subunits, which was probably a result 
from the combination of single mutations (bFT-E18A and bFT-M52L) that also yielded greater 
proportion of smaller subunits than 24-mer cluster (Table 3.6).  For bFT-E18A/E94A, the 24-
subunit formation is higher than that of bFT-E18A/M52L.  A possible explanation is that the 
single mutation bFT-E94A yielded more 24-mer proportionally to that of bFT-M52L.  The 12-
mer might exist in bFT-E18A/E94A; however, this peak in the chromatogram was not clearly 
observed.  The Superose 6 chromatogram of bFT-M52L/E94A showed a favored dimeric 
structure (Figure 3.18), suggesting the effect of M52L and E94A to the structure of 24-subunit.  
However, the positions of these two amino acid residues had less possibility to interfere with 
protein-protein interactions.  The 24-subunit and the smaller subunits of bFT-M52L were in 
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reverse proportion to those of bFT-E94A; therefore, the combination of both mutants was 
expected to yield 50/50:24-subunit/smaller subunits (Table 3.4).  However, this prediction was 
not correct. 
The triple mutant, bFT-E18A/M52L/E94A, had a similar Superose 6 chromatogram to 
that of bFT-WT (Figure 3.19), and it consisted of three forms of protein, 24-subunit cluster, a 
dimer, and a monomer.  However, the dimer was found to be the predominant form.  The 
proportion of the 24-subunit and smaller subunits were also considered from its components of 
single mutations and double mutations.  Since all mutants except bFT-E94A yielded higher 
proportions of smaller subunits than the 24-mer, it was expected that the triple mutant would 
possess similar proportions (Table 3.6).  In order to test for stability of the dimer, the eluted 
dimeric peak was concentrated and reloaded onto the Superose 6 column.  It was shown that 
the concentrated dimer does not reform the 24-mer.  However, this might be due to its lower 
protein concentration (0.40 mg/mL) (Figure 3.20).  The eluted 24-subunit fraction was also 
concentrated and similarly tested for stability.  It was observed that this protein fraction 
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Figure 3.13: The normalized Superose 6 chromatograms of 3.35 mg/mL bFT-WT (blue) and 1.35 
mg/mL bFT-E18A (black) in 20 mM Tris-OH (pH 8.0) and 100 mM NaCl showing the overlap of 
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Figure 3.14: The normalized Superose 6 chromatograms of 3.35 mg/mL bFT-WT (blue) and 1.35 
mg/mL bFT-M52L (black) in 20 mM Tris-OH (pH 8.0) and 100 mM NaCl showing the overlap of 
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Figure 3.15: The normalized Superose 6 chromatograms of 3.35 mg/mL bFT-WT (black) and 
1.35 mg/mL bFT-E94A (blue) in 20 mM Tris-OH (pH 8.0) and 100 mM NaCl showing the overlap 
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Figure 3.16: The normalized Superose 6 chromatograms of 3.35 mg/mL bFT-WT (blue) and 1.35 
mg/mL bFT-E18A/M52L (black) in 20 mM Tris-OH (pH 8.0) and 100 mM NaCl showing the 
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Figure 3.17: The normalized Superose 6 chromatograms of 3.35 mg/mL bFT-WT (black) and 
1.35 mg/mL bFT-E18A/E94A (blue) in 20 mM Tris-OH (pH 8.0) and 100 mM NaCl showing the 
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Figure 3.18: The normalized Superose 6 chromatograms of 3.35 mg/mL bFT-WT (blue) and 1.35 
mg/mL bFT-M52L/E94A (black) in 20 mM Tris-OH (pH 8.0) and 100 mM NaCl showing the 
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Figure 3.19: The normalized Superose 6 chromatograms of 3.35 mg/mL bFT-WT (black) and 
3.35 mg/mL bFT-E18A/M52L/E94A (blue) in 20 mM Tris-OH (pH 8.0) and 100 mM NaCl 
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Figure 3.20: The normalized Superose 6 chromatograms of 3.35 mg/mL bFT-E18A/M52L/E94A 
(blue) and 0.40 mg/mL 2-subunit peak of bFT-E18A/M52L/E94A (black) in 20 mM Tris-OH (pH 
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Figure 3.21: The normalized Superose 6 chromatograms of 1.01 mg/mL 24-mer peak (black) and 
5.89 mg/mL bFT-E18A/M52L/E94A (blue) in 20 mM Tris-OH (pH 8.0) and 100 mM NaCl show 






























Figure 3.22: The ribbon structure of E. coli bFT showing Glu18 and Glu94, which are facing the 
inner core (a) and locating at the outer helixes (b) (PDB entry 1BCF) (Frolow et al., 1994).  The 




Table 3.6: A summary of the protein structure, 24-subunit and smaller subunits (dimer and 
monomer), of wild-type bFT compared with bFT variants. 
 
Samples Protein concentration  Protein conformation‡ (%) 
 (mg/mL) 24-subunit Dimer and monomer
bFT-WT 3.35 80 20 
bFT-E18A 1.35 20 80 
bFT-M52L 1.35 40 60 
bFT-E94A 1.35 60 40 
bFT-E18A/M52L 1.35 25 70 
bFT-E18A/E94A 1.35 40 60 
bFT-M52L/E94A 1.35 0 100 
bFT-E18A/M52L/E94A 3.35 30 70 





























 The control experiments suggest that a suitable condition for stabilizing the 24-subunit 
structure includes use of high protein concentration in buffer containing 20 mM Tris-OH (pH 
8.0) and 100 mM NaCl.  The heat denaturation and ammonium sulfate precipitation steps were 
sufficient methods for protein purification.  The Superose 6 gel filtration chromatographic 
results indicate the approximate amount of 24-subunit clusters of bFT-WT and bFT variants.  
All except bFT-M52L/E94A formed mixtures of the self-associated cluster, 24-subunit, and 
smaller subunit conformations.  The only mutant that showed significant presence of dimer 
was the bFT-M52L/E94A mutant.  All variants were unable to remain high proportion of 
completely in the intact 24-subunit form after purification as bFT-WT, although the specific 
amino acid positions seemed to have no easily explainable reason for their effect on the 24-mer 
formation.   
In order to study the use of bFT in encapsulation, it is necessary to use bFT or a variant 
that produces high levels of stable 24-mer cluster.  Since the dimer structure is favored in the 
ferroxidase- and heme-free variant (bFT-E18A/M52L/E94A), wild-type bFT was used for 
further study of the potential for this protein to be useful in encapsulation studies as shown in 
the next chapter. 
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CHAPTER 4: OVEREXPRESSION, PURIFICATION, AND 
ENCAPSULATION PROPERTIES OF C-TERMINAL HIS6-TAGGED 
BACTERIOFERRITIN 
 
4.1: Literature Research on C-terminal Extension and Encapsulation of Bacterioferritin 
The work by Andrews and co-workers had previously shown that the bFT subunits with 
an extra 14 amino acid residues at the C-terminus could form a normal protein shell, in which 
they called this C-terminal extension bFT a BFR-λ hybrid protein (Andrews et al., 1990).  This 
hybrid replaced four C-terminal residues (REEG) in bFT-WT by 18 residues 
(RLPFTSCAVCLQDSMRSR).  Based on native PAGE, heat denaturation, Q-Sepharose 
anion-exchange chromatography, and Superose 6 gel permeation chromatography, it was found 
that both wild type and hybrid proteins had similar functions and properties.  These results 
suggested that the additional residues at the C-terminus project into the central molecular 
cavity and do not disrupt the protein shell or influence the properties of the external surface.  
Further information based on crystallization experiments had shown that these extra 14 amino 
acid residues filled roughly 60% of the hollow cavity and possibly blocked the access of iron 
ions such that the BFR-λ hybrid protein failed to take up iron in vitro.  They also suggested 
that many of the heme-binding pockets of the protein might be disrupted. 
Andrews and co-workers later developed protocols to purify the wild-type bFT and 
BFR-λ hybrid proteins (Andrews et al., 1993).  Their results showed that the overproduction of 
wild-type bFT protein was 120-fold, while it was only 50-fold for the hybrid protein.  The X-
ray diffraction patterns showed that the additional C-terminus residues were present within the 
cavity of the 24-subunit protein, and the visible spectrum showed that the heme content of the 
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λ hybrid was approximately 1-2 hemes/tetracosamer, while bFT-WT had 3.5-10.5 
hemes/tetracosamer.  Non-denaturing PAGE experiments indicated that the BFR-λ hybrid was 
stabilized by the presence of the additional C-terminal residues.   
While most published applications of protein cages for host-guest studies are based on 
FT with various types of guest molecules i.e. metals, peptides, small protein, or drugs (Chapter 
1.3), previous encapsulation studies using bFT have focused on the replacement of the Fe(III) 
core with other metals.  Further study on kinetics of metals binding to bFT (in term of 
dissociation constant) had shown that the order of divalent metal ion binding was Cu(II) < 
Co(II) < Zn(II) (Baaghil et al., 2002; Le Brun et al., 1996). 
Based on the study of dissociation and reassociation of horse spleen apoFT (Chapter 2) 
and knowledge of suitable conditions for maintaining its quaternary structure (Chapter 3), the 
encapsulation of bFT was examined in this thesis under three steps of encapsulation, which 
included (1) subunit-declustering in acidic solution, (2) encapsulation of guest molecules, and 
(3) reclustering at neutral pH (Figure 4.1).  The conditions used to maximize the amount of 
encapsulated guest molecules and allow for the 24-subunit reclustering after declustering in 
acidic solution were investigated.  The encapsulations were studied using the bFT subunit 
derivative with a His6-tag at the C-terminal end of the protein as host.  It was anticipated that 
this system would provide a protein cage for binding of a nickel nitrilotriacetic acid (Ni2+-
NTA) derivative (dye molecules in Pro-Q® sapphire 365 oligohistidine gel stain) that acts as a 
guest molecule.  The linkage was the interaction between His-tag protein and Ni2+-NTA 
derivative.  Since the C-terminal bFT points toward the protein cavity, the host-guest 
interaction could provide for the encapsulation of guest molecules inside the protein cage.  The 
host protein containing the affinity tag was generated by PCR amplification and insertion into 
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the pET-22b(+) vector.  The properties of the dye molecules in Pro-Q® sapphire 365 
oligohistidine gel stain (Invitrogen Molecular Probes) including extinction coefficient, MW, 
dye concentration, and possible dye structure were also investigated.  The amount of Ni2+ 
contained in the dye solution was quantitated by metal analysis.  The encapsulation of the dye 
molecules into the protein cavity was demonstrated using fluorescence spectroscopy.  The 
stability of the host-guest complex after encapsulation was tested using Superose 6 gel 
filtration chromatography and laser light scattering techniques.  The number of encapsulated 
dye molecules under optimized conditions was calculated along with its efficiency.  In 
addition, the effect of the presence of heme groups and iron ions incorporated into bFT on 



























     
 
 
Figure 4.1: A schematic representation of the encapsulation process using bFT as host particle.  
The 24-subunit bFT (green) with His6-tag at the C-terminus (red) (a) is declustered in acidic 
solution yielding subunits (b).  By adding Ni2+-NTA binding dye (yellow), the interaction between 
His6-tag and Ni2+-NTA is formed (c).  The encapsulation of dye inside protein cavity (reclustering) 
is expected when altering the pH back to neutral, which would allow for protein reclustering to 
the 24-mer (d).  
Low pH 
NTA-Ni2+











4.2: Reagents, Materials, and Equipment 
 Reagents and materials 
All reagents and materials used in this chapter are stated below otherwise they are 
included in Chapter 2 and 3. 
Dye reagents including Pro-Q® sapphire 365 oligohistidine gel stain was obtained from 
Invitrogen Molecular Probes (Burlington, ON) and 1,4-piperazinebis(ethanesulfonic acid) 
(PIPES) was obtained from J.T Baker (Toronto, ON).  Denaturant, guanidinium hydrochloride 
(Gdn-HCl), was obtained from Sigma Chemical Company (St. Louis, MO). 
 
Equipment 
All equipment used in this chapter is listed below otherwise they are included in 
Chapter 2 and 3. 
Fluorescence measurements used in the study of dye in corporation and extinction 
coefficient determination of  Pro-Q® sapphire 365 oligohistidine gel stain were achieved using 
a PTI Fluorometer with light source supplied from a LPS-220B Lamp (Model 101M 
monochromator), Photon-Counting Photomultiplier Detector (Model 814 Analog), and 
FeliX32 software (version 1.0) from PTI Photo Technology International, PicoQuant GmbH 
(Berlin, Germany). 
 
4.3: Experimental Protocols 
4.3.1: PCR Amplification and Insertion into pET-22b(+) 
The protocols to generate bFT with His6-tag at the C-terminal were similar to that of 
bFT-E94A in Chapter 3.  First, bFT-WT plasmids with a NdeI digestion site at the N-terminus 
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and a XhoI digestion site at the C-terminus were generated by PCR using pT7bFT as host 
plasmid, the forward primers had a NdeI digestion site, and the reverse primers had a XhoI 
digestion site (Table 4.1).  PCR reagents and materials were prepared under optimized 
conditions as shown in Table 4.2 and PCR protocols were programmed as in Table 4.3.  The 
DNA product from the PCR reaction was digested with NdeI and XhoI restriction enzymes for 
3 hours at 37 ºC.  The DNA fragments were purified by using DNA electrophoresis (1% 
agarose gel) before visualizing under UV light.  The gel containing the desired DNA fragment 
was cut and purified using a QIAprep Spin Miniprep Kit before it was inserted into pET-
22b(+) vectors that were digested with the same restriction enzymes.  The ligation using T4 
ligase enzyme was performed at 14-16 ºC for 3 hours.  Since pET-22b(+) vector possesses six 
histidine residues next to the XhoI digestion site, this ligation yielded bFT-WT DNA with a 
His6-tag at the C-terminus.  The ligated DNA was heat shock transformed into E. coli cells 
(strain DH5α), which were then subsequently grown on agar plates containing Amp overnight 
at 37 ºC.  A single colony was selected and inoculated into 5 mL LB containing Amp (50 
μg/mL LB) and left to shake overnight at 37 ºC (220 rpm).  Plasmid purification was 
performed using a QIAprep Spin Miniprep Kit.  The DNA concentration was measured 
spectrophotometrically (OD260) before samples were sent for DNA sequencing (Mobix Central 
facility).  The successful insertion was confirmed by analysis of the obtained DNA sequence 









Table 4.1: The forward and reverse primers used to generate bFT-WT with a NdeI cutting site at 
the 5' end and a XhoI cutting site at the 3' end. 
 
Primers Sequences of primers (5′ to 3′) Melting temperature 
(Tm) 
BfrNdeI.For CCAGGATCCATATGAAAGGTGATACTAAAG‡ 59 
BfrXhoI.Rev CCGCTCGAGACCTTCTTCGCG‡ 60 




Table 4.2: PCR conditions for generating a bFT-WT construct with a NdeI cutting site at the 5' 
end and a XhoI cutting site at the 3' end. 
 
Plasmids/Reagents Stock Concentration Amount Used (μL) Final Concentration 
bFT-WT template 115 ng 10 23 ng 
Primer.For 10 μM 3 600 nM 
Primer.Rev 10 μM 3 600 nM 
dNTP 10 mM 1.0 200 μM 
PWO Buffer 10× 5.0  
Mg2+ 25 mM x y 
ddH2O  z  
PWO polymerase  0.5  
Total  50.0  
x were 1, 2, or 3 μL Mg2+, where y was the final concentration of Mg2+ used (0.5 mM, 1.0 mM, 
and 1.5 mM, respectively) to maximize PCR products.  




Table 4.3: PCR Programming sets for generating the bFT-WT construct with a NdeI cutting site 
at the 5' end and a XhoI cutting site at the 3' end. 
 
Steps Temperature (ºC) Time 
Initial Denaturation 95 2 min 
Hot Start 85  
Denaturation 95 30 sec 
Annealing 55 1 min 
Elongation 72 45 sec 
Final Extension 72 2  min 




Repeat 30 cycles 
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4.3.2: Protein Expression, Induction, and Purification  
 Protein expression, induction, and purification of bFT with His6-tag at the C-terminus 
was similar to those of bFT-WT and bFT variants described in Chapter 3 except the last step 
where dialysis buffer and running buffer for the Superose 6 gel filtration chromatograph was 
replaced by buffer containing 10 mM PIPES buffer (pH 8.0) and 100 mM NaCl.   
 
4.3.3: Identification of Dye Molecule 
Little information on the exact chemical structure of the dye used in the Pro-Q® 
sapphire 365 oligohistidine gel stain was available from Invitrogen Molecular Probes due to 
the proprietary nature of the dye.  Hence some effort was made to determine additional 
information on the dye.  The dye molecules have fluorescent absorption with a maximum 
excitation wavelength at 345 nm and maximum emission wavelength at 440 nm (Figure 4.2).  
However, the UV-visible spectrum of the dye solution represents the highest absorption at 345 
nm, while there is low intensity at 440 nm (Figure 4.3).  The dye molecules were dissolved in 
PIPES solution (soluble at pH > 6.1).  This dye solution is commercially sold for the detection 
of oligohistidine fusion proteins in SDS PAGE gels.  Other properties of the dye in Pro-Q® 
sapphire 365 oligohistidine gel stain such as its molecular weight, predicted structure, and 






Figure 4.2: The excitation spectrum scanning from 300-420 nm with the fixed emission 
wavelength at 440 nm (—) and the emission spectrum scanning from 380-550 nm with the fixed 











Figure 4.3: The UV-visible spectrum of Pro-Q® sapphire 365 oligohistidine gel stain scanned from 
300-550 nm showing the highest absorption at 345 nm. 
 
 
The molecular weight of the dye molecule was examined by electrospray MS.  Since 
the stock solution of Pro-Q® sapphire 365 oligohistidine gel stain contained a high 
concentration of PIPES (57.3 mM) that can interfere with MS, PIPES was precipitated out 
under acidic solution.  A 200 μL stock solution of stain was mixed with 2% formic acid and 
then PIPES was allowed to precipitate for two days at 4 ºC.  The solution was centrifuged at  
13 000 rpm for 30 seconds before withdrawing a 100 μL supernatant aliquot.  The sample was 
then diluted 10 times with 50/50 acetonitrile to water containing 0.2% formic acid before 
measuring the mass spectrum. 
The predicted structure of the dye molecules in this stain was searched using an internet 
patent database, International Application Published under the Patent Cooperation Treaty 
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(PCT) of World Intellectual Property Organization, using the key word “site-specific labeling 
of affinity tags in fusion proteins”.  The predicted structure with known molecular weight was 
used for the calculation of the dye concentration in Pro-Q® sapphire 365 oligohistidine gel 
stain and to estimate the extinction coefficient of the dye molecules.   
The estimated extinction coefficient was predicted from a comparison between a 
fluorophore of the dye and the known compound that possesses the same fluorophore (or its 
derivative).  If the solvent of the known compound with similar maximum excitation 
wavelength and emission wavelength as the dye molecules (excitation wavelength at 345 nm 
and emission wavelength at 440 nm) was the same as the solvent of the dye solution, then their 
extinction coefficients were similar.   
In order to compare the actual extinction coefficient of the dye with the estimated 
extinction coefficient that was determined from the dye related structure, the experimental 
extinction coefficient was calculated using the Beer-Lambert law.  The dye samples were 
prepared by diluting a stock solution of Pro-Q® sapphire 365 oligohistidine gel stain with 
Milli-Q water in the following series dilution: 100%, 50%, 25%, 12.5%, 7.25%, and 3.125% of 
dye (v/v) concentration.  The samples were loaded into a low volume quartz cuvette (45 μL) 
before scanning for the emission wavelength between 400-550 nm with a fixed excitation at 
345 nm.  Another set of experiments was to scan the excitation wavelength between 300-400 
nm with a fixed emission wavelength at 440 nm.  The size of the incoming slit and the 
outgoing slit were set to 1 nm with a 1 nm step size and a 1 second integration.  All 
measurements were done in duplicate at room temperature.  The reading at 440 nm was 
collected for the emission scan, and the reading at 345 nm was obtained for the excitation scan.  
A graph of emission intensities versus dye concentration and the graph of excitation intensity 
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versus dye concentration were plotted.  The extinction coefficient of dye molecule could be 
calculated from the expected linear trend of each experiment, which corresponded to the Beer-
Lambert law, A = ε'345BC, where A is absorbance, ε'345 is the fluorescence determined 
extinction coefficient (cm-1M-1) at 345 nm, B is the path length of cuvette (1 cm), and C is 
concentration (M).  The measurement was performed at room temperature using a 57.3 mM 
PIPES solution (same concentration as stock solution) as blank.   
Since dye molecules that might be in close proximity may possess their fluorescence 
quenching (decrease in fluorescent intensity), which might affect the fluorescence intensities in 
the measurement of the encapsulated dye molecules in bFT, this extinction coefficient might 
not be correct.  Therefore, the extinction coefficient measured by UV-visible spectroscopy was 
calculated to compare with the extinction coefficient that was determined by the fluorescence 
experiment.  The extinction coefficient of the dye solution determined by a UV-visible 
spectrophotometer was performed similarly to that of the fluorescence determinations.  The 
samples were prepared with the same dilution factor (100%, 50%, 25%, 12.5%, and 6.25% v/v 
dye).  The protein samples were loaded into 1 mL quartz cuvettes before measuring their 
optical density at 345 nm.  The extinction coefficient was determined from the linear trend of 
the plot between OD345 and dye concentration, which corresponds to the Beer-Lambert law, A 
= ε345BC, where A is absorbance, ε345 is the UV-visible extinction coefficient (cm-1M-1) at 345 
nm, B is the path length of cuvette (1 cm), and C is concentration (M).   
The concentration of the dye in Pro-Q® sapphire 365 oligohistidine gel stain was 
calculated using the Beer-Lambert law, A = ε345BC.  The measurement for the absorption of 
the dye was performed in duplicate at room temperature by loading 45 μL of Pro-Q® sapphire 
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365 oligohistidine gel stain to a low volume quartz cuvette (45 μL).  The absorption of the 
sample was measured at 345 nm using spectrophotometer. 
The quenching of dye molecules in Pro-Q® sapphire 365 oligohistidine gel stain can be 
evaluated using fluorescence experiments.  The dye solution was diluted with 6 M Gdn-HCl 
(final concentration of 5 M Gdn-HCl with total volume of 400 μL) and was incubated at room 
temperature for 2 hours.  The sample was loaded into a low volume quartz cuvette (45 μL) 
before scanning for the emission wavelength between 400-550 nm with a fixed excitation at 
345 nm.  The size of the incoming slit and the outgoing slit were set to 1 nm with a 1 nm step 
size and a 1 second integration.  The control experiments were (1) the dye solution that was 
diluted in PIPES buffer (pH 8.0) containing 100 mM NaCl (same dye dilution factor as the one 
that diluted in Gdn-HCl solution), (2) PIPES buffer (pH 8.0) containing 100 mM NaCl, and (3) 
6 M Gdn-HCl solution. 
In addition to the attempts to determine the extinction coefficient and the structure of 
the dye molecules, the amount of Ni2+ contained in Pro-Q® sapphire 365 oligohistidine gel 
stain was examined by metal analysis (ETL Chemspec Analytical Ltd., Waterloo, ON).  The 
dye sample was 5 times diluted from stock solution with Chelex treated water with the total 
volume of solution being 20 mL.  Two identical samples were analyzed by Inductively 
Coupled Plasma Mass Spectrometry (ICP-MS) and a Chelex treated water solution was also 
used as a control.  The concentration of Ni2+ and the ratio of Ni2+ to NTA-binding dye 
molecule were calculated.  Chelex treated water was prepared by filtering Milli-Q water 
through a 0.22 μm GV filter membrane before pumping it through a 5-10 mL plastic column 
packed with Chelex® 100 chelating ion exchange resin (Bio-Rad, Hercules, CA) (flow rate ~1-
2 mL/min).  Containers used for the samples were soaked in 10% nitric acid for 30 min before 
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rinsing with ddH2O followed by rinsing several times with Chelex treated water.  The 
containers were then allowed to dry overnight. 
 
4.3.4: Preparation for Encapsulation Experiments 
The 24-subunit protein samples, wild-type bFT with and without His6-tag at the C-
terminus (Histag and WT protein, respectively) were prepared by performing Superose 6 gel 
filtration chromatography.  The concentrations of isolated 24-subunit proteins were calculated 
by the Bradford assay method.  The size and stability of the proteins were investigated by laser 
light scattering and Superose 6 gel filtration chromatography.  The proteins were then used for 
further experiments on optimizing declustering and reclustering, and hence the effect of 
declustering time, encapsulating time, protein subunit homogeneity, protein concentration, and 
dialysis time were evaluated.  Control experiments that included attempts to encapsulate the 
dye into wild-type bFT, elimination of non-specific dye binding, and the use of proteins with 
non-encapsulated dye, which were performed to evaluate the encapsulation of dye molecules 
by bFT with His6-tag at the C-terminus.  The encapsulation processes studied included 
declustering of the protein in acidic solution (pH 2.0), binding dissociated His6-tag protein 
subunits with Ni2+-NTA binding dye (Pro-Q® Sapphire 365 oligohistidine gel stain), and 
reclustering at neutral pH.  The general concept of the encapsulating protocols is shown as a 
flow chart in Figure 4.4.  The lists below represent the specific terms that were used for the 
encapsulation experiments: 
- Histag protein: wild-type bFT with an extend His6-tagged C-terminus 
- WT: wild-type bFT 
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- 24-mer protein: the 24-subunit protein that was isolated by Superose 6 gel filtration 
chromatography 
- protein with encapsulated dye: the protein after encapsulation experiments, which 
included incubating in acidic pH solution, binding with dye molecules, reclustering at 
neutral pH, and removing non-specific binding of the dye 
- non-specific dye binding protein: the protein that was not declustered (was not exposed 
to acidic pH) but was directly incubated with dye at pH 8.0 
- non-encapsulated protein: the protein that was declustered in acidic pH solution and 
















Protein prepared from heat denaturation and ammonium sulfate precipitation 
          Gel filtration chromatography 
Collected 24-subunit fraction and measured concentration by Bradford assay method 
 
Confirmed stability and size of the protein by DLS and gel filtration chromatography 
 
Declustered by dialysis in buffer A 
  X time 
Binding and reclustering (encapsulating) by dialysis in buffer B containing dye (50% v/v) 
  Y time 
Non-specific dye binding removal by dialysis in buffer B 
  Z time 
Filtered through a 0.2 μm GHP filter membrane 
 
Measured protein concentration by Bradford assay method 
 
Checked for encapsulation by measuring fluorescence intensity 
 
Checked for protein stability by DLS and Superose 6 gel filtration chromatography 
 
 
Figure 4.4: A summary showing the encapsulating protocols, where buffer A is 10 mM PIPES 
(pH 2.0) solution containing 150 mM NaCl and 10% glycerol and buffer B is 10 mM PIPES (pH 
8.0) solution containing 100 mM NaCl.  The X, Y, and Z are the variables that were altered to 
optimize conditional tests. 
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After encapsulation, the proteins were filtered through a 0.2 μm GHP membrane and 
their concentration was re-measured using the Bradford assay method.  Since the fluorescence 
intensities of the Pro-Q® sapphire 365 oligohistidine gel stain are more sensitive than the 
optical densities presenting in the UV-visible spectrum, the existence of successful 
encapsulation of the dye was examined by measuring the fluorescence intensity using a 
fluorescence spectrophotometer.  The excitation wavelength was fixed at 345 nm, while the 
emission intensity was scanned at wavelengths between 400-550 nm.  The size of the incoming 
slit was set to 1 nm and the outgoing slit was set to 14 nm to maximize the detected intensity.  
The step size was 1 nm with an integration of 1 second.  A low volume quartz cuvette (45 μL) 
was used.  Superose 6 gel filtration chromatography and light scattering analysis of these 
protein samples were then re-performed to investigate protein stability and confirm the 
existence of the 24-subunit cluster after encapsulation had been completed. 
 
Effect of Declustering Time 
 Gel filtration chromatography of His-tagged bFT was performed, and the 24-subunit 
protein was declustered by dialysis against buffer containing 10 mM PIPES (pH 2.0), 150 mM 
NaCl, and 10% glycerol for 30, 60, and 90 min.  Then the declustered protein was incubated in 
a solution containing dye solution (50% v/v) for 3 hours, and the reclustering step was 
performed by dialysis in buffer containing 10 mM PIPES (pH 8.0) and 100 mM NaCl 
overnight.  The Histag protein after the encapsulation procedure had been performed are called 
Histag protein with encapsulated dye.  In order to evaluate non-specific surface binding of the 
dye to the protein, some experiments used proteins that were not declustered but were directly 
incubated with dye at pH 8.0 and 100 mM NaCl as above.   
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Effect of Encapsulation Time  
 Superose 6 gel filtration chromatography was performed on the Histag protein, which 
was dialyzed (90 min) against buffer containing 10 mM PIPES (pH 2.0), 150 mM NaCl, and 
10% glycerol (declustering step).  The binding and reclustering step were varied by 1, 2, and 3 
hours incubation time with dye solution (50% v/v).  Then the elimination of non-specific dye 
binding was accomplished by dialysis of the encapsulated protein in buffer containing 10 mM 
PIPES (pH 8.0) and 100 mM NaCl overnight.  The Superose 6 gel filtration chromatography 
and DLS of the 24-subunit Histag protein were performed as control experiments.  In addition, 
protein concentrations after the various binding and reclustering steps were calculated. 
 
Effect of Protein Subunit Homogeneity 
Superose 6 gel filtration chromatography of Histag and WT bFT yielded 24-subunit 
proteins, which were then mixed at various combinations of 100% Histag (100/0:Histag/WT), 
60% Histag with 40% WT (60/40:Histag/WT), 50% Histag with 50% WT (50/50:Histag/WT), 
40% Histag with 60% WT (40/60:Histag/WT), and 100% WT (0/100:Histag/WT).  The 
declustering step was then done on these mixtures under dialysis condition in the buffer 
containing 10 mM PIPES (pH 2.0), 150 mM NaCl, and 10% glycerol for 90 min.  The binding 
and reclustering step was undertaken for two hours in duration with dye (50% v/v) and then 
followed by overnight dialysis against buffer containing 10 mM PIPES (pH 8.0) and 100 mM 
NaCl.  The protein concentrations were measured to determine suitable protein combinations 




Effect of Protein Concentration 
The 24-subunit cluster of Histag protein (0.5 mg/mL) from Superose 6 gel filtration 
chromatography was adjusted to 0.15 mg/mL and 0.45 mg/mL and then declustered in buffer 
containing 10 mM PIPES (pH 2.0), 150 mM NaCl, and 10% glycerol for 90 min.  The proteins 
were encapsulated with dye (50% v/v) for 3 hours.  The elimination of non-specific dye 
binding step was performed by dialysis against buffer containing 10 mM PIPES (pH 8.0) and 
100 mM NaCl overnight.  The control sample, 24-subunit Histag, was performed utilizing DLS 
and Superose 6 gel filtration chromatography. 
 
Effect of Dialysis Time 
The 24-subunit proteins of Histag and WT bFT from gel filtration chromatography 
were mixed in a combination of 100% Histag (100/0:Histag/WT) and 60% Histag with 40% 
WT (60/40:Histag/WT), in which both protein combinations were declustered in buffer 
containing 10 mM PIPES (pH 2.0), 150 mM NaCl, and 10% glycerol for 90 min.  The proteins 
were then permitted to interact with dye (50% v/v) for two hours, then the elimination of non-
specific dye binding in buffer containing 10 mM PIPES (pH 8.0) and 100 mM NaCl overnight 
was accomplished.  The dialysis buffer was changed and dialysis was continued for an 
additional 5 hours.  After measuring protein concentration, half of the samples were adjusted to 
a concentration of 0.23 mg/mL before measuring fluorescence, DLS, and Superose 6 gel 





Encapsulation by Wild-type Bacterioferritin 
 The bFT-WT protein was purified using Superose 6 gel filtration chromatography to 
obtain pure 24-subunit cluster.  This was then declustered in buffer containing 10 mM PIPES 
(pH 2.0), 150 mM NaCl, and 10% glycerol for 90 min.  The encapsulation was then undertaken 
by incubating the subunits with dye (50% v/v) for 3 hours.  This was followed by the 
elimination of non-specific dye binding by dialysis against buffer containing 10 mM PIPES 
(pH 8.0) and 100 mM NaCl overnight.  The dialysis buffer was changed and dialysis continued 
for an additional 5 hours. 
 
Elimination of Non-specific Dye Binding 
 Superose 6 gel filtration chromatography in this set of experiments was performed on 
WT and Histag protein.  The declustering step was skipped and the intact protein was simply 
incubated with dye (50% v/v) for 3 hours.  The proteins were then dialyzed against buffer 
containing 10 mM PIPES (pH 8.0) and 100 mM NaCl overnight followed by an additional 5 
hours with fresh dialysis buffer. 
 
Non-encapsulated Proteins 
 The 24-subunit WT and Histag proteins were isolated from Superose 6 gel filtration 
chromatography.  The combination of 100% Histag (100/0:Histag/WT), 60% Histag with 40% 
WT (60/40:Histag/WT), and 100% WT (0/100:Histag/WT) were declustered in buffer 
containing 10 mM PIPES (pH 2.0), 150 mM NaCl, and 10% glycerol for 90 min.  The 
encapsulation processes skipped the binding of the dye but were reclustered, in which the 
protein samples were dialyzed against buffer containing 10 mM PIPES (pH 8.0) and 100 mM 
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NaCl overnight followed by an additional 5 hours of dialysis time with fresh dialysis buffer.  
The proteins, 100% Histag (100/0:Histag/WT), 60% Histag with 40% WT (60/40:Histag/WT), 
and 100% WT (0/100:Histag/WT), after encapsulation process were called non-encapsulated 
Histag, non-encapsulated 60/40:Histag/WT, and non-encapsulated WT, respectively. 
 
4.3.5: Determination of the Fluorescence Quenching 
 
In the encapsulation experiments, the fluorescence of the encapsulated dye might be 
quenched by other dye molecules in close proximity or by proteins, causing lower fluorescence 
intensity than the one of non-encapsulated dye.  The fluorescence quenching of the dye 
molecules encapsulated in the proteins was determined by denaturing proteins in a high 
concentration of Gdn-HCl, allowing dye molecules to become exposed to the solvent.  The dye 
molecules were then expected to exhibit their actual fluorescence properties.  In order to 
investigate the fluorescence quenching, the 24-subunit of Histag and WT proteins isolated by 
Superose 6 gel filtration chromatography were mixed at a combinations of 60% Histag with 
40% WT (60/40:Histag/WT).  The mixture was declustering in the buffer containing 10 mM 
PIPES (pH 2.0), 150 mM NaCl, and 10% glycerol for 90 min.  The encapsulating step was 
undertaken for two hours (with 50% v/v dye) and then followed by overnight dialysis against 
buffer containing 10 mM PIPES (pH 8.0) and 100 mM NaCl.  The mixture with encapsulated 
dye was incubated with 6 M Gdn-HCl for 2 hours at room temperature (final concentration of 4 
M Gdn-HCl with total volume of 50 μL).  The sample was then loaded into a low volume 
quartz cuvette (45 μL) before scanning for the emission wavelength between 400-550 nm with 
a fixed excitation at 345 nm.  The size of the incoming slit and the outgoing slit were set to 1 
nm with a 1 nm step size and a 1 second integration.  The control experiments were (1) the 
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60/40:Histag/WT mixture with encapsulated dye in PIPES buffer (pH 8.0) containing 100 mM 
NaCl (same dye dilution factor as the one that diluted in Gdn-HCl solution), (2) 24-mer Histag 
protein in 6 M Gdn-HCl solution, and (3) 6 M Gdn-HCl solution. 
 
4.3.6: Measurement of Heme Groups Incorporated in Bacterioferritin  
 The absorption at 417 nm (hem group absorbance) for the protein samples, native bFT-
WT, native bFT with His6-tag at the C-terminus, and bFT with His6-tag at the C-terminus with 
encapsulated dye were measured using a UV-visible spectrophotometer at room temperature.  
These were performed by filtering 0.42 mg/mL samples through 0.2 μm GHP membranes 
before loading them into low volume quartz cuvettes (45 μL).  The 24-subunit fractions of 
native proteins isolated by Superose 6 gel filtration chromatography were scanned directly for 
absorption at 417 nm.  The proteins with encapsulated dye were performed as before: (1) 
dialysis of samples for 90 min against buffer containing 10 mM PIPES (pH 2.0), 150 mM 
NaCl, and 10% glycerol, (2) incubation of these declustered proteins with dye (50% v/v) in 
buffer containing 10 mM PIPES (pH 8.0) and 100 mM NaCl for 3 hours, and (3) dialysis 
against buffer containing 10 mM PIPES (pH 8.0) and 100 mM NaCl overnight with/without an 
additional 5 hours of dialysis time with fresh dialysis buffer.  The extent of encapsulation of 
the dye molecules was examined by fluorescence spectroscopy, and protein stability was 
evaluated by Superose 6 gel filtration chromatography as well as dynamic light scattering 
stated in section 4.3.2. 
The number of heme groups incorporated into protein samples was calculated from the 
Beer-Lambert law, A = εBC, where A is absorption measured at 417 nm, B is the cuvette path 
length (1 cm), C is the concentration of heme incorporated in samples, and ε417 is the extinction 
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coefficient at 417 nm (ε417 = 137 000 cm-1M-1 per heme per E. coli ferricytochrome protein) 
(Yariv et al., 1981).  
 
4.3.7: Determination of the Presence of Iron Atoms in Bacterioferritin 
 The 24-subunit fraction obtained from Superose 6 gel filtration chromatography was 
dialyzed in Chelex treated water overnight at 4 ºC.  The protein concentration was measured by 
the Bradford assay method.  All containers and dialysis tubing were soaked in Chelex treated 
water before use.  The sample was diluted six times with Chelex treated water to a final 
volume of 15 mL.  This sample was sent for metal analysis in duplicate (ETL Chemspec 
Analytical Ltd.).  The dialysis buffer that was also prepared similarly for metal analysis was 
sent as a control. 
 
4.3.8: Determination of the Number of Dye Molecules Encapsulated into Bacterioferritin  
 The protein samples with encapsulated dye used for the calculation of the number of 
encapsulated dye molecules inside the protein cavity were bFT-WT with a His6-tag at the C-
terminus (100% Histag protein) and the combination of 60% bFT with His6-tag at the C-
terminus with 40% bFT-WT without His6-tag at the C-terminus (60/40:Histag/WT mixture).  
The dye molecules were encapsulated under the following conditions: (1) dialysis of the 
protein samples for 90 min against buffer containing 10 mM PIPES (pH 2.0), 150 mM NaCl, 
and 10% glycerol, (2) declustering of the proteins in the presence of 50% dye (v/v) in buffer 
containing 10 mM PIPES (pH 8.0) and 100 mM NaCl for 2 hours, and (3) dialysis against 
buffer containing 10 mM PIPES (pH 8.0) and 100 mM NaCl overnight followed by an 
additional 5 hours of dialysis time with fresh dialysis buffer.  The proteins with encapsulated 
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dye were filtered through 0.2 μm GHP membranes before calculating their protein 
concentration using the Bradford assay method.  The samples were then examined by 
fluorescence spectroscopy, Superose 6 gel filtration chromatography, and DLS to investigate 
the stability of the 24-subunit clusters and the extent of successful encapsulation (similar 
protocols as in section 4.3.4).  The UV-visible spectrophotometer was operated to measure 
absorption at 345 nm at room temperature using a 1 mL quartz cuvette.  Each sample was 
performed in duplicate.  The buffer containing 20 mM PIPES (pH 8.0) and 100 mM NaCl was 
used as a blank.  The concentrations of encapsulated dye were calculated from the Beer-
Lambert law with the experimental extinction coefficient (the results from section 4.3.3).  The 
number of encapsulated dye molecules was determined from the ratio of these calculated dye 
concentrations and the protein concentrations measured after the encapsulation processes. 
 
4.4: Results and Discussion 
4.4.1: DNA Cloning and Protein Purification 
The PCR products of bFT-WT with NdeI and XhoI cutting sites (~470 bp) are shown in 
Figure 4.5.  This fragment was then inserted into the pET-22b(+) vector to generate a plasmid 
containing the gene coding for bFT with a His6-tag at the C-terminus (sequence is shown in 
Appendix 4).  The results of overexpression and protein purification utilizing heat denaturation 
and ammonium sulfate precipitation are shown in the SDS PAGE gel figure (Figure 4.6).  A 
monomeric subunit of bFT with a His6-tag at the C-terminus is shown as a band with MW 
~18.5 kDa.  It should be noted that based on experiment, the bFT proteins have tight 
interaction in the dimeric form such that some dimer is observed in gels (MW ~40 kDa) even 
under SDS PAGE conditions.  The existence of monomeric subunit mass was confirmed by 
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electrospray MS (Appendix 5).  Further purification was accomplished by Superose 6 gel 








Figure 4.5: The 1% agarose gel representing PCR products of bFT-WT with NdeI cutting site at 








Figure 4.6:  SDS PAGE of protein purification of bFT with His6-tag at the C-terminus by heat 
denaturation and ammonium sulfate precipitation.  The molecular weight at 18.5 kDa represents 
monomer and 40 kDa represents dimeric bFT mutant.  The samples that were loaded in each lane 
are shown as followed. 
 
Lane Sample                                            Lane       Sample 
1 MWM                                                6          Pellet from 25% ammonium sulfate 
2 Pellet from sonication                        7          Supernatant from 25% ammonium sulfate 
3 Supernatant from sonication              8          Pellet from 40% ammonium sulfate 
4 Pellet from heat denaturation             9          Supernatant from 40% ammonium sulfate 
5 Supernatant from heat denaturation   
 
 




















1 1 kb DNA ladder 
2 PCR with 1 μL Mg2+ 
3 PCR with 2 μL Mg2+ 




4.4.2: Dye Identification 
  Pro-Q® sapphire 365 oligohistidine gel stain is a commercially available fluorescent 
dye containing a nickel-NTA group that shows high affinity to His-tag containing proteins.  As 
such it is used for fluorescent identification of His-tag proteins, especially useful for gel 
staining (Hart et al., 2003).  Rather than synthesizing our own fluorescent labeled nickel-NTA 
dye, we utilized this well known dye in our attempts to develop methods to encapsulate host 
molecules into the cavity of bFT (or rather bFT with a C-terminal Histag).  Although described 
in a patent application (PCT-WO 2004/025259 A2, site-specific labeling of affinity tags in 
fusion proteins) by Molecular Probes, we wished to confirm some of the properties of this dye.  
Hence an analysis of the commercial dye stain was undertaken.  The commercial solution 
(P21876) is said to contain 57.3 mM PIPES buffer, but no mention is made of Ni2+ or dye 
concentrations.  Molecular Probes declined supplying additional information on this dye.  The 
first investigation we undertook was to determine the mass spectrum of the dye solution. 
The literature search retrieved from a patent application for a site-specific labeling of 
affinity tags in fusion proteins suggested that the dye molecules in Pro-Q® sapphire 365 
oligohistidine gel stain might have a structure related to coumarin (Figure 4.7a).   The patent 
search suggested that the potential dye might be 7-amino-3-(1-carboxy-1-
(bis(carboxymethyl)amino)-5-(acetylamino))pentyl-4-methylcoumarin-6-sulfonic acid (MW = 
553 Da) (Figure 4.7b). 
By incubating the dye solution with 2% formic acid to precipitate PIPES that might 
interfere with the electrospray MS, the MW of dye molecules was calculated.  The electrospray 
mass spectrum of commercial PIPES shows the intensities at 347 m/z, which might correspond 
to the mass of one molecule of PIPES (MW = 302 Da) with two adducts of Na+, at 671 m/z, 
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which might be the mass of two molecules of PIPES with three adducts of Na+, and at 995 m/z, 
which is similar to the MW of three molecules PIPES with four adducts Na+ (Figure 4.8).  
Comparing the MS of pure PIPES, it is observed that the intensity at 631 m/z might be the 
potential MW of 7-amino-3-(1-carboxy-1-(bis(carboxymethyl)amino)-5-(acetylamino))pentyl-
4-methylcoumarin-6-sulfonic acid (MW = 553 Da) with one adduct of Ni2+ and one adduct of 
Na+ (Figure 4.9).  The intensity at 641 m/z might correspond to the MW of one dye molecule 
with four adducts of Na+.  The high intensity at 437 m/z might correspond to the MW of one 
molecule PIPES with six adducts of Na+ (MW = 440 Da).   
From the predicted structure of the dye, it is found that Alexa Fluoro 350 
(aminocoumarin conjugate) has a similar structure (Figure 4.7c).  Alexa Fluoro® 350 
carboxylic acid is a product of Invitrogen Molecular Probes (Burlington, ON) that can be used 
in many multicolor fluorescence applications.  Alexa Fluoro 350 is an amine-reactive 7-
aminocoumarin derivative with the maximum absorption at 346 nm and maximum emission 
intensity at 445 nm.  Its extinction coefficient measured at 346 nm in a solvent pH 7.0 is 19 
000 M-1cm-1 (data retrieved from the Handbook of Fluorescent Probes and Research Products, 
Invitrogen Molecular Probes, Burlington, ON).  Since both compounds share the same 
fluorophore (coumarin) as a part of their structures, they should have very similar if not 
identical extinction coefficients.  By using the Beer-Lambert law (A = εBC), the extinction 
coefficient of the dye molecule determined by a fluorescence measurement and UV-visible 
spectrum was calculated to be 23 000 cm-1M-1 (Appendix 8), which is similar to the estimated 
extinction coefficients (19 000 cm-1M-1) determined by the related structure of the dye 
molecule. 
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The dye concentration was calculated by this experimental extinction coefficient using 
the Beer-Lambert law, A = ε345BC, where A is absorption of Pro-Q® sapphire 365 
oligohistidine gel stain measured at 345 nm (average OD345 of the dye is 0.2117), B is the 
cuvette path length (1 cm), C is the concentration of the dye in a solution, and ε345 is the 
experimental extinction coefficient at 345 nm (23 000 M-1cm-1), the concentration of the dye in 
Pro-Q® sapphire 365 oligohistidine gel stain was approximately 9.2 μM. 
The amount of metals present in the Pro-Q® sapphire 365 oligohistidine gel stain were 
evaluated in Appendix 11.  It was determined by ICP-MS that only Ni2+ and Na+ ions are 
present in the stain.  The concentration of Ni2+ was determined to 7.125 mg/L (60.7 μM), and 
the ratio of Ni2+/dye molecule was approximated 6.6 in the Pro-Q® sapphire 365 oligohistidine 
gel stain.  The sodium concentration was found to be 120 mM. 
The fluorescence quenching of the dye molecules might occur in the Pro-Q® sapphire 
365 oligohistidine gel stain, causing low fluorescence intensity.  This quenching might have 
resulted from the dye molecules that are blocked by their neighbors such that when the samples 
were excited at 345 nm, only some part of the fluorescence was emitted.  Other possibilities are 
these dye molecules might form a complex once they are in a close proximity or it might be 
due to the ionic strength of these dye molecules.  To investigate the dye quenching, the dye 
molecules in Pro-Q® sapphire 365 oligohistidine gel stain were treated with 6 M Gdn-HCl, 
isolating the dye complex to be free from each other.  The emission spectra with the fixed 
excitation at 345 nm show that the denaturant-treated dye molecules possess higher emission 
intensity than the native dye (Figure 4.10).  Once the encapsulations of the dye molecules into 
bFT proteins are performed, the measured fluorescence intensity is expected to be lower than 































Figure 4.7: The structure of coumarin (a), 7-amino-3-(1-carboxy-1-(bis(carboxymethyl)amino)-5-


































































































































































































































































































































































































































































































































































































































































































































Figure 4.10: The emission spectra scanned between wavelengths 400-550 nm with the fixed 
excitation at 345 nm of the native dye molecules in Pro-Q® sapphire 365 oligohistidine gel stain 
(PIPES buffer pH 7.0), the denaturant-treated dye molecules in 6 M Gdn-HCl solution, PIPES 
buffer, and 6 M Gdn-HCl solution showing maximum fluorescence intensity at 440 nm. 
 
 
4.4.3: Optimum Conditions for Encapsulation of Bacterioferritin  
Effect of Declustering Time 
The collected 24-mer fraction of Histag protein from the Superose 6 gel filtration 
chromatography yielded ~0.50 mg/mL, which were reduced to ~0.45 mg/mL after the 
encapsulation process.  The decreased protein concentration could be due to poor solubility 
over the pH range 3.5-5.4 resulting in aggregation close to the protein’s pI of 4.6.  From 
fluorescence measurements, it was shown that the highest fluorescence intensity of 
Native dye molecules 












encapsulated dye was obtained for the protein using a 90 min declustering time (Figure 4.11).  
The Superose 6 gel filtration chromatograms showed that the proteins were stable under the 
encapsulated conditions, in which the intensity of 24-subunit peak (~30 min eluted time) was 
higher than that of the dimer peak (~35 min eluted time) (Figure 4.12c, d, e), and they behaved 
similarly to those of the 24-mer Histag protein (Figure 4.12a) and non-specific dye binding 
protein (Figure 4.12b).  The DLS results, on the other hand, showed that the proteins with 
encapsulated dye were not as stable as the 24-subunit cluster such that there was small peak at 
~50 nm (aggregates)  presented in the sample with 90 min declustering time, while the other 












Figure 4.11: The emission spectra scanned between wavelengths 400-550 nm with the fixed 
excitation at 345 nm of the 24-mer Histag protein, non-specific dye binding Histag protein, Histag 
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60 min Declustering time 










   
 
 







Figure 4.12: The Superose 6 gel filtration chromatograms of 24-mer Histag protein (a), non-
specific dye binding Histag protein (b), Histag protein with encapsulated dye after 30 min 
declustering time (c), Histag protein with encapsulated dye after 60 min declustering time (d), 
Histag protein with encapsulated dye after 90 min declustering time (e).  The first peak at ~30 












































Figure 4.13: The size distribution by intensity plot of 24-subunit Histag protein (black), Histag 
protein with encapsulated dye after 30 min (red), 60 min (green), and 90 min (blue) declustering 
time.  The peak at ~16 nm represents 24-subunit protein and the peak at higher diameter 
represents higher self-aggregation (multi 24-subunit clusters). 
 
 
Effect of Encapsulation Time  
The 24-subunit fraction used for encapsulation was ~0.50 mg/mL and yielded ~0.23 
mg/mL after the encapsulating process.  It was shown that the two-hour encapsulation time 
yielded the highest fluorescence intensity of dye associated protein (Figure 4.14).  However, 
the calculation of protein concentration suggested that the longer encapsulation time resulted in 
greater amounts of protein aggregation (i.e. less protein concentration after encapsulation 
process) (Table 4.4).  Therefore, two hours might be the most suitable encapsulation time for 
these specific conditions.  The results from Superose 6 gel filtration chromatography showed 
that proteins were less stable after the encapsulation process compared to that of an intact 24-
subunit Histag starting protein (Figure 4.15), while DLS results showed that protein stability 
for the two-hour encapsulation time was better than the others, in which higher self-








Figure 4.14: The emission spectra scanned between wavelengths 400-550 nm with the fixed 
excitation wavelength at 345 nm of Histag protein after encapsulated with dye molecules for 1, 2, 




Table 4.4: The protein concentrations of the Histag protein that encapsulated dye molecules at 
various periods encapsulating time were calculated after dialysis overnight. 
 
Sample Concentration after dialysis (mg/mL)
Histag protein after encapsulated with dye for 1 hour 0.30 
Histag protein after encapsulated with dye for 2 hours 0.29 




1 Hour encapsulation time 
2 Hours encapsulation time 










      
 
 
     
 
 
Figure 4.15: The Superose 6 gel filtration chromatograms of 24-mer Histag protein (a), Histag 
protein after encapsulated with dye molecules for 1 hour (b), 2 hours (c), and 3 hours (d).  The 





















Figure 4.16: The size distribution by intensity plot of 24-mer Histag protein (red), Histag protein 
after encapsulated with dye molecules for 1 hour (green), 2 hours (blue), and 3 hours (black).  






















Effect of Protein Subunit Homogeneity 
The concentration of ~0.50 mg/mL for the 24-subunit proteins prepared by Superose 6 
gel filtration chromatography was decreased after the encapsulation experiments due to 
aggregation proportional to the increasing amount of the Histag protein present in the mixture 
(Histag:WT proteins) (Table 4.5).  This suggested that the encapsulation of the dye could cause 
some steric effects that interfered with successful reclustering.  While 100% Histag protein 
seemed to produce the highest aggregation, it was also found to have the highest fluorescence 
intensity or consequently the highest amount of dye encapsulated inside the protein cavity 
(Figure 4.17).  The combination of 60/40:Histag/WT mixture yielded the second highest 
fluorescence intensity, while the rest gave much lower intensities.  Therefore, in order to 
compare and consider advantages between using 100% Histag or a 60/40:Histag/WT ratio for 
encapsulation studies, Superose 6 gel filtration chromatograms and DLS results were 
evaluated.  The Superose 6 chromatograms for the 100% Histag experiments yielded a higher 
intensity of 24-subunit than dimer quaternary structure, while that of the 60/40:Histag/WT 
mixture yielded similar intensity for these two forms (Figure 4.18c, d).  It was suggested that 
100% Histag protein might be more stable than 60/40:Histag/WT mixture after the 
encapsulation experiments.  The DLS results indicated that stability of 100% Histag protein 
was lower than the 60/40:Histag/WT mixture, because the 100% Histag protein system formed 











Table 4.5: The protein concentrations of Histag/WT mixtures calculated after dialysis overnight. 
 












Figure 4.17: The emission spectra scanned between wavelengths 400-550 nm with the fixed 
excitation at 345 nm of the various combinations of Histag/WT mixture with encapsulated dye 

















     
 
 
       
 
 
Figure 4.18: The Superose 6 gel filtration chromatograms of 24-mer WT protein (a), 24-mer 
Histag protein (b), 100/0:Histag/WT mixture with encapsulated dye (c), and 60/40:Histag/WT 
mixture with encapsulated dye (d).  The first peak at ~30 min represents 24-subunit and the 




















Figure 4.19: The size distribution by intensity plot of 24-mer Histag protein (green), 24-mer WT 
protein (red), 100/0:Histag/WT mixture with encapsulated dye (blue), and 60/40:Histag/WT 
mixture with encapsulated dye (black).  The peak at ~16 nm represents 24-mer protein and the 




















Effect of Protein Concentration 
The concentration of the ~0.50 mg/mL 24-subunit of Histag protein was adjusted to 
0.15 mg/mL and 0.45 mg/mL used for the encapsulation experiments.  It was found that higher 
protein concentrations yielded higher fluorescence intensity after encapsulation experiments, 
where a larger amount of protein could accept more dye molecules for encapsulation (Figure 
4.20).  The results from Superose 6 chromatograms (Figure 4.21) and DLS (Figure 4.22) 
showed that protein stability was dependent on protein concentration, in which a greater 
protein concentration yielded higher stability.  In addition, lower protein concentration tended 





Figure 4.20: The emission spectra scanned between wavelengths 400-550 nm with the fixed 
excitation wavelength at 345 nm of 0.15 and 0.45 mg/mL Histag protein with encapsulated dye 
showing maximum fluorescence intensity at 440 nm. 
0.45 mg/mL Histag 
















Figure 4.21: The Superose 6 gel filtration chromatograms of 24-mer Histag protein (a), 0.15 
mg/mL (b) and 0.45 mg/mL (c) Histag protein with encapsulated dye.  The first peak at ~30 min 






















Figure 4.22: The size distribution by intensity plot of 24-mer Histag (red), 0.15 mg/mL (green) 
and 0.45 mg/mL (blue) Histag protein with encapsulated dye.  The peak at ~16 nm represents 24-
















Effect of Dialysis Time 
A ~0.5 mg/mL protein solution of purified 24-subunit Histag was prepared for 
encapsulation experiments.  It was found that by performing an additional 5 hours of dialysis 
time with fresh dialysis buffer (other than overnight dialysis) could eliminate non-specific 
surface binding of the dye as well as perhaps remove dye produced from unstable 24-subunit 
proteins that allow encapsulated dye molecules to escape from their cavity (Figure 4.23).  Low 
amount of protein aggregation was observed in the encapsulation experiments with an 
additional 5 hours of dialysis time.  This can be determined by protein concentration (Table 
4.6).  Compared with the protein concentration in the encapsulation experiments without an 
additional dialysis step, the higher protein concentrations for both 100% Histag protein (0.37 
mg/mL) and 60/40:Histag/WT mixture (0.67 mg/mL) with an additional 5 hours of dialysis 
time were observed.  However, after adjusting all protein concentrations to 0.23 mg/mL, it was 
observed that 100% Histag protein yielded a higher fluorescence intensity for both before and 
after elimination of the non-specific surface binding of the dye (Figure 4.23).  Since a higher 
intensity of dimeric protein was found after an additional 5 hours of dialysis time on Superose 
6 gel filtration chromatograms, this additional dialysis time might relate to protein stability 
such that this procedure increases amounts of dimeric protein.  In contrast to 60/40:Histag/WT 
mixture, it was also found that the 24-subunit peak using 100% Histag protein was higher than 
the dimer peak, which suggested a greater ability of the 100% Histag system to maintain 24-
subunit quaternary structures than that of the 60/40:Histag/WT mixture (Figure 4.24 and 4.25).  
The stability tests by DLS were similar for both the 100% Histag protein and 60/40:Histag/WT 
mixture, although the 100% Histag protein was found to be more stable (similar intensity as 
24-mer Histag) (Figure 4.26 and 4.27).   
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Table 4.6: The protein concentrations of Histag protein and the combination of Histag/WT 
mixture calculated after dialysis overnight with and without an additional 5 hours of dialysis 
time. 
 
Sample Protein Concentration (mg/mL) 
100/0:Histag/WT 0.23 
60/40:Histag/WT 0.34 
100/0:Histag/WT after an additional 5 hrs of dialysis time 0.37 










Figure 4.23: The emission spectra scanned between wavelengths 400-550 nm with the fixed 
excitation wavelength at 345 nm of 0.23 mg/mL of 100% Histag protein with encapsulated dye 
with and without an additional 5 hours of dialysis time and 0.23 mg/mL of 60/40:Histag/WT 
mixture with encapsulated dye with and without an additional 5 hours of dialysis time showing 
maximum fluorescence intensity at 440 nm. 
 
100/0:Histag/WT with encapsulated dye 
60/40:Histag/WT with encapsulated dye 
100/0:Histag/WT with encapsulated dye 
with an additional 5 hrs of dialysis time 
60/40:Histag/WT with encapsulated dye 










    
 
 




Figure 4.24: The Superose 6 gel filtration chromatograms of 24-mer Histag protein (a), 24-mer 
WT protein (b), 100/0:Histag/WT mixture with encapsulated dye before an additional 5 hours of 
dialysis time (c), and 100/0:Histag/WT mixture with encapsulated dye after an additional 5 hours 
of dialysis time (d) without adjusting protein concentration.  The first peak at ~30 min represents 


































Figure 4.25: The Superose 6 gel filtration chromatograms of 60/40:Histag/WT mixture with 
encapsulated dye before an additional 5 hours of dialysis time (a), 60/40:Histag/WT mixture with 
encapsulated dye after an additional 5 hours of dialysis time (b), 60/40:Histag/WT mixture with 
encapsulated dye after an additional 5 hours of dialysis time (without adjusting protein 
concentration) (c).  The first peak at ~30 min represents 24-subunit and the second peak at ~37 
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Figure 4.26: The size distribution by intensity plot of 24-mer Histag protein (red), 
100/0:Histag/WT mixture with encapsulated dye (blue), 100/0:Histag/WT mixture with an 
additional 5 hours of dialysis time (green), and 100/0:Histag/WT mixture with an additional 5 































Figure 4.27: The size distribution by intensity plot of 24-mer Histag protein (red), 
60/40:Histag/WT mixture with encapsulated dye (green), 60/40:Histag/WT mixture with an 
additional 5 hours of dialysis time (blue), 60/40:Histag/WT mixture with an additional 5 hours of 
dialysis time without adjusting protein concentration (black). 
 
 
4.4.4: Control Experiments for Encapsulation by Bacterioferritin  
Encapsulation by Wild-type Bacterioferritin 
A 0.7 mg/mL solution of the 24-subunit WT protein was investigated for its ability to 
act as an encapsulation protein.  The protein concentrations before and after the encapsulation 
processes were similar, and it was found that no dye was encapsulated within the WT cavity 
(Figure 4.28).  By comparing these results with the 100% Histag system, it was found that the 
encapsulation of the dye seemed to lead to some protein aggregation.  The decrease in 
fluorescence intensity for dye encapsulated into WT protein with an additional 5 hours of 
dialysis time confirmed that non-specific binding of the dye could be eliminated by this 
method.  The dimer peak in Superose 6 gel filtration chromatograms was higher than that of 
the 24-subunit for WT protein in encapsulation experiments with and without an additional 5 
hours of dialysis time (Figure 4.29b and 4.29c).  DLS results showed that both WT proteins 
(with/without an additional 5 hours of dialysis time) had a smaller size than a starting 24-mer 
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WT protein (Figure 4.30).  These results suggest that the encapsulation of dye might support 







Figure 4.28: The emission spectra scanned between wavelengths 400-550 nm with the fixed 
excitation wavelength at 345 nm of 24-mer WT protein, WT protein in encapsulation 
experiments, and WT protein in encapsulation experiments with an additional 5 hours of dialysis 
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Figure 4.29: The Superose 6 gel filtration chromatograms of 24-mer WT protein (a), WT protein 
in encapsulation experiments after dialysis overnight (b), and WT protein in encapsulation 
experiments with an additional 5 hours of dialysis time (c).  The first peak at ~30 min represents 






















Figure 4.30: The size distribution by intensity plot of 24-mer WT protein (red), WT protein in 
encapsulation experiments (blue), and WT protein in encapsulation experiments with an 
















Elimination of Non-specific Dye Binding 
A 0.65 mg/mL solution of the 24-subunit Histag and WT proteins were used in 
encapsulation studies without a declustering step (so called non-specific dye binding Histag 
and non-specific dye binding WT, respectively) to investigate non-specific binding of the dye.  
Compared to the non-specific dye binding proteins without an extend dialysis time (both 
Histag and WT), a large decrease in fluorescence intensity after an additional 5 hours of 
dialysis time suggested the elimination of non-specific binding of the dye (Figure 4.31).  The 
Superose 6 chromatograms and DLS results indicated that stable proteins for both with and 
without an additional 5 hours of dialysis time were produced (Figure 4.32, 4.33, and 4.34).  
Therefore, the decrease of fluorescence intensity of the protein with encapsulated dye after 
extensive dialysis is due to the elimination of non-specific (possibly surface binding) dye 








Figure 4.31: The emission spectra scanned between wavelengths 400-550 nm with the fixed 
excitation wavelength at 345 nm of 24-mer Histag protein, 24-mer WT protein, non-specific dye 
binding Histag protein with and without an additional 5 hours of dialysis time, and non-specific 
dye binding WT protein with and without an additional 5 hours of dialysis time showing 
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Figure 4.32: The Superose 6 gel filtration chromatograms of 24-mer Histag protein (a), 24-mer 
WT protein (b), non-specific dye binding Histag protein without (c) and with (e) an additional 5 
hours of dialysis time, and non-specific dye binding WT protein without (d) and with (f) an 
additional 5 hours of dialysis time.  The first peak at ~30 min represents 24-subunit and the 

















































Figure 4.33: The size distribution by intensity plot of 24-mer WT protein (red), non-specific dye 
binding WT protein with an additional 5 hours of dialysis time (blue), and non-specific dye 
binding WT protein without an additional 5 hours of dialysis time (green).  The peak at ~16 nm 




















Figure 4.34: The size distribution by intensity plot of 24-mer Histag protein (red), non-specific 
dye binding Histag protein with an additional 5 hours of dialysis time (blue), and non-specific dye 
binding Histag protein without an additional 5 hours of dialysis time (green).  The peak at ~16 nm 




Solutions of 0.7 mg/mL of the 24-subunit proteins (Histag and WT) were reduced to 
0.65 mg/mL after the encapsulation procedures.  In order to investigate protein stability, these 
experiments skipped the encapsulating step.  By comparing these results with those involving 
the encapsulating step (section 4.4.3), the Superose 6 chromatograms exhibited higher amounts 
of dimeric protein for both with and without an additional 5 hours of dialysis time (Figure 4.35 
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and 4.36), and the sizes of non-encapsulated proteins were smaller than 24-mer size as shown 
in DLS results (Figure 4.37 and 4.38).  These results suggest that encapsulation of dye might 





     
 
 
Figure 4.35: The Superose 6 gel filtration chromatograms of 24-mer Histag protein (a), 24-mer 
WT protein (b), non-encapsulated Histag protein (c), non-encapsulated WT protein (d), and non-
encapsulated 60/40:Histag/WT mixture (e).  All non-encapsulated proteins were dialyzed 
overnight.  The first peak at 29 min represents 24-subunit and the second peak at ~36 min 





























Figure 4.36: The Superose 6 gel filtration chromatograms of non-encapsulated Histag protein (a), 
non-encapsulated WT protein (b), and non-encapsulated 60/40:Histag/WT mixture (c).  All non- 
encapsulated proteins were dialyzed overnight followed by change of dialysis buffer and then 
dialyzed for an additional 5 hours.  The first peak at ~29 min represents 24-subunit and the 



















Figure 4.37: The size distribution by intensity plot of 24-mer Histag protein (black), non-
encapsulated Histag protein (red), non-encapsulated WT protein (green), and non-encapsulated 
60/40:Histag/WT mixture (blue).  All non-encapsulated proteins were dialyzed overnight.  The 
peak at ~16 nm represents 24-mer protein, the peak at higher diameter represents self-
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Figure 4.38: The size distribution by intensity plot of 24-mer Histag protein (black), non-
encapsulated Histag protein (red), non-encapsulated WT protein (green), and non-encapsulated 
60/40:Histag/WT mixture (blue).  All non-encapsulated proteins were dialyzed overnight followed 
by change of dialysis buffer and then dialyzed for an additional 5 hours. 
 
 
4.4.5: Fluorescence Quenching of the Dye Encapsulated Bacterioferritin 
 The results from section 4.4.2 suggest that the dye molecules might quench each other 
if they are in a close distance (high concentration of the dye).  However, only 50% (v/v) dye 
was used in the encapsulation experiments, so the fluorescence quenching of the encapsulated 
dye molecules might come from their interaction with the protein.  The fluorescence 
measurements of the denatured 60/40:Histag/WT mixture with encapsulated dye compared 
with the native 60/40:Histag/WT mixture with encapsulated dye suggest that the protein shells 










Figure 4.39: The emission spectra scanned between wavelengths 400-550 nm with the fixed 
excitation at 345 nm of the 60/40:Histag/WT mixture with encapsulated dye, the denatured 
60/40:Histag/WT mixture with encapsulated dye (with 6 M Gdn-HCl solution), denatured 24-mer 
Histag protein (with 6 M Gdn-HCl), and 6 M Gdn-HCl solution showing maximum fluorescence 
intensity at 440 nm. 
 
 
4.4.6: Heme-incorporated Encapsulated Bacterioferritin  
The results for fluorescence measurement, Superose 6 gel filtration chromatography, 
and DLS of encapsulation with bFT with His6-tag at the C-terminus with/without an additional 
5 hours of dialysis time were similar to those of the encapsulation with 100/0:Histag/WT 
protein (section 4.4.3).  The determination of the heme groups present in bFT is presented in 









Native 60/40:Histag/WT mixture 
with encapsulated dye 
Denatured 60/40:Histag/WT 
mixture with encapsulated dye 
24-mer Histag in Gdn-HCl 
Gdn-HCl solution 
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without His6-tag at the C-terminus were similar (~12 heme groups per 24-subunit protein).  
Therefore, the presence of the His-tag as well as the encapsulation process itself does not seem 
to affect the heme binding pocket.   
 
4.4.7: Iron Storage in Bacterioferritin 
 The results from metal analysis of the 24-subunit bFT containing His6-tag at the C-
terminus isolated by Superose 6 gel filtration chromatography showed that this protein 
possessed low amounts of iron atoms (Appendix 12).  High amount of sodium and zinc, which 
are common ions found in water, might be the contaminants from environments such as 
container, air, or even from Chelex treated water.  A trace of sulfur might also come from 
environments and might be related to amino acid residue such as methionine in the protein. 
 
4.4.8: Dye Molecules Encapsulated in Bacterioferritin  
Protein concentration of 100% Histag and the combination of 60/40:Histag/WT as 
determined in section 4.4.3 (Table 4.6) were used to determine the average number of dye 
molecules encapsulated by the declustering and reclustering procedure.  The fluorescence 
measurements that suggested successful encapsulation were presented in Figure 4.23.  The 
stabilities for encapsulated dye molecules in the protein were represented by the Superose 6 gel 
filtration chromatograms (Figure 4.24 and 4.25) and the size distribution by intensity plots 
(Figure 4.26 and 4.27).  The calculation of encapsulated dye molecules is shown in Appendix 
10.  It was calculated that for both the 100% Histag protein and the 60/40:Histag/WT mixture, 
dye encapsulation was similar (~6-7 molecules).  However, since 100% Histag had higher 
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Dye molecules in Pro-Q® sapphire 365 oligohistidine gel stain possess the following 
properties: (1) maximum excitation wavelength at 345 nm and maximum emission wavelength 
at 440 nm, (2) a MW of 553 Da, (3) an extinction coefficient (ε345) of ~19 000-23 000 cm-1M-1, 
(4) a concentration of ~9.2 μM in the stock solution, and (5) approximately a 6.6 ratio of 
Ni2+/dye molecule.  The predicted structure of the dye molecules was expected to be a 
coumarin based dye system. 
It was determined that the encapsulation of Ni2+-NTA linked dye by bFT with His6-tag 
at the C-terminus required three steps to be successful: (1) declustering of the native protein for 
90 min by dialysis against an acidic solution (pH 2.0) containing 10 mM PIPES, 150 mM NaCl 
and 10% glycerol, (2) binding and reclustering (encapsulating) of the Ni2+-NTA dye with His6-
tag protein and reclustering in buffer pH 8.0 for 2 hours, and (3) eliminating non-specific 
binding of the dye by dialysis against wash buffer (pH 8.0) containing 10 mM PIPES and 100 
mM NaCl overnight and then for an additional 5 hours with fresh dialysis buffer.  A high 
protein concentration was required to maintain the 24-subunit clusters after the encapsulation 
experiments.  The experimental data suggests that at least 0.5 mg/mL of the 24-subunit protein 
prepared by Superose 6 gel filtration chromatography is needed for step 1 of the encapsulation 
experiments.  The protein combination of 60/40:Histag/WT mixture had higher recoveries after 
the encapsulation process, while the 100% Histag protein system had greater protein stability 
to maintain 24-subunit cluster after encapsulation.  Although both proteins yielded similar 
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amounts of encapsulated dye (~6-7 molecules), the combination of 60/40:Histag/WT mixture 
had higher dye encapsulation efficiency (~43%) for the number of His-tag sites available.  
Small amount of encapsulated dye molecules in the 100% Histag protein suggested that all 
His6-tags at the C-terminal bFT subunits were not available for dye binding (Figure 4.40).  
Steric or electrostatic interactions among adjacent His-tag regions or secondary interactions 
between other parts of the protein and variants His-tags may reduce the number of final His-tag 
binding sites available for dye interaction.  In addition, it was found that encapsulation does 
not influence the heme binding pocket and low amount of iron atoms were found to have no 
effect on the encapsulation process. 
Control experiments to study the encapsulation by bFT-WT taking into account non-
specific binding confirmed the results of the encapsulation process.  There was no 
encapsulation of dye molecules for bFT-WT, which is consistent with the interaction between 
His6-tag protein and Ni2+-NTA binding dye, while non-encapsulated protein provided 
information on protein stability and non-specific binding of the dye.  It is suggested that the 
encapsulated dye molecules might be involved in 24-subunit reformation.  There are two 
possibilities to explain the observation that fluorescence decreased with utilization of an 
additional 5 hours of dialysis time in the reclustering step.  One possibility is the elimination of 
non-specific dye binding and the second could be protein dissociation.  The loss of 
fluorescence for non-specific binding of the dye on native proteins confirmed that the decrease 
in fluorescence intensity for the protein with encapsulated dye after extensive dialysis was 
























































































































































































































































CHAPTER 5: SUMMARY AND FUTURE WORK 
 
5.1: Summary 
 The bacterial protein, bFT, consisting of 24 identical subunits with a maximum of 12 
heme groups was used as a host particle in encapsulation experiments.  Each subunit possesses 
two iron atoms forming a ferroxidase center.  Encapsulation of a dye using bFT requires three 
main steps to complete an encapsulation process and include (1) subunit dissociation in acidic 
pH (declustering), (2) binding of each subunit with a guest molecule, and (3) reassociation at 
neutal pH (reclustering).   
The development of dissociation and reassociation conditions was preliminarily 
performed on commercially available apoFT, an iron-free FT that resembles bFT in terms of its 
size and function.  The optimized conditions for declustering and reclustering of multisubunit 
apoFT were investigated by measuring the size of the protein using dynamic light scattering 
methods.  It was found that the apoFT subunit dissociation can be accomplished at pH between 
1.0-2.5 in the presence of 200 mM NaCl and 10% glycerol.  Multisubunit reassociation can be 
achieved by raising the pH to neutral.  A high protein concentration is required due to the 
sensitivity of the particle sizer.   
In order to encapsulate guest molecules, the internal protein cavity needs to be free of 
its iron core.  The ferroxidase- and heme-free bFT mutant (bFT-E18A/M52L/E94A), as well as 
other variants that are composed of various combinations of these three mutations, were 
generated by site directed mutagenesis.  Protein purifications were performed using a sequence 
of steps, which included heat denaturation, ammonium sulfate precipitation, and gel filtration 
chromatography.  Protein stability was investigated by Superose 6 gel filtration 
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chromatography and the protein sizes were determined by DLS.  Optimized conditions to 
isolate these proteins by Superose 6 gel filtration chromatography required (1) at least 0.5 
mg/mL of protein concentration, and (2) buffer (pH 8.0) containing 20 mM Tris-OH and 100 
mM NaCl.  All bFT variants except for bFT-E94A resulted in high amounts of smaller subunit 
structures (dimer and monomer).  It was also found that the bFT-M52L/E94A variant (not 
previously reported) only possessed dimeric quaternary structure.  Since only bFT-WT 
exhibited a stable 24-subunit quaternary structure isolated by Superose 6 gel filtration 
chromatography, it was used for the encapsulation experiments and not the variants of the 
wild-type bFT. 
 By obtaining knowledge of the optimized conditions needed for the declustering and 
reclustering of apoFT, the optimized conditions for the isolation of bFT by gel filtration 
chromatography, and the investigation of the stability of the 24-subunit quaternary structure of 
these proteins, the encapsulation experiments using bFT with His6-tag at the C-terminus as a 
host particle and dye molecules in Pro-Q® sapphire 365 oligohistidine gel stain as encapsulated 
guests were studied.  The electrospray MS and the patent searching suggest that this 
commercial dye is 7-amino-3-(1-carboxy-1-(bis(carboxymethyl)amino)-5-
(acetylamino))pentyl-4-methylcoumarin-6-sulfonic acid (MW = 553 Da), which is a Ni2+-NTA 
derivative.  This dye possesses the following properties: (1) maximum excitation wavelength at 
345 nm and maximum emission wavelength at 440 nm, (2) dye concentration of ~9.2 μM in 
Pro-Q® sapphire 365 oligohistidine gel stain, (3) an estimated extinction coefficient (ε345) of  
23 000 M-1cm-1, (4) a 6.6 ratio of Ni2+/dye molecule.  This Ni2+-NTA derivative dye (structure 
resembling coumarin) is able to form strong interactions with His6-tag at the C-terminal bFT in 
the encapsulation experiments, yielding evidence for encapsulated dye in the bFT cavity.  The 
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optimized conditions for dye encapsulation were (1) subunit dissociations occur during ~90 
minutes in the acidic solution (pH 2.0) containing 10 mM PIPES, 150 mM NaCl, and 10% 
glycerol, (2) encapsulation and reclustering of dye molecules for 2 hours in buffer (pH 8.0) 
containing 10 mM PIPES and 100 mM NaCl, and (3) elimination of non-specific dye binding 
by overnight dialysis in buffer (pH 8.0) containing 10 mM PIPES and 100 mM NaCl followed 
by an additional 5 hours of dialysis with fresh buffer.  In addition, it was found that the heme 
groups and iron atoms do not affect the encapsulation experiments.  The amount of 
encapsulated dye molecules was found to be similar for both 100% bFT with His6-tag at the C-
terminus and the combination of 60% bFT with His6-tag at the C-terminus and 40% bFT 
without His6-tag at the C-terminus (~6-7 molecules).  However, the encapsulation efficiency of 
100% bFT with His6-tag at the C-terminus (~25%) was lower than the one of the combination 
of 60% bFT with His6-tag at the C-terminus and 40% bFT without His6-tag at the C-terminus 
(~43%).  These results suggest that not all His6-tag at the C-terminal bFT are available for dye 
binding.   
 
5.2: Future Work 
 Since there are only small amounts of dye molecules that could be encapsulated within 
the His-tagged bFT, methods to increase the number of encapsulated dye molecules in the 
encapsulation experiments should be developed.  One possibility is to separate the binding step 
and the reclustering step and allow a longer time for the binding step.  In our encapsulation 
experiments, these two steps were performed together (the declustered proteins in acidic buffer 
(pH 2.0) were bound with dye molecules in the dye solution (pH 8.0)).  If the binding time for 
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dye molecules and the protein is allowed to be longer before the reclustering step, perhaps a 
greater number of encapsulated dye molecules will be obtained. 
 Other host-guest affinity methods such as use of a S-tag could also be useful for future 
encapsulation studies.  S-tag is a 15 amino-acid peptide, which can form a stable interaction 
with S-protein (S-fragment of RNaseA) (Terpe, 2003).  However, the cost of this affinity tag is 
higher than that of the His-tag affinity.  Other linkage that can form strong interaction between 
host particle and a guest molecule is to perform protein engineering (fusion protein), in which a 
guest gene is directly linked to the host gene.  In this case, a linker with various sizes between 
host and guest might be required.  In addition, the reclustering to reform 24-subunit of this 
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Digest with DpnI, which is 
specific to methylated 
DNA, to eliminate the non-
mutated parental DNA 
template 
Transform into E. coli cells 
(strain DH5α), which 
repaired the nicks of 
mutated plasmid 
Grow on Amp 
containing agar plates 
overnight at 37 ºC before 
selecting single colony 
Inoculated overnight in 
LB containing Amp  
(5 mL) 
Plasmid purification 
The experiment was 
repeated to generate 
double and triple 
mutants 
Measure DNA 
concentration and send 
sequencing 
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1. Digest with BsmI and HindIII (3 hours) 
2. Run digested products on 1% agarose gel (2 hours at 100 V) 
3. Select and cut desired band under UV light 
4. Do plasmid purification using a QIAprep Spin Miniprep Kit 
BsmI 
HindIII 
Ligations for 3 hours at 14-16 ºC 
1. Heat shock transformation into E.coli cells (strain DH5α) 
2. Grow overnight on Amp containing agar plates 
3. Pick one colony and inoculate overnight in LB containing Amp (5 mL) 
4. Plasmid purification using a QIAprep Spin Miniprep Kit 











Appendix 3: Flow Chart for Protein Purification 
 
Resuspend pellet in 20 mM Tris buffer pH 8.0 (1g/3 mL) and add lysozyme (1mg/mL) 
 
Break cell wall by placing in liquid nitrogen then hot water (60-70 ºC) (repeat 5 times) 
 
Heat at 60-70 ºC for 15 min to denature other proteins and lysozyme (heat inactivate) 
 
Sonication for 15-20 x 10 sec (on ice) before centrifugation at 20 000 rpm for 15 min 
 
Supernatant                    Pellet  
 
Heat for 15 min at 60–70 oC, then cool to 4 ºC             Discard 
 
Centrifuge 20 000 rpm for 15 min 
 
              Supernatant                       Pellet 
 
Slowly add 25% ammonium sulfate for 15 min on ice    Discard 
 
Centrifuge 15 000 g for 30 min 
 
           Supernatant          Pellet 
 
Add 40% ammonium sulfate                 Discard  
 
 Centrifuge 15 000 g for 30 min 
 
           Supernatant          Pellet 
 
   Discard              Dialysis with 20 mM Tris pH 8.0 overnight at 4 ºC 
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Appendix 4: Sequencing Results for Wild Type and Variants of 
Bacterioferritin 
 
All DNA samples, wild-type bFT and bFT variants, were sent for sequencing (Mobix, 
McMaster).  The sequencing process required at least 100 ng/μL (for double strand DNA < 10 
kb).  The forward primer for the promoter T7 was used for sequencing of bFT-WT and 
mutated bFT, so the results were in the forward direction (5´ to 3´).  For the sequence of bFT 
with His6-tag at the C-terminus, the result form Mobix is in the reverse form due to the position 
of tag.  The reverse primer of promoter T7 was used for this sequencing.  The forward 
sequence was received using Reverse Complement software 
(http://bioinformatics.org/sms/rev_comp.html) (Stothard, 2000).  The results are in two forms, 
FASTA format and sequencing chromatogram.  The mutated sequence in FASTA format was 
checked using the BLAST2 program (http://www.ncbi.nlm.nih.gov/blast/bl2seq/wblast2.cgi) 
(Tatusova and Madden, 1999).  Blast2 results represent Query as literature sequence of wild-
type bFT and Sbjct as experimental cloning sequence.  The bold letters and number above the 
specific three amino acids (emphasized by highlight) show correctly mutated residues.  The 
sequencing chromatograms were used to confirm the FASTA format and check for the 









Sequence for pT7.Bfr-WT 
 


















Blast2 Result:  
 
Query: 1   atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgtc 60 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 75  atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgtc 134 
                                                                       
Query: 61  gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 120 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 135 gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 194 
                                                                       
Query: 121 aatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattgag 180 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 195 aatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattgag 254 
                                                                     
Query: 181 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 240 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 255 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 314 
                                                                     
Query: 241 gaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaagaat 300 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 315 gaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaagaat 374 
                                                                       
Query: 301 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 360 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 375 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 434 
                                                                        
Query: 361 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 420 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 435 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 494 
                                                                   
Query: 421 attcagaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggttga 477 
           ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 




Sequence for pT7.Bfr-E18A 
 


















Blast2 Result:  
 
        E18A 
Query: 1   atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgtc 60 
           |||||||||||||||||||||||||||||||||||||||||||||||||||| ||||||| 
Sbjct: 70  atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgcgcttgtc 129 
                                                                        
Query: 61  gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 120 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 130 gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 189 
                                                                        
Query: 121 aatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattgag 180 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 190 aatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattgag 249 
                                                                       
Query: 181 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 240 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 250 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 309 
                                                                        
Query: 241 gaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaagaat 300 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 310 gaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaagaat 369 
                                                                        
Query: 301 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 360 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 370 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 429 
                                                                        
Query: 361 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 420 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 430 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 489 
                                                                     
Query: 421 attcagaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggttga 477 
           ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 




Sequence for pT7.Bfr-M52L 
 

















Blast2 Result:  
 
Query: 1   atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgtc 60 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 72  atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgtc 131 
                                                                        
Query: 61  gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 120 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 132 gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 191 
 
                                            M52L                            
Query: 121 aatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattgag 180 
           |||||||||||||||||||||||||||||||||.|||||||||||||||||||||||||| 
Sbjct: 192 aatgatgtggagtatcatgaatccattgatgagctgaaacacgccgatcgttatattgag 251 
                                                                        
Query: 181 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 240 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 252 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 311 
                                                                        
Query: 241 gaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaagaat 300 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 312 gaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaagaat 371 
                                                                        
Query: 301 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 360 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 372 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 431 
                                                                        
Query: 361 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 420 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 432 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 491 
                                                                     
Query: 421 attcagaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggttga 477 
           ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 




Sequence for pT7.Bfr-E94A 
 



















Blast2 Result:  
 
Query: 1   atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgtc 60 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 71  atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgtc 130 
                                                                        
Query: 61  gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 120 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 131 gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 190 
                                                                        
Query: 121 aatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattgag 180 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 191 aatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattgag 250 
                                                                        
Query: 181 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 240 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 251 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 310 
 
                                                  E94A                      
Query: 241 gaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaagaat 300 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 311 gaagatgttgaggaaatgctgcgttctgatctggcacttgcgctggatggcgcgaagaat 370 
                                                                      
Query: 301 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 360 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 371 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 430 
                                                                        
Query: 361 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 420 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 431 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 490 
                                                                     
Query: 421 attcagaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggttga 477 
           ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 491 attcagaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggttga 547 
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Sequence for pT7.Bfr-E18A/E94A 
 


















Blast2 Result:  
 
            E18A 
Query: 1   atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgtc 60 
           |||||||||||||||||||||||||||||||||||||||||||||||||||| ||||||| 
Sbjct: 68  atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgcgcttgtc 127 
                                                                       
Query: 61  gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 120 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 128 gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 187 
                                                                        
Query: 121 aatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattgag 180 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 188 aatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattgag 247 
                                                                        
Query: 181 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 240 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 248 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 307 
 
                             E94A                                  
Query: 241 gaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaagaat 300 
           |||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||| 
Sbjct: 308 gaagatgttgaggaaatgctgcgttctgatctggcacttgcgctggatggcgcgaagaat 367 
                                                                        
Query: 301 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 360 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 368 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 427 
                                                                        
Query: 361 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 420 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 428 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 487 
                                                                     
Query: 421 attcagaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggttga 477 
           ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 488 attcagaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggttga 544 
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Sequence for pT7.Bfr-E18A/M52L 
 


















Blast2 Result:  
 
             E18A 
Query: 1   atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgtc 60 
           |||||||||||||||||||||||||||||||||||||||||||||||||||| ||||||| 
Sbjct: 74  atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgcgcttgtc 133 
                                                                        
Query: 61  gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 120 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 134 gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 193 
 
                 M52L                                          
Query: 121 aatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattgag 180 
           |||||||||||||||||||||||||||||||||.|||||||||||||||||||||||||| 
Sbjct: 194 aatgatgtggagtatcatgaatccattgatgagctgaaacacgccgatcgttatattgag 253 
                                                                        
Query: 181 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 240 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 254 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 313 
                                                                        
Query: 241 gaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaagaat 300 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 314 gaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaagaat 373 
                                                                        
Query: 301 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 360 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 374 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 433 
                                                                        
Query: 361 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 420 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 434 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 493 
                                                                    
Query: 421 attcagaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggttga 477 
           ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 494 attcagaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggttga 550 
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Sequence for pT7.Bfr-M52L/E94A 
 

















Blast2 Result:  
 
Query: 1   atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgtc 60 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 72  atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgtc 131 
                                                                       
Query: 61  gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 120 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 132 gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 191 
 
                                            M52L                            
Query: 121 aatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattgag 180 
           |||||||||||||||||||||||||||||||||.|||||||||||||||||||||||||| 
Sbjct: 192 aatgatgtggagtatcatgaatccattgatgagctgaaacacgccgatcgttatattgag 251 
                                                                       
Query: 181 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 240 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 252 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 311 
 
                                                  E94A                      
Query: 241 gaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaagaat 300 
           |||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||| 
Sbjct: 312 gaagatgttgaggaaatgctgcgttctgatctggcacttgcgctggatggcgcgaagaat 371 
                                                                        
Query: 301 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 360 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 372 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 431 
                                                                        
Query: 361 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 420 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 432 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 491 
                                                                     
Query: 421 attcagaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggttga 477 
           ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 492 attcagaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggttga 548 
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Sequence for pT7.Bfr-E18A/M52L/E94A 
 


















Blast2 Result:  
 
        E18A 
Query: 1   atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgt- 59 
           |||||||||||||||||||||||||||||||||||||||||||||||||||| ||||||  
Sbjct: 81  atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgcgcttgtt 140 
                                                                       
Query: 60  cgca-atcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtc 118 
           |||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 141 cgcacatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtc 200 
 
                                              M52L                          
Query: 119 tcaatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattg 178 
           |||||||||||||||||||||||||||||||||||.|||||||||||||||||||||||| 
Sbjct: 201 tcaatgatgtggagtatcatgaatccattgatgagctgaaacacgccgatcgttatattg 260 
                                                                        
Query: 179 agcgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattg 238 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 261 agcgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattg 320 
 
                                                    E94A                    
Query: 239 gtgaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaaga 298 
           |||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||| 
Sbjct: 321 gtgaagatgttgaggaaatgctgcgttctgatctggcacttgcgctggatggcgcgaaga 380 
                                                                        
Query: 299 atttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatga 358 
           |||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||| 
Sbjct: 381 atttgcgtgaggcaattggttatgccgatagcgttcatgattacntcagccgcgatatga 440 
                                                                        
Query: 359 tgatagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatc 418 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 441 tgatagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatc 500 
                                                                       
Query: 419 tgattcagaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggttga 477 
           ||||||| ||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 501 tgattcanaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggttga 559 
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Sequence for pT7.Bfr-WT with His6-tag at the C-terminus 
 




































Note: ATG is coding for the starting amino acid and GGT is the end of the sequence without 
the stop codons, TGA, as in bFT-WT.  CTCGAG is the extra sequence from XhoI cutting site 



















Query: 1   atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgtc 60 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 551 atgaaaggtgatactaaagttataaattatctcaacaaactgttgggaaatgagcttgtc 492 
 
                                                                        
Query: 61  gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 120 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 491 gcaatcaatcagtactttctccatgcccgaatgtttaaaaactggggtctcaaacgtctc 432 
 
                                                                        
Query: 121 aatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattgag 180 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 431 aatgatgtggagtatcatgaatccattgatgagatgaaacacgccgatcgttatattgag 372 
 
                                                                        
Query: 181 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 240 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 371 cgcattctttttctggaaggtcttccaaacttacaggacctgggcaaactgaacattggt 312 
 
                                                                        
Query: 241 gaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaagaat 300 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 311 gaagatgttgaggaaatgctgcgttctgatctggcacttgagctggatggcgcgaagaat 252 
 
                                                                        
Query: 301 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 360 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 251 ttgcgtgaggcaattggttatgccgatagcgttcatgattacgtcagccgcgatatgatg 192 
 
                                                                        
Query: 361 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 420 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 191 atagaaattttgcgtgatgaagaaggccatatcgactggctggaaacggaacttgatctg 132 
 
                                                                  
Query: 421 attcagaagatgggcctgcaaaattatctgcaagcacagatccgcgaagaaggt 474 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||| 




Appendix 5: Mass Spectrometric Results 
 
The protein samples (bFT-WT and all bFT variants) were prepared for electrospray 
mass spectrometry from heat denaturation and ammonium sulfate precipitation purification 
steps.  The solution used for MS contained 50:50/MeCN:H2O and 0.2% FA.  The calculated 
mass was determined by mass calculation using the amino acid sequence.  This predicted mass 
was compared to that mass MS, in which graph a) represents the overall calculation 
mass/charge, graph b) represents high percent intensity of mass/charge, and graph c) is the 












































































Figure A5.1: The electrospray mass spectrums of wild-type bFT showing the molecular weight of 

























































Figure A5.2: The electrospray mass spectrums of bFT-E18A showing the molecular weight of 

























































Figure A5.3: The electrospray mass spectrums of bFT-M52L showing the molecular weight of 


























































Figure A5.4: The electrospray mass spectrums of bFT-E94A showing the molecular weight of 



























































Figure A5.5: The electrospray mass spectrums of bFT-E18A/M52L showing the molecular weight 








Bfr-E18A/E94A in 50/50 MeCN: water + 0.2% FA















































Bfr-E18A/E94A in 50/50 MeCN: water + 0.2% FA









Figure A5.6: The electrospray mass spectrums of bFT-E18A/E94A showing the molecular weight 
of single subunit at 18379.00 Da comparing to the calculated mass of 18378.95 Da. 
 
Bfr-E18A/E94A in 50/50 MeCN: water + 0.2% FA


































Figure A5.7: The electrospray mass spectrums of bFT-M52L/E94A showing the molecular weight 












Figure A5.8: The electrospray mass spectrums of bFT-E18A/M52L/E94A showing the molecular 


















































Figure A5.9: The electrospray mass spectrums of bFT-WT with His6-tag at the C-terminus 
showing the molecular weight of single subunit at 19560.50 Da comparing to the calculated mass 




Appendix 6: Spectrophotometric Results for Wild Type and Variants of 
Bacterioferritin 
 
The spectrum of wild-type and bFT variants confirmed the existence of heme-
incorporated protein.  The absorption peaks at 418, 525, and 560 nm associated with the Soret, 






Figure A6.1: A spectroscopic scan of bFT-WT shows the absorption at 418, 525, and 560 nm.  The 

















Figure A6.2: A comparison of spectroscopic scans between wild-type bFT (red) compared with 








Figure A6.3: A comparison of spectroscopic scans between wild-type bFT (red) compared with 















Figure A6.4: A comparison of spectroscopic scans between wild-type bFT (blue) compared with 










Figure A6.5: A comparison of spectroscopic scans between wild-type bFT (green) compared with 














Figure A6.6: A comparison of spectroscopic scans between wild-type bFT (green) compared with 






   
 
Figure A6.7: A comparison of spectroscopic scans between wild-type bFT (red) compared with 














Figure A6.8: A comparison of spectroscopic scans between wild-type bFT (blue) compared with 
that of bFT-E18A/M52L/E94A (red). 
 
 232
Appendix 7: Gel Filtration Chromatographic Results (Superose 6) of Wild-
type and Variants of Bacterioferritin 
 
 Bio-Rad gel filtration standard protein plot was done by performing Superose 6 gel 
filtration chromatography on a set of known mixed proteins, thyroglobulin (679 kDa), γ-
globulin (158 kDa), ovalbumin (44 kDa), myoglobulin (17 kDa), and vitamin B12 (1.35 kDa) 
(Figure A7.1).  The standard proteins in a solution containing 20 mM Tris-OH (pH 8.0) and 
100 mM NaCl was run through a Superose 6 column with 0.5 mL/min flow rate.  The eluted 
volumes of each protein were calculated in terms of Ka (Table A7.1), where Ka is (Ve – V0)/  
(Vt - V0), V0 is the void volume, Ve is the elution volume, and Vt is the total bed volume.  The 
void volume is 8 mL determined from Blue Dextran eluted volume (Figure A7.2).  The total 
bed volume, which is the volume of the Superose 6 column resin is 24 mL.  Then Ka was 
plotted as a function of log (MW) (Figure A7.3).  Example of calculation for thyroglobulin is 
Ka = (12.8 – 8.0)/(24.0 – 8.0) = 0.29688 (Table A7.1).   
    
 
 
Figure A7.1: The Superose 6 gel filtration chromatogram of Bio-Rad standard protein.  Each 















Figure A7.2: The Superose 6 gel filtration chromatogram of Blue Dextran shows the void volume 























Figure A7.3: Bio-Rad protein standard curve used for molecular weight calculation of protein 
samples.  The data for this plot was shown in Table A7.1. 
 
 
Table A7.1: The table shows the molecular weight of standard protein and eluted volumes in 







Ve (trial 1) 
(mL) 




Blue Dextran (Vo)     8.00 8.00    
Thyroglobulin 670.00 2.826075 12.90 12.60 12.75 0.29688
γ-globulin 158.00 2.198657 16.00 15.70 15.85 0.49063
Ovalbumin 44.00 1.643453 17.50 17.30 17.40 0.58750
Myoglobin 17.00 1.230449 18.80 18.80 18.80 0.67500






 It was found earlier that the MW of 24-subunit apoFT determined from Superose 6 gel 
filtration chromatography is less than that of the literature (~450 kDa) (Chapter 3), and it was 
suggested that the gel filtration chromatography could not be used to determine protein MW 
(for bFT and apoFT).  In order to prove that even though the calculated MW of 24-subunit 
apoFT determined by Superose 6 gel filtration chromatography is incorrect and the Superose 6 
chromatograms can be used to determine a degree of quaternary structures, the Stokes radius of 
apoFT is determined from the plot of protein standards’ Stokes radius versus their elution 
volumes.  In addition, its MW can be calculated using the Stokes-Einstein and Svedberg 
equations and the plot of MW versus sedimentation coefficient times Stokes radius.  The 
molecular weight, Stokes radius, and sedimentation coefficient of protein standards 
(thyroglobulin (670 kDa, Stokes radius of 85 Å, sedimentation coefficient of 19S), γ-globulin 
(158 kDa, 48.1 Å, 6.6S), ovalbumin (45 kDa, 30.5 Å, 3.55S), myoglobin (17 kDa, 21.2 Å, 2S), 
and vitamin B12 (1.35 kDa, 8.5 Å)) are received from the literature (Qasim and Salahuddin, 
1979; Andrews, 1970; Cui et al., 2002; Husain and Sadana, 1974; Siegel and Monty, 1966; 
Post et al., 2002; Venkatesh and Deshpande, 1999) (Table A7.2), while the experimental 
average elution volumes are from Table A7.1.  The Stokes radius for apoFT is calculated from 
the linear equation, which is received from the plot of Stokes radius versus elution volumes, y 
= -8.5464x + 186.68, where y is the Stokes radius (Å) and x is the elution volume (mL) (Figure 
A7.2).  Since the experimental elution volume of apoFT is 14.5 mL, its Stokes radius is 
calculated to be ((-8.5464 × 14.5) + 186.68) 62.8 Å.  The molecular weight of 24-subunit 
apoFT can be determined from the Stokes-Einstein and Svedberg equations:  
M = (6πη r N s20,w)/(1 - νρ), 
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where M is the molecular weight, η is the solvent viscosity, r is the Stokes radius, N is 
Avogadro’s number, s20,w is the sedimentation coefficient, ν is the apparent partial specific 
volume of the protein, and ρ is the density of the solvent (Notides and Williams-Ashman, 
1967).  From the plot of molecular weight versus the Stokes radius times the sedimentation 
coefficient, the linear equation y = 0.4179x, where y is the molecular weight (kDa) and x is the 
sedimentation coefficient times Stokes radius (Å × S), is used to calculate the MW of 24-
subunit apoFT.  By using this equation, the calculated Stokes radius (62.8 Å), and the literature 
sedimentation coefficient (17S) (Rothen, 1944), it is found that apoFT has a MW of (0.4179 × 
62.8 × 17) 446 kDa.   
 
Table A7.2: The table shows the molecular weight, the Stokes radius, the average elution 
volumes, the sedimentation coefficient, and the sedimentation coefficient times Stokes radius of 















Stokes radius  
(Å × S) 
Thyroglobulin 670 85.0 12.75 19.00 1615.00 
γ-globulin 158 48.1 15.85 6.60 317.46 
Ovalbumin 44 30.5 17.40 3.55 126.03 
Myoglobin 17 21.2 18.80 2.00 42.40 
Vitamin b-12 1.35 8.5 21.80   
 
 236



























Figure A7.4: The plot of Stokes radius versus elution volumes of protein standards showing the 



























Figure A7.5: The plot of molecular weights versus Stokes radius times sedimentation coefficients 
of protein standards showing the linear equation that is related to the Stokes-Einstein and 




The samples for gel filtration chromatography (Superose 6) were wild-type bFT and all 
bFT variants.  The samples were prepared from protein purification processes, which included 
heat denaturation and ammonium sulfate precipitation, followed by filtration and injection into 
100 μL loop of a HPLC.  The concentration of sample was 1.35 mg/mL in buffer containing 20 
mM Tris-OH (pH 8.0) and 100 mM NaCl running through the Superose 6 column with a 0.5 
mL/min flow rate.  The following data presents the gel filtration chromatograms (Superose 6) 
of each protein sample.  Each eluted fraction was calculated for its MW by comparing with the 
protein standards.  SDS PAGE was used to confirm the existence of desired monomeric 
protein.  Example of the calculation for peak 1 of bFT-WT is Ka = (14.6 - 8.0)/(24.0 - 8.0) = 
0.4125 (Figure A7.6).  Then logMW (y-value) was found in the standard protein plot (Figure 
A7.5) by insert Ka value as x-value in the equation y = -4.806x + 4.4053, where logMW = (-
4.806 × 0.4125) + 4.4053 = 2.4633, and so MW is 290.6 kDa (Table A7.3). 
 



















Table A7.3: The calculated molecular weight of each eluted Superose 6 fraction from bFT-WT 
 
bFT-WT MW (kDa) log (MW) Ve (mL) Ka 
Peak 1 (24-subunit) 290.6 2.4633 14.6 0.4125 
Peak 2 (monomer) 17.3 1.2383 18.6 0.6625 
Peak 3 5.6 0.7482 20.2 0.7625 
Peak 4 2.6 0.4113 21.3 0.8313 









Figure A7.7: The SDS PAGE results of Superose 6 eluted fractions of bFT-WT.  The lists below 
indicate proteins contained in each eluted fraction. 
 
Lane  Sample     
  1  MWM        
  2  Eluted peak 1 of bFT-WT     
  3  Eluted peak 2 of bFT-WT   
  4  Eluted peak 3 of bFT-WT 
  5  Eluted peak 4 of bFT-WT 






























Figure A7.8: The Superose 6 gel filtration chromatogram of bFT-E18A shows two eluted peaks. 
 
 
Table A7.4: The calculated molecular weight of each eluted Superose 6 fraction of bFT-E18A 
 
bFT-E18A MW (kDa) log (MW) Ve (mL) Ka 
Peak 1 (24-subunit) 290.6 2.4633 14.6 0.4125 








Figure A7.9: The SDS PAGE results of Superose 6 eluted fractions of bFT-E18A.  The lists below 
indicate proteins contained in each eluted fraction. 
 
Lane  Sample 
  1  MWM 
  2  Eluted peak 1 of bFT-E18A 




























Table A7.5: The calculated molecular weight of each eluted Superose 6 fraction of bFT-M52L 
 
bFT-M52L MW (kDa) log (MW) Ve (mL) Ka 
Peak 1 (24-subunit) 264.7 2.4228 14.6 0.4125 








Figure A7.11: The SDS PAGE results of Superose 6 eluted peaks of bFT-M52L.  The lists below 
indicate proteins contained in each eluted fraction. 
 
Lane  Sample 
  1  MWM 
  2  Eluted peak 1 of bFT-M52L 


























Figure A7.12: The Superose 6 gel filtration chromatogram of bFT-E94A shows two eluted peaks 
 
 
Table A7.6: The calculated molecular weight of each eluted Superose 6 fraction of bFT-E94A 
 
bFT-E94A MW (kDa) log (MW) Ve (mL) Ka 
Peak 1 (24-subunit) 289.7 2.4620 14.5 0.4063 






Figure A7.13: The SDS PAGE results of Superose 6 eluted fractions of bFT-E94A.  The lists 
below indicate proteins contained in each eluted fraction. 
 
Lane  Sample     
  1  MWM        
  2  Eluted peak 1 of bFT-E94A 
  3  Eluted peak 2 of bFT-E94A 
1
2


























Table A7.7: The molecular weight of each eluted Superose 6 fraction of bFT-E18A/M52L 
 
bFT-E18A/M52L MW (kDa) log (MW) Ve (mL) Ka 
Peak 1 (aggregates) 29199.5 4.4654 7.8 -0.0125 
Peak 2 (aggregates) 985.2 2.9935 12.7 0.2938 
Peak 3 (24-subunit) 264.7 2.4228 14.6 0.4125 






Figure A7.15: The SDS PAGE results of Superose 6 eluted fractions of bFT-E18A/M52L.  The 
lists below indicate proteins contained in each eluted fraction. 
 
Lane Sample     Lane Sample 
  1 MWM        4 Eluted peak 3 of Bfr-E18A/M52L 
  2 Eluted peak 1 of Bfr-E18A/M52L    5 Eluted peak 4 of Bfr-E18A/M52L 

































Table A7.8: The calculated molecular weight of each eluted Superose 6 fraction of bFT-
M52L/E94A 
 
bFT-M52L/E94A MW (kDa) log (MW) Ve (mL) Ka 
Peak 1 (aggregates) 35152.3 4.5460 7.8 -0.0125 







Figure A7.17: The SDS PAGE results of Superose 6 eluted fractions of bFT-M52L/E94A.  The 
lists below indicate proteins contained in each eluted fraction. 
 
Lane  Sample 
  1  MWM 
  2  Eluted peak 1 of bFT-M52L/E94A 
  3  Eluted peak 2 of bFT-M52L/E94A 





























Table A7.9: The calculated molecular weight of each eluted Superose 6 fraction of bFT-
E18A/E94A 
 
bFT-E18A/E94A MW (kDa) log (MW) Ve (mL) Ka 
Peak 1 (aggregates) 35152.3 4.5460 7.8 -0.0125 
Peak 2 (aggregates) 1109.8 3.0452 12.7 0.2938 
Peak 3 (24-subunit) 290.6 2.4633 14.6 0.4125 
Peak 4 (monomer) 17.3 1.2383 18.6 0.6625 
































Figure A7.19: The SDS PAGE results of Superose 6 eluted peaks of bFT-E18A/E94A.  The lists 
below indicate proteins contained in each eluted fraction. 
 
Lane     Sample         
  1     MWM          
  2     Eluted peak 1 of bFT-E18A/E94A       
  3     Eluted peak 2 of bFT-E18A/E94A       
  4     Eluted peak 3 of bFT-E18A/E94A 
  5     Eluted peak 4 of bFT-E18A/E94A 


































Table A7.10: The calculated molecular weight of each eluted Superose 6 fraction of bFT-
E18A/M52L/E94A 
 
bFT-E18A/M52L/E94A MW (kDa) log (MW) Ve (mL) Ka 
Peak 1 (aggregates) 1277.9 3.1065 12.5 0.2813 
Peak 2 (24-subunit) 334.6 2.5246 14.4 0.4000 
Peak 3 (monomer) 18.6 1.2689 18.5 0.6563 









Figure A7.21: The SDS PAGE results of Superose 6 eluted fractions of bFT-E18A/M52L/E94A.  
The lists below indicate proteins contained in each eluted fraction. 
 
Lane  Sample 
  1  MWM 
  2  Eluted peak 1 of bFT-E18A/M52L/E94A 
  3  Eluted peak 2 of bFT-E18A/M52L/E94A 
  4  Eluted peak 3 of bFT-E18A/M52L/E94A 
































Figure A7.22: The Superose 6 gel filtration chromatogram of bFT with His6-tag at the C-terminus 




Table A7.11: The calculated molecular weight of each eluted Superose 6 fraction of bFT with 
His6-tag at the C-terminus 
 
Bfr with His6-tag MW (kDa) log (MW) Ve (mL) Ka 
Peak 1 (aggregates) 37723.4 4.5766 7.8 -0.0178 
Peak 2 (24-subunit) 300.2 2.4773 14.8 0.4222 




































Figure A7.23: The SDS PAGE results of Superose 6 eluted fractions of bFT with His6-tag at the 
C-terminus.  The lists below indicate proteins contained in each eluted fraction. 
 
Lane  Sample 
  1  MWM 
  2  Eluted peak 1 of bFT with His6-tag at the C-terminus 
  3  Eluted peak 2 of bFT with His6-tag at the C-terminus 
  4  Eluted peak 3 of bFT with His6-tag at the C-terminus 
40 kDa
18.5 kDa











Appendix 8: Calculation of Extinction Coefficient for Dye Molecules in Pro-
Q® Sapphire 365 Oligohistidine Gel Strain 
 
A series of different dye stain dilutions were scanned for emission intensity between 
400-550 nm (Figure A8.1) and for excitation intensity between 300-400 nm (Figure A8.2).  
The maximum fluorescence intensities at 440 for the emission scan and at 345 nm for the 
excitation scan were collected (Table A8.1).  Graphs of the emission fluorescence intensities 
versus dye concentration and the graph of excitation fluorescence intensity versus dye 
concentration were plotted (Figure A8.3).  Since the slope of this trend line corresponds to 
Beer-Lambert law (A = ε'BC), where A is absorption, B is the cuvette path length (1 cm), C is 
concentration (M), and ε' is the fluorescence extinction coefficient (cm-1M-1), ε' for both 
experiments (excitation scan and emission scan) of Pro-Q® sapphire 365 oligohistidine gel 
stain is calculated to be approximately ~23 000 cm-1M-1.   
Calculations of the extinction coefficient measured by UV-visible spectrophotometer 
were performed in parallel with the one using fluorescence measurements and are shown as 
follows.  By using the Beer-Lambert law (A = ε345BC), the extinction coefficient (ε345) is 







Figure A8.1: The emission spectra scanned between wavelengths 400-550 nm with fixed excitation 




















Figure A8.2: The excitation spectra scanned between wavelengths 300-400 nm with fixed emission 



































































Figure A8.3: The plot of fluorescent intensity of emission wavelength 440 nm and excitation 
wavelength at 345 nm versus % dye concentration.  The slope of the trend lines represents 




Table A8.1: Collected data for emission intensity and excitation intensity of the series of different 
dye stain dilutions.  These data were used for the plot of fluorescence intensity versus dye 






















3.175 82115.0 92042.0 87078.5 84296.0 107973.0 96134.5
6.250 165645.0 164724.0 165184.5 165579.0 157802.0 161690.5
12.500 332857.0 309239.0 321048.0 330376.0 333612.0 331994.0
25.000 710203.0 598118.0 654160.5 659272.0 617396.0 638334.0
50.000 1237826.0 1362989.0 1300407.5 1185799.0 1296792.0 1241295.5
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Figure A8.4: The plots of fluorescent intensity of excitation wavelength at 345 nm versus dye 
concentration compared with that of optical density versus dye concentration showing the slopes 





Table A8.2: Collected data for optical densities of the series of different dye stain dilutions.  These 
data were used for the plot of optical density versus dye concentration as above. 
 




trial 2 Average OD345 
6.25 0.0397 0.0365 0.0381 
12.50 0.0413 0.0424 0.0419 
25.00 0.0849 0.0824 0.0837 
50.00 0.1249 0.1224 0.1237 




Fluorescence intensity  
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Appendix 9: Calculations of Heme Groups Present in Bacterioferritin  
 
 The spectrophotometric absorption of bFT-WT, bFT with His6-tag at the C-terminus, 
and encapsulated bFT with His6-tag at the C-terminus at 417 nm corresponds to the absorption 
of the Soret band of the oxidized heme moiety.  The number of heme groups incorporated in 
each protein sample was calculated using the Beer-Lambert law, A = ε417BC, where A is 
absorption, B is the path length of cuvette (1 cm), C is concentration (M), and ε417 is the 
extinction coefficient measured at 417 nm (M-1cm-1).  The results of the calculation are shown 
in Table A9.1.  An example of bFT-WT heme group calculation is as follows.  The protein 
concentration of 0.42 mg/mL was converted to 97 μM from the calculation using the MW of 
bFT, which is 444 kDa.  From the Beer-Lambert law, A is 0.0686, B is 1 cm, and ε417 is 137 
000 M-1cm-1 per heme per E. coli ferricytochrome protein (Yariv et al., 1981).  Therefore, the 
concentration of heme is 50 μM, and each bFT subunit contains 0.53 heme groups or ~12 heme 
groups per 24 subunits. 
 
Table A9.1: The table represents the number of heme groups incorporated in various bFT 
samples 
 
Samples with 0.42 mg/mL protein concentration  OD417 
Amount of 
heme groups 
Native bFT-WT 0.0686 12 
Native bFT with His6-tag at the C-terminus 0.0602 10 
bFT with His6-tag at the C-terminus with encapsulated dye 0.0740 12 
bFT with His6-tag at the C-terminus after additional 5 hours of 
dialysis time with encapsulated dye 0.0493 9 
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Appendix 10: Calculations of Encapsulated Dye inside Protein Cavity 
 
From the Beer-Lambert law, the concentration of dye molecules encapsulated in the 
protein cavity can be calculated from the equation A = ε345BC, where A is absorbance of the 
dye in Pro-Q® sapphire 365 oligohistidine gel stain measured at 345 nm, B is the cuvette path 
length (1 cm), C is the concentration of dye inserted in the protein core (M), and ε345 is the 
experimental extinction coefficient at 345 nm (23 000 M-1cm-1) (Appendix 8).  With the 
calculated dye concentration and known concentrations of proteins (measured using Bradford 
assay), the number of encapsulated dye molecules for each of the protein samples was 
determined (Table A10.1).  An example of a calculation for the amount of dye encapsulated in 
a combination of 60/40:Histag/WT is as follows.  The concentration of protein was measured 
and shown in section 4.4.3 (Table 4.6), which was 0.672 mg/mL or 1.51 μM (MW of the 
protein is approximately 444 kDa).  The average absorbance measured from duplicated 
experiments at 345 nm is 0.2044.  The concentration of dye is calculated from C = A/εB = 8.9 
μM, where A = 0.2044, B = 1 cm, and ε345 = 23 000 M-1cm-1.  Therefore, the number of dye 
molecules encapsulated inside 1 molecule of protein on average is calculated from the ratio of 
encapsulated dye concentration and protein concentration (~6 molecules).  Since there is only 
60% Histag in this combination protein, so the maximum dye that can be encapsulated is (24 × 
0.6) ~14 dye molecules.  The efficiency of this experiment is ~43%.  The calculations for the 
amount of dye molecules encapsulated in 100% Histag protein is similar, and it is shown that 
there are ~6 encapsulated dye molecules.  The encapsulated dye molecules of this protein are 
maximized when each subunit binds one molecules of dye, which are 24 dye molecules in 
total.  Therefore, efficiency of this encapsulated protein is 25%. 
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Table A10.1: The table shows data for the calculation of encapsulated dye molecules in 100% 





















protein 0.83 0.1053 0.1360 0.1206 5.2 6 
60:40/Histag/WT 





Appendix 11: Metal Analysis of Pro-Q® Sapphire 365 Oligohistidine Gel 
Stain 
 
 The results from metal analysis are shown in Table A11.1.  Calculations of the amount 
of Ni2+ in Pro-Q® sapphire 365 oligohistidine gel stain are as follows.  The average Ni2+ 
concentration from duplicate experiments (ICP-MS) is (1.48 + 1.37) ÷ 2 = 1.425 mg/L.  The 
samples were diluted 5 times before performing metal analysis; therefore, the actual 
concentration of Ni2+ is 1.43 × 5 = 7.15 mg/L or 60.7 μM (molar mass of Ni2+ is 58.69 g/mol).  
Since the concentration of dye molecule in Pro-Q® sapphire 365 oligohistidine gel stain was 
~9.2 μM, the ratio of Ni2+/dye is ~6.6. 
 The high concentration of Na+ is also observed.  The average Na+ concentration is (557 
+ 567) ÷ 2 = 562 mg/L.  With 5 times dilution, the concentration of Na+ becomes (562 × 5) 











Table A11.1: ALS Laboratory Group Analytical Report for metal analysis results representing 























Aluminum (Al) 0.1 <0.1 <0.1 <0.1 
Antimony (Sb) 0.05 <0.05 <0.05 <0.05 
Arsenic (As) 0.01 <0.01 <0.01 <0.01 
Barium (Ba) 0.1 <0.1 <0.1 <0.1 
Berylium (Be) 0.01 <0.01 <0.01 <0.01 
Bismuth (Bi) 0.01 <0.01 <0.01 <0.01 
Boron (B) 0.5 <0.5 <0.5 <0.5 
Cadmium (Cd) 0.001 <0.001 <0.001 <0.001 
Calcium (Ca) 5 <5 <5 <5 
Chromium (Cr) 0.01 <0.01 <0.01 <0.01 
Cobalt (Co) 0.005 <0.005 <0.005 <0.005 
Copper (Cu) 0.01 <0.01 <0.01 <0.01 
Iron (Fe) 0.5 <0.5 <0.5 <0.5 
Lead (Pb) 0.01 <0.01 <0.01 <0.01 
Magnesium (Mg) 5 <5 <5 <5 
Manganese (Mn) 0.01 <0.01 <0.01 <0.01 
Molybdenum (Mo) 0.01 <0.01 <0.01 <0.01 
Nickel (Ni) 0.02 1.48 1.37 <0.02 
Phosphorus (P) 0.5 0.6 0.5 <0.5 
Potassium (K) 10 <10 <10 <10 
Selenium (Se) 0.05 <0.05 <0.05 <0.05 
Silicon (Si) 1 <1 <1 <1 
Silver (Ag) 0.001 <0.001 <0.001 <0.001 
Sodium (Na) 5 557 567 <5 
Strontium (Sr) 0.01 <0.01 <0.01 <0.01 
Thallium (Tl) 0.003 <0.003 <0.003 <0.003 
Tin (Sn) 0.01 <0.01 <0.01 <0.01 
Titanium (Ti) 0.02 <0.02 <0.02 <0.02 
Tungsten (W) 0.1 <0.1 <0.1 <0.1 
Uranium (U) 0.05 <0.05 <0.05 <0.05 
Vanadium (V) 0.01 0.02 0.02 0.02 
Zinc (Zn) 0.03 <0.03 <0.03 <0.03 
Zirconium (Zr) 0.04 <0.04 <0.04 <0.04 
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Appendix 12: Metal Analysis of Iron Ions Incorporated in 24-Subunit 
Bacterioferritin  
 
The results from metal analysis are shown in Table A12.1, where the metal detection 
was found in 24-subunit bFT with His6-tag at the C-terminus (0.50 mg/mL), which was 


















Table A12.1: ALS Laboratory Group Analytical Report for metal analysis results representing 
the metal detection in 24-subunit bFT with His6-tag at the C-terminus (two trials sample) and 






















Aluminum (Al) 0.1 <0.1 <0.1 <0.1 
Antimony (Sb) 0.05 <0.05 <0.05 <0.05 
Arsenic (As) 0.01 <0.01 <0.01 <0.01 
Barium (Ba) 0.1 <0.1 <0.1 <0.1 
Berylium (Be) 0.01 <0.01 <0.01 <0.01 
Bismuth (Bi) 0.01 <0.01 <0.01 <0.01 
Boron (B) 0.5 <0.5 <0.5 <0.5 
Cadmium (Cd) 0.001 0.002 0.002 0.002 
Calcium (Ca) 5 <5 <5 <5 
Chromium (Cr) 0.01 <0.01 <0.01 <0.01 
Cobalt (Co) 0.005 <0.005 <0.005 <0.005 
Copper (Cu) 0.01 <0.01 0.01 <0.01 
Iron (Fe) 0.5 <0.5 <0.5 <0.5 
Lead (Pb) 0.01 0.04 0.04 0.03 
Magnesium (Mg) 5 <5 <5 <5 
Manganese (Mn) 0.01 0.02 <0.01 <0.01 
Molybdenum (Mo) 0.01 <0.01 <0.01 <0.01 
Nickel (Ni) 0.02 <0.02 <0.02 <0.02 
Phosphorus (P) 0.5 <0.5 <0.5 <0.5 
Potassium (K) 10 20 20 20 
Selenium (Se) 0.05 <0.05 <0.05 <0.05 
Silicon (Si) 1 <1 <1 <1 
Silver (Ag) 0.001 <0.001 <0.001 <0.001 
Sodium (Na) 5 15 15 <5 
Strontium (Sr) 0.01 0.01 <0.01 <0.01 
Thallium (Tl) 0.003 <0.003 <0.003 <0.003 
Tin (Sn) 0.01 <0.01 <0.01 <0.01 
Titanium (Ti) 0.02 <0.02 <0.02 <0.02 
Tungsten (W) 0.1 <0.1 <0.1 <0.1 
Uranium (U) 0.05 <0.05 <0.05 <0.05 
Vanadium (V) 0.01 <0.01 <0.01 <0.01 
Zinc (Zn) 0.03 0.19 0.2 <0.03 
Zirconium (Zr) 0.04 <0.04 <0.04 <0.04 
Sulfur (S) 10 20 20 <10 
 
